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ABSTRACT 
Daniel Copley Schmitt 
Complexity-Building Transformations of Silyl Glyoxylates 
(Under the direction of Jeffrey S. Johnson) 
 
Silyl glyoxylates are reagents used for the geminal difunctionalization of a 
glycolic acid junction with nucleophilic and electrophilic species.  The research 
summarized herein describes the development of new reactions that utilize silyl 
glyoxylates to generate multiple CC bonds and stereogenic centers.  Significant results 
include: (1) completion of the synthesis of (+)-zaragozic acid C; (2) development of a 
tandem Brook/Ireland Claisen rearrangement for the synthesis of functionalized ,-
unsaturated glycolic acids; (3) development of a nitrile-oxide cycloaddition for the 
synthesis of 3,4-disubstituted isoxazoles; (4) development of a three component glycolate 
Michael reaction; (5) application of the glycolate Michael reaction to the synthesis of (+)-
trachyspic acid dimethyl ester. 
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 CHAPTER 1 
TOTAL SYNTHESIS OF ZARAGOZIC ACID C 
1.1 Introduction 
1.1.1 Reactivity of Silyl Glyoxylates 
Complex molecule synthesis continues to be revolutionized by the development 
of cascade sequences.  Chemical reactions that generate multiple CC bonds in a single 
operation are valuable transformations as they reduce overall step count, providing time 
and cost effective alternatives to multistep routes.
1
  Silyl glyoxylate 1, an easily 
accessible reagent developed in our group, has been utilized in such cascade reactions 
(Scheme 1-1).
2,3
  Reagent design hinges on a nucleophile-triggered [1,2]-Brook 
rearrangement (2 → 3) to achieve umpolung reactivity at what was the carbonyl carbon.4  
Trapping the nascent carbanion (enolate, 3) with an electrophile provides the 2,2-
difunctionalized product 4.  Thus, the silyl glyoxylate serves as a useful conjunctive 
reagent for the one-pot, geminal grafting of both nucleophilic (organometallic species, 
enolates, and hydride sources) and electrophilic (carbonyl compounds and Michael 
acceptors) species to a glycolic acid framework.   
2 
 
Scheme 1-1. General Reaction Scheme Involving Silyl Glyoxylates 
 
 To date, several three component coupling reactions have been developed that 
rely on silyl glyoxylate to provide molecular complexity from simple, achiral building 
blocks.  Examples of compatible reactants include zinc acetylides or Grignard reagents 
with aldehydes (a and b, Scheme 1-2),
2
 vinyl Grignard reagent with nitroolefins (c),
3
 and 
Reformatsky reagents with ketones (d).
5
 
Scheme 1-2. Effective Nucleophile/Electrophile Pairs 
 
The glycolate subunit can be found in several biologically active natural products 
and therapeutics (Figure 1-1).
6-11
  While many elegant syntheses of these bioactive 
glycolates have been completed, none had the strategic benefit engendered by the silyl 
glyoxylate.  Its ability to undergo geminal difunctionalization allows facile access to 
challenging targets, with minimal refunctionalization or oxidation state modification.  No 
other general synthetic tactic is known which is applicable to such an abundance of 
stereochemically-dense, glycolic acid-containing molecules.  
3 
 
Figure 1-1. The Glycolic Acid Subunit in Biologically-Active Compounds 
 
1.1.2 The Zaragozic Acids 
 The zaragozic acids and the squalestatins constitute a class of squalene synthase 
inhibitors isolated from various fungal strains in 1991.
12
  In mammals, squalene synthase 
is responsible for the biosynthesis of cholesterol; therefore, the zaragozic acids have 
potential as pharmaceutical agents for the treatment of hypercholesterolemia.
9
 
Structurally, the zaragozic acids all contain a densely functionalized 2,8-
dioxabicyclo[3.2.1]octane core, and are differentiated by their C1-alkyl and C6-acyl 
sidechains (Figure 1-2). 
 
 
 
 
 
 
 
 
4 
 
Figure 1-2. Zaragozic Acid Structure 
 
 Due to their biological activity and novel structure, the zaragozic acids have 
attracted significant attention from the synthetic community.  The six contiguous chiral 
centers of the core constitute the principal obstacle to synthesis, and have inspired many 
unique solutions.
13-29
  The first synthesis of zaragozic acid C was completed by Carreira 
and Du Bois in 1994, requiring 32 linear steps from commercially available starting 
materials.
14
  Prior to our work, the shortest route to zaragozic acid C was reported by the 
Evans group, involving 23 linear steps from D-tartaric acid.
18
  Notably, all prior 
approaches to the zaragozic acids rely on multistep alterations in functionality and 
oxidation state.  In contrast, we aimed to achieve a “self-consistent synthesis”, defined by 
Hendrickson as a sequence of constructions not requiring any intervening 
refunctionalizations.
30
 
1.1.3 Retrosynthetic Analysis and Multicomponent Coupling 
 What we found striking about zaragozic acid C was that the global complexity 
masks an elementary composition of simple building blocks.  Analysis of the C1-C7 
5 
 
bicyclic ketal by deconstruction into simple synthons reveals a repeating series of 
glycolic acid fragments (Scheme 1-3).  Because silyl glyoxylates serve as geminal dipolar 
glycolic acid synthons, a trimerization of glycolic acid units represents a reasonable 
synthetic approach to the zaragozic acid core.   
Scheme 1-3. Retrosynthetic Plan Incorporating Geminal Diaddition 
 
 David Nicewicz tested the hypothesis that enchainment of multiple equivalents of 
silyl glyoxylate could assemble most of the zaragozic acid skeleton in one step.  
Nicewicz found that the addition of one equivalent of vinyl Grignard reagent to two 
equivalents of 1a at -78 °C initiated the oligomerization process (Scheme 1-4).  In the 
absence of an alternative secondary electrophile, the glycolate enolate intermediate 9 
reacted with a second equivalent of silyl glyoxylate, which underwent Brook 
rearrangement prior to termination of the oligomerization sequence by addition of t-butyl 
glyoxylate.  The multicomponent coupling provided -hydroxy ester 12 with >10:1 d.r. 
and up to 50% yield.  The major byproduct resulted from vinylogous addition and 
subsequent enchainment of a third equivalent of silyl glyoxylate to provide enolsilane 13.  
This polyaddition reaction introduces the C3-C6 framework in one step with correct 
establishment of the relative stereochemistry at the most challenging sites: C4 and C5.   
6 
 
Scheme 1-4. Multicomponent Coupling 
 
1.2 Total Synthesis of Zaragozic Acid C 
1.2.1 Completion of the Dioxabicyclo[3.2.1]octane Core 
Racemic hydroxy ester 12 was subjected to oxidative kinetic resolution providing 
()-12 in 90% ee (Scheme 1-5).31 The C3 alcohol was acylated with benzyloxyacetyl 
chloride to provide glycolate ester 14.  Subsequent ozonolysis of the terminal olefin 
revealed the C6 aldehyde.  Kinetic enolization with LDA induced an intramolecular 
glycolate aldol addition to afford 16 after TMSCl trapping of the aldolate.  The aldol 
reaction created the C6 and C7 stereogenic centers, where C6 was generated with 
undesired stereochemistry.  This result can be rationalized by the closed transition state 
15, wherein the C6 aldehyde, the C7 OBn, and the C1 enolate chelate to the Li 
counterion.  -Lactone 16 possesses the full carbon skeleton of the zaragozic acid core, 
obtained in 5 steps from silyl glyoxylate 1a. 
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Scheme 1-5. Synthesis of C1-C7 -Lactone 
 
The C1 alkyl sidechain was introduced by means of a nucleophilic addition of the 
organolithium 17 to lactone 16 (Scheme 1-6).  Treatment of the resulting ketol/lactol 
mixture with TsOH induced the desired ketalization onto C1; however, a -lactone was 
also formed, likely as a consequence of the incorrect stereochemistry at C3 and C6.   
Scheme 1-6. Tricyclic Ketalization 
 
The undesired -lactone ultimately served as a means to correct the C6 
stereochemistry; treatment of tricycle 19 with KO
t
Bu in 
t
BuOH at room temperature 
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resulted in lactone opening as well as epimerization of C6.  The mechanism (Scheme 1-7) 
of this fortuitous transformation may be initiated by alkoxide addition to the C3 lactone 
(not shown) or deprotonation of the C3 lactone with subsequent ketene formation.  The 
resulting C6 alkoxide could trigger a retro-aldol fragmentation of the C5-C6 bond, 
producing a C6 aldehyde and a C5 glycolate enolate.  Rotation of the C6 aldehyde, 
followed by aldol closure of the C5-C6 bond would result in the observed stereochemical 
correction.  If C3 ketene formation is involved, aqueous workup would result in C3 
carboxylic acid formation.  t-Butyl esterification was then performed on the crude 
mixture to provide triester 21.  Notably, this transformation was only possible because 
the zaragozic acid core had been assembled in the correct oxidation state from the outset 
of the synthesis. 
Scheme 1-7. Proposed Mechanism of C6 Stereochemical Correction 
 
 Although this protocol achieved two necessary transformations (lactone opening 
and C6 epimerization), the yield was only 22%.  Before graduating, Nicewicz found that 
the zaragozic acid core could be completed by inversion of C3 with NaOMe; the only 
remaining transformations for completion of the synthesis included installation of the C6 
sidechain and deprotections.  In collaboration with Andrew Satterfield, efforts 
commenced to finish the synthesis, starting with optimization of the lactone opening.   
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Initial efforts involved attempts to reductively cleave the lactone, which could 
likely be reoxidized to the carboxylic acid.  NaBH4 and DIBAL both selectively reduced 
methyl esters in preference to the lactone.  Borane reducing agents proved to be 
unreactive.  We next investigated conversion of the lactone to a cleavable vinyl ether, 
with the expectation that the additional carbon atom could be removed through a 
haloform reaction.  However, both Tebbe and Petasis reagents provided only unreacted 
starting material when exposed to lactone tricycle 19.   
 Efforts then shifted back to optimization of the originally developed conditions of 
KO
t
Bu in 
t
BuOH, using model system 19b.  A major byproduct of this protocol resulted 
from transesterification of the methyl esters to t-butyl esters without lactone opening 
(19c, Scheme 1-8).   Resubjection of this transesterified tricycle to the reaction conditions 
resulted in increased yields of the C6-corrected triester 21b.  Noting that sterically 
hindered esters underwent cleaner lactone opening, we attempted to saponify the methyl 
esters of 19b and then re-esterify them to bulkier esters.  Evaluation of various 
saponification conditions led to the unexpected finding that KO
t
Bu in t-amyl alcohol at 
35 °C induced rapid saponification and lactone opening.  Treatment of the crude mixture 
with isourea 22 provided C6-epimerized triester 21 in synthetically useful yield (b, 
Scheme 1-8).  Subsequently, treatment with the previously developed conditions of 
NaOMe in MeOH resulted in correction of the C3 stereocenter as well as unanticipated 
saponification to the tricarboxylic acid.  This unwanted hydrolysis necessitated re-
esterification with isourea 22, furnishing triester 23. 
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Scheme 1-8. Inversion of C6 and C3 
 
1.2.2 Completion of (+)-Zaragozic Acid C 
 With a scalable route developed for the synthesis of the dioxabicyclooctane core, 
we shifted our focus towards the completion of zaragozic acid C.  The C6 hydroxyl was 
the sole unprotected secondary alcohol at this stage, providing an opportunity to install 
the C6 acyl sidechain.  However, completion of the synthesis would require deprotection 
of the benzyl ethers, which would likely involve a process incompatible with the olefin of 
the C6 sidechain.  Alternative benzyl deprotection conditions were tested on simplified 
substrate 24b (Scheme 1-9).  After a variety of conditions failed to cleanly deprotect the 
C7 benzyl ether of model substrate 24b, photoirradiation in conjunction with DDQ 
provided the desired transformation in high yield.
32,33
 When the same procedure was 
repeated on olefin 24c, decomposition resulted.  As we were unable to deprotect the 
benzyl ethers in the presence of the C6 sidechain, we sought an alternative completion 
strategy. 
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Scheme 1-9. Benzyl Deprotection Incompatible with Olefin 
 
 The Carreira synthesis of zaragozic acid C utilizes a series of remarkably selective 
late-stage modifications that effectively distinguish the three secondary alcohols at C4’, 
C6, and C7.
13
  Deprotection of the benzyl ethers of bicyclic ketal 23, followed by 
triacetylation of C4’, C6, and C7 provided Carreira’s triacetate 26 (Scheme 1-10).  At this 
point, we utilized the Carreira protocol for completion of the synthesis, first involving 
selective deprotection of the C6 and C7 acetates.  Presumably, this was possible due to 
their elevated electrophilicity relative to the C4’ sidechain acetate, owing to inductive 
effects of the highly-oxygenated core.  Differentiation of the C6 and C7 alcohols was 
performed by selective O-Boc protection of the C7 hydroxyl group, which Carreira and 
Du Bois found to be more reactive than the C6-OH in their model studies on derivatives 
of zaragozic acid A.  Subsequent DCC coupling with the C6 acyl sidechain and treatment 
with TFA completed the synthesis of (+)-zaragozic acid C.
34
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Scheme 1-10. Completion of Zaragozic Acid C 
 
 The synthesis of zaragozic acid C was completed in 18 linear steps, constituting 
the shortest synthesis to date.  This was made possible by the rapid buildup of molecular 
complexity engendered by the silyl glyoxylate multicomponent reaction.  Furthermore, 
the brevity of the sequence is also due in part to its “self-consistent” nature, as there was 
only one oxidation state modification throughout the synthesis (C6 ozonolysis).   
1.3 Efforts Toward a Second-Generation Synthesis 
1.3.1 Retrosynthesis Involving a C6 Electrophile 
 Although our completed synthesis constituted a concise route to zaragozic acid C, 
we postulated that a shorter synthesis was possible. This premise was based on the 
stereochemical outcome of the multicomponent coupling step (Scheme 1-11).  The first 
generation synthesis utilized two equivalents of silyl glyoxylate to serve as the C4 and C5 
glycolic acid units and t-butyl glyoxylate to serve as the C3 glycolic acid.  Since the C3 
stereocenter is created with undesired relative stereochemistry, multiple correction steps 
were required.  We noticed that the enantiomeric multicomponent coupling product (+)-
12 would provide the correct stereochemistry at C6. 
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Scheme 1-11. Stereochemistry of Multicomponent Coupling 
 
Another improvement would be to utilize an alternative terminal electrophile that 
would facilitate manipulation of C7 and C1 (an ,-unsaturated aldehyde).  To this end, 
the cascade reaction was tested with cinnamaldehyde as the terminal electrophile, which 
provided the multicomponent coupling product in usable 40% yield and >10:1 d.r. with 
correct C6 stereochemistry.  At this juncture, we had established the feasibility of 
assembling C4-C6 in one step with correct stereochemistry; however, we recognized that 
the use of vinyl Grignard reagent as the nucleophilic initiator would necessitate 
substantial modification for the installation of C3 functionality.  The ideal C3 nucleophile 
would be prefunctionalized, initiate silyl glyoxylate dimerization, and generate C3, C4, 
C5, and C6 with proper relative stereochemistry.   
Based on this idealized assembly, a revised retrosynthesis was considered.  
Zaragozic acid C could potentially be accessed by 1,4-reduction and ketalization of enone 
28.  Enone 28 could be accessed by allylic oxidation and cross metathesis from allylic 
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alcohol 29.  Triol 29 could be prepared by asymmetric dihydroxylation and Lindlar 
reduction of cascade product 30.  This direct route hinged on the identification of a 
proper nucleophilic cascade trigger to constitute C3. 
Scheme 1-12. Second-Generation Retrosynthesis of Zaragozic Acid C 
 
1.3.2 MPV-Initiated Multicomponent Couplings 
We considered the Meerwein-Ponndorf-Verley (MPV) reduction/aldol sequence 
developed by former group members Xin Linghu and Andrew Satterfield (eq. 1, Scheme 
1-13) as a potential solution to the C3 nucleophile problem.
35
  Mechanistically, the 
reaction is proposed to involve Oppenauer oxidation of a magnesium alkoxide 
(generating aldehyde 31), with concurrent MPV reduction of silyl glyoxylate (generating 
magnesium alkoxide 32).  Subsequent Brook rearrangement generates a glycolate 
enolate, which undergoes aldol coupling with the aldehyde 31 that was generated in situ 
from the alkoxide. 
Scheme 1-13. Aldol Triggered by Oppenauer Oxidation/MPV Reduction 
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We hypothesized that employing a sterically hindered secondary magnesium 
alkoxide 33 would permit MPV reduction of the silyl glyoxylate, and would induce aldol 
addition to a second equivalent of silyl glyoxylate in preference to the sterically hindered 
ketone 34 (Scheme 1-14).  After addition to a second equivalent of silyl glyoxylate 1a 
and subsequent Brook rearrangement, enchainment of a third silyl glyoxylate unit would 
be possible.  Finally, a third Brook rearrangement and aldol addition to the terminal 
electrophile (aldehyde 35) would provide multicomponent coupling product 30.   
Scheme 1-14. Proposed MPV-Initiated Multicomponent Coupling 
 
 Chemoselectivity could potentially be controlled by stoichiometry and order of 
reagent addition, but the reaction would need to provide adequate stereoselectivity to be 
useful.  The proposed coupling would install four contiguous stereocenters (C3-C6); 
while a relevant model for proper establishment of C3 relative stereochemistry was 
lacking, C4-C6 would preferably be formed with analogous stereochemistry to the parent 
vinyl Grignard-initiated coupling.  
Initial experiments employed hindered magnesium alkoxide 33b, three 
equivalents of silyl glyoxylate 1a, and cinnamaldehyde as a model ,-unsaturated 
aldehyde.  Reactions where the silyl glyoxylate and the alkoxide were warmed to rt prior 
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to addition of cinnamaldehyde resulted in uncontrolled silyl glyoxylate oligomerization 
(entries 1-2, Table 1-1).  This indicated that the magnesium alkoxide was effectively 
inducing MPV reduction of the silyl glyoxylate, and the resulting hindered ketone was 
not undergoing undesired aldol coupling.  In an effort to control the degree of 
oligomerization, the hindered alkoxide 33b and the silyl glyoxylate were stirred at -50 °C 
prior to addition of cinnamaldehyde (entry 3).  The product, 38, resulted from MPV 
reduction, Brook rearrangement, and addition to cinnamaldehyde.  Since only one silyl 
glyoxylate was incorporated, we next increased the temperature prior to addition of 
cinnamaldehyde.  Dimerization/aldol product 39 was obtained when the reaction was 
warmed to 0 °C (entry 4).  Attempts to incorporate the third silyl glyoxylate unit by 
holding at -10 °C for extended periods resulted in mixtures of uncontrolled 
oligomerization products 37 (entry 5).  Another attempt (not shown) involved sequential 
introduction of two equivalents of TBS silyl glyoxylate 1a, followed by one equivalent of 
trimethylsilyl glyoxylate.  Despite the reduced hindrance of trimethylsilyl glyoxylate, the 
third silyl glyoxylate was not incorporated. 
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Table 1-1. Influence of Temperature on MPV-Initiated Cascade 
 
entry temperature 1 temperature 2 major product 
1 rt rt 37 
2 -78 °C to rt -78 °C 37 
3 -50 °C -50 °C 38 
4 -78 to 0 °C -78 °C 39 
5 -78 to -10 °C (5 h) -78 °C 37 
 
 Due to the challenges associated with controlling the degree of oligomerization, 
we next investigated an intramolecular cascade using tethered silyl glyoxylates.  The first 
objective was to synthesize a compound comprised of three silyl glyoxylate units.  
Previous studies in our group had revealed that t-butyl silyl glyoxylate could be cleanly 
modified to the silyl glyoxylic acid by treatment with TFA (Table 1-2, 1a → 43).  
Subsequent triesterification of glycerol with the silyl glyoxylic acid 43 under either 
Mukaiyama
36
 or DCC conditions was unsuccessful, as acylsilane decomposition occurred 
in each case.  Conversion of the silyl glyoxylic acid to the acid chloride was also 
unsuccessful using oxalyl or thionyl chloride.   
 We next tried using the silyl glyoxylic acid as a nucleophile to displace a benzylic 
halide leaving group.  p-Azido benzyl bromide 42 was employed as the electrophile, due 
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to its potential for elaboration under mild conditions via Huisgen cycloaddition.
37
  Initial 
nucleophilic esterification attempts resulted in poor yields (Table 1-2).  However, heating 
the reaction to reflux (1:1 CH2Cl2:Et2O) resulted in 55% yield of the benzylic ester 44 
(entry 5).   
Table 1-2. Optimization of Nucleophilic Esterification
 
entry     equiv NBu4I     equiv 42   T (°C)    isolated yield 
1 0.01 1.5 0 to rt 15% 
2 0.01 3.0 0 to rt 12% 
3 0.01 1.5 -78 to rt <5% 
4 0.01 1.5 rt 14% 
5 0.01 1.5 reflux 55% 
6 0 1.5 reflux 0% 
  
 Having developed a scalable route to the azide-containing silyl glyoxylate 44, we 
next prepared a triyne for a triple azide/alkyne [3+2] reaction.  Glycerol was selected as a 
readily available triyne precursor; treatment with propargyl bromide and NaH afforded 
triyne 45.  Subsequent triple Huisgen cycloaddition provided tethered silyl glyoxylate 46. 
Scheme 1-15. Preparation of Tethered Silyl Glyoxylate for Intramolecular Cascade  
 
19 
 
 Attempts to induce the MPV-initiated intramolecular coupling were met with no 
success.  In order to initiate any reactivity, four equivalents of magnesium alkoxide 33b 
were required.  This may have been due to coordination of the three triazole moieties to 
the first three equivalents of magnesium, which would presumably inhibit formation of 
the six-membered transition state necessary for Oppenauer oxidation/MPV reduction.  
Nonetheless, using four or more equivalents of the hydride source caused decomposition 
to occur in each case.  The products could not be identified, but may have resulted from 
multiple MPV reductions of tri-silyl glyoxylate 46.  In some cases, attack of the terminal 
electrophile (cinnamaldehyde) occurred, but the desired coupling product was never 
isolated.   
 In order to be successful, the MPV/double intramolecular aldol/intermolecular 
aldol cascade will likely require a different tether.  Intramolecular silyl glyoxylate 
coupling with triazole 46 would have required formation of two large rings; a more 
feasible coupling would involve the closure of smaller rings.  In an effort to generate a 
smaller and more rigid tether, esterification of dibromide 47 was performed (Scheme 1-
16).  Due to the low yield of formation of di-silyl glyoxylate 48, we did not attempt 
analogous triesterification.  In an effort to simplify the multicomponent coupling, we next 
considered prefunctionalization of the initial nucleophile.   
Scheme 1-16. Nucleophilic Esterification of a Benzylic Dibromide 
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1.3.3 Enolate-Initiated Multicomponent Couplings 
 Evans’ synthesis of zaragozic acid C established the C4C5 bond via an aldol 
reaction between tartrate silyl ketene acetal 49 and aldehyde 50 (Scheme 1-17).
18
  The 
high stereoselectivity at C4 is believed to result from approach of the aldehyde from the 
less hindered face of the tartrate ketal.  We hypothesized that a prefunctionalized 
nucleophilic initiator, such as 49, would reduce the number of components necessary in 
the multicomponent coupling.   
Scheme 1-17. Known Stereoselective Aldol with Tartrate Enolate 
 
 A three component coupling of a protected tartrate enolate (C3 and C4), a silyl 
glyoxylate (C5), and an aldehyde (C6) could provide the majority of the zaragozic acid 
core (Scheme 1-18).  Ideally, the C6 aldehyde 52 would be oxygenated at both the - 
(C7) and - (C1) positions, and possess an alkene for installation of the C1 sidechain via 
cross metathesis.  However, for test reactions, benzaldehyde was used. 
Scheme 1-18. Proposed Three Component Coupling with Tartrate Enolate 
 
 A series of protected tartaric acid derivatives were prepared.  After direct t-butyl 
esterification of ()-tartaric acid failed to proceed cleanly, ketals 49 and 49c were 
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prepared according to the Evans procedure: ()-tartaric acid was acylated with 
chloroacetyl chloride and esterified with condensed isobutylene to furnish tetra-ester 
54.
18
  Deprotection of the secondary alcohols and ketalization with 1,1-dimethoxy 
cyclopentane provided ketal 49c.  Enolization and TMS trapping provided silyl ketene 
acetal 49.  Additionally, furan 49d was prepared with the expectation that the 2-furyl 
substituent could be ozonolyzed to reveal a carboxylic acid later in the synthesis.
38
 
Beginning with commercially available 3-(2-furyl)acrylic acid 55, furan 49d was 
synthesized via an esterification, asymmetric dihydroxylation, and ketalization 
sequence.
39
 
Scheme 1-19. Synthesis of t-Butyl Tartrate Derivatives 
 
Cyclopentyl ketal 49c was used in initial experiments.  Stirring ketal 49c with LiHMDS, 
followed by sequential addition of silyl glyoxylate and finally benzaldehyde, surprisingly 
resulted in recovery of ketal 49c (entry 1, Table 1-3).  In an effort to ensure the reactivity 
of the tartrate enolate, a simple aldol reaction was attempted with benzaldehyde (entry 2).  
Although the reaction was warmed to room temperature in an effort to increase 
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conversion, the unreacted tartrate ketal 49c was the sole identifiable product.  Based on 
this result, we postulated that a retro-aldol reaction was occurring at elevated 
temperatures, regenerating ketal 49c.  However, holding the temperature at -78 °C for the 
duration of the reaction still resulted in no conversion of ketal 49c.  We reasoned that 
enolate formation was a problem, so silyl ketene acetal 49 was prepared.  Using a 
modification of the Evans conditions (entry 4), alcohol 57 was obtained; this product may 
be formed by MPV reduction of the silyl glyoxylate by TiCl3(O
i
Pr)3, with no subsequent 
Brook rearrangement (Si migration may be blocked by the OTi bond).  In effort to 
generate the magnesium tartrate enolate, silyl ketene acetal 49 was reacted with 
tetrabutylammonium difluorotriphenylsilicate (TBAT) (entry 5).  However, this only 
resulted in regeneration of diester 49c.     
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Table 1-3.  Tartrate Enolate Initiated Three Component Coupling Attempts 
 
entry conditions major product 
1 49c; LiHMDS; 1a; PhCHO (-78 °C to rt)   49c 
2 49c; LiHMDS; PhCHO (rt) 49c 
3 49c; LiHMDS; PhCHO (-78 °C) 49c 
4 49; TiCl3(O
i
Pr); MgBr2; 1a; PhCHO (-78 °C to rt)   
 
5 49; MgBr2 + TBAT; 1a; PhCHO (-78 °C to rt)   49c 
6 49d; LDA; 1a; PhCHO (-78 °C to rt)   
 
7 49d; LDA; PhCHO + 1a (-78 °C to rt)   
 
8 49e; LDA; 1a; PhCHO (-78 °C to rt)   49e 
 
We sought to further simplify the proposed reaction by employing a C3-C4 
nucleophile with only one enolizable site.  Reaction of furan 49d sequentially with LDA, 
silyl glyoxylate 1a, and benzaldehyde resulted in the first observation of addition to the 
silyl glyoxylate, although the terminal electrophile was not incorporated (entry 6, Table 
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1-3).  Simultaneous addition of benzaldehyde and silyl glyoxylate to a solution of the 
enolate of 49d resulted in formation of three component coupling product 59 (entry 7).  
Initially, this product was believed to be the desired C3-C6 coupling product, as the 
product’s mass and 1H NMR spectrum appeared to be correct.   
Further analysis confirmed incorrect connectivity: (1) the IR spectrum revealed no 
OH stretch, and (2) no exchangeable protons were revealed by 
1
H NMR after stirring 
with D2O.  Additionally, preparation of 59 was possible by treatment of alcohol 60 with 
LDA and silyl glyoxylate (Scheme 1-20).  This indicated that the three component 
product resulted from an aldol reaction between the enolate of 49d and benzaldehyde, 
then alkoxide addition to silyl glyoxylate, Brook rearrangement, and a proton quench.  
We then conjectured that a less hindered tartrate enolate would be necessary, and 
prepared the formaldehyde acetal of diethyl tartrate.
40
  However, treatment of 49e with 
LDA, silyl glyoxylate, and benzaldehyde resulted in low conversion (entry 8).   
Scheme 1-20. Determination of the Connectivity of Three Component Product 59 
 
 Due to the difficulties associated with the tartrate enolate initiated couplings, we 
considered an alternative approach.  Rather than employing the silyl glyoxylate to link 
nucleophilic and electrophilic fragments, we investigated an umpolung coupling between 
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an aldehyde (C6) and ketoester 62 (C3-C5) (Scheme 1-21).  In the proposed reaction, a 
silyl lithium reagent would add to the ketone of 62 and induce Brook rearrangement to 
form enolate 63.  Aldol reaction between enolate 63 and a C6 aldehyde would provide the 
desired C5-C6 bond. 
Scheme 1-21. Umpolung C5-C6 Strategy 
 
 Ketoester 62 was prepared by means of an aldol reaction of furan 49d with ethyl 
glyoxylate followed by Dess-Martin oxidation.  Treatment of ketoester 62 with 
LiSiMe2Ph followed by isobutyraldehyde did not result in any of the desired coupling 
product; instead, retro-Claisen fragmentation product 49d was formed (eq. 1, Scheme 1-
22).  Addition of LiSiMe2Ph to a premixed solution of ketoester 62 and isobutyraldehyde 
resulted in poor chemoselectivity for silyl lithium addition (eq. 2, Scheme 1-22).  Disilyl 
zinc nucleophiles were also evaluated without success.  Based on the experimental 
observations, the creation of the C4-C5 bond or the C5-C6 bond will be challenging due 
to a combination of steric demand and the reversibility of each bond construction.   
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Scheme 1-22. Attempted Couplings of Ketoester with Isobutyraldehyde. 
 
 
1.4 Conclusion 
 In summary, a silyl glyoxylate cascade reaction allowed for the synthesis of (+)-
zaragozic acid C in 18 linear steps.  In addition to the multicomponent coupling, key 
steps included an intramolecular aldol reaction, and a one-pot lactone opening/retro-
aldol/aldol sequence.  The minimization of redox chemistry contributed to both the 
conciseness of the synthesis and to the unexpected solution for correction of C6 
stereochemistry.  This work further highlights the utility of silyl glyoxylates as geminal 
dipolar glycolic acid synthons. 
 In an effort to complete a shorter, second generation synthesis, various 
approaches were investigated.  A silyl glyoxylate trimerization/aldol cascade initiated by 
MPV reduction was explored, but the degree of oligomerization was difficult to control.  
Three component couplings between a tartrate-derived enolate, silyl glyoxylate, and an 
aldehyde resulted in low conversions, which was likely due to steric hindrance.  We are 
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still interested in an improved synthesis of the zaragozic acids, and the development of 
new cascade reactions is ongoing. 
1.5 Experimental 
Materials and Methods: General.  Infrared (IR) spectra were obtained using a Nicolet 
560-E.S.P. infrared spectrometer.  Proton and carbon nuclear magnetic resonance spectra 
(
1
H and 
13
C NMR) were recorded on either a Bruker model Avance 500 (
1
H at 500 MHz 
and 
13
C NMR at 125 MHz), Bruker model Avance 400 (
1
H NMR at 400 MHz and 
13
C 
NMR at 100 MHz), or a Varian Gemini 300 (
1
H NMR at 300 MHz and 
13
C at 75 MHz) 
spectrometer with solvent resonance as the internal standard (
1
H NMR: CDCl3 at 7.23 
ppm; C6D6 at 7.15 ppm and 
13
C NMR: CDCl3 at 77.0 ppm and C6D6 at 128.62 ppm).  
1
H 
NMR data are reported as follows: chemical shift, multiplicity (s = singlet, br s = broad 
singlet, d = doublet, t = triplet, q = quartet, sept = septet, m = multiplet), coupling 
constants (Hz), and integration.  Enantiomeric excesses were obtained using a Berger 
Supercritical Fluid Chromatograph model FCM 1100/1200 equipped with an Agilent 
1100 series UV-Vis detector using a Chiralcel Chiralpak AS HPLC column. Samples 
were eluted with SFC grade CO2 at the indicated percentage of MeOH.  Combustion 
analyses were performed by Atlantic Microlab Inc., Norcross, GA.  Analytical thin layer 
chromatography (TLC) was performed on Whatman 0.25 mm silica gel 60 plates.  
Visualization was accomplished with UV light and aqueous ceric ammonium molybdate 
solution followed by heating.  Purification of the reaction products was carried out by 
flash chromatography using Sorbent Technologies silica gel 60 (32-63 µm).  All reactions 
were carried out under an atmosphere of nitrogen in oven-dried glassware with magnetic 
stirring.  Yield refers to isolated yield of analytically pure material.  Yields are reported 
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for a specific experiment and as a result may differ slightly from those found in the 
figures, which are averages of at least two experiments.  Diethyl ether, tetrahydrofuran, 
and toluene were dried by passage through a column of neutral alumina under nitrogen 
prior to use. Unless otherwise noted, reagents were obtained from commercial sources 
and used without further purification.  Triethylamine was freshly distilled from CaH2 
under Ar prior to use.  Side chains 53 and 30 were prepared according to the literature 
procedure.
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3-tert-Butoxycarbonyl-2,3-bis-(tert-butyl-dimethyl-silanyloxy)-4-hydroxy-2-vinyl-
pentanedioic acid di-tert-butyl ester (12).  A solution of 31.7 mL (31.7 mmol, 1.1 
equiv) of vinylmagnesium bromide in THF (150 mL) was cooled to -78 °C and a solution 
of 15 mL (57.7 mmol, 1.1 equiv) of tert-butyl tert-butyldimethylsilyl glyoxylate (1a) in 
THF (50 mL) was added via cannula down the wall of the flask over 15 min.  Once 
addition of the silyl glyoxylate was complete, the reaction was slowly warmed to -45 °C 
over 15 min.  Once the cooling bath had reached -45 °C, the reaction was again cooled to 
-78 °C and 4.9 mL (43.3 mmol, 1.5 equiv) of tert-butyl glyoxylate was added via syringe.  
After stirring for 1 h at -78 °C, the reaction was quenched with 30 mL of saturated 
aqueous ammonium chloride solution.  The two layers were separated and the aqueous 
layer was extracted with Et2O (3 x 40 mL).  The combined organic layers were dried 
(MgSO4) and concentrated in vacuo to furnish the crude product which was purified by 
flash chromatography (1:2 CH2Cl2: petroleum ether linear gradient to 4:1 
CH2Cl2:petroleum ether) to furnish 8.3 g (44%) of the pure product (12).  The product 
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crystallized slowly (ca. 24 h) from a small amount (ca. 15 mL) of petroleum ether and 
yielded crystals suitable for X-ray analysis.  Analytical data for 12: IR (thin film, cm-1) 
3534, 2931, 2856, 1734, 1645, 1472, 1393, 1368, 1248, 1147, 1001; 
1
H NMR (400 MHz, 
CDCl3) 6.30 (dd, 18.0, 10.8 Hz, 1H), 5.17 (d, J = 11.6 Hz, 1H), 5.17 (d, J = 16.8, 1H), 
4.56 (d, J = 10.4, 1H), 3.64 (d, J = 10.8 Hz, 1H), 1.52 (s, 9H), 1.50 (s, 9H), 1.44 (s, 9H), 
0.92 (s, 9H), 0.81 (s, 9H), 0.22 (s, 3H), 0.12 (s, 3H), 0.11 (s, 3H), 0.09 (s, 3H); 
13
C NMR 
(100 MHz, CDCl3) 170.6, 169.2, 169.1, 138.0, 117.2, 83.8, 83.0, 82.1, 77.4, 75.8, 74.7, 
28.7, 28.6, 28.4, 26.9, 26.7, 19.7, 19.2, -1.0, -1.1, -1.5, -1.6; TLC (5:95 EtOAc: 
petroleum ether) Rf 0.33. Anal. Calcd for C32H62O9Si2: C, 59.40; H, 9.66. Found: C, 
59.47; H, 9.74. 
 
3-tert-Butoxycarbonyl-2,3-bis-(tert-butyl-dimethyl-silanyloxy)-4-hydroxy-2-vinyl-
pentanedioic acid di-tert-butyl ester ()-12.  A 50 mL round bottomed flask equipped 
with a stirbar was purged with O2 and charged with 82.2 mg (0.246 mmol, 0.055 equiv) 
of the salen ligand A in dry toluene (11.3 mL) and treated with 53 μL (0.224 mmol, 0.05 
equiv) of VO(O
i
Pr)3 under a dry O2 atmosphere.  The resultant dark brown solution was 
stirred for 30 min.  A solution of 2.9 g (4.48 mmol, 1.0 equiv) of racemic alcohol 12 in 
toluene (11.3 mL) was added via cannula to the catalyst solution.  After 48 h, the reaction 
was passed through a plug of silica gel eluted with 1:9 Et2O:petroleum ether.  After 
concentration of collected fractions in vacuo, 
1
H NMR analysis revealed 50% conversion 
to α-keto ester.  The alcohol was purified by flash chromatography (5:95 Et2O:petroleum 
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ether) to furnish 1.5 g (51%) of alcohol ()-12 (e.r. 90:10).  The enantiomer ratio was 
determined by CSP-SFC analysis of lactone 51. 
 
3,4-Dihydroxy-5-oxo-2-vinyl-tetrahydrofuran-2,3-dicarboxylic acid di-tert-butyl 
ester (S1).  A solution of 150 mg (0.23 mmol, 1.0 equiv) of bis-TBS ether ()-12 in THF 
(3.0 mL) at -45 °C was treated with 0.51 mL (0.51 mmol, 2.2 equiv) of a 1.0 M solution 
of tetrabutylammonium fluoride in THF.  The solution was warmed to -20 °C and 
maintained at that temperature.  After 1 h, 1.0 mL of H2O was added and the reaction was 
extracted with CH2Cl2 (3 x 5 mL).  The combined extracts were dried (Na2SO4) and 
concentrated in vacuo to furnish the crude diol which was purified by flash 
chromatography (2:3 EtOAc: petroleum ether), to furnish 63 mg (80%) of the pure diol 
(S1) as a white foam.  Analytical data for S1: IR (Nujol mull, cm-1) 3525, 3439, 2912, 
2858, 1801, 1760, 1729, 1458, 1377, 1304, 1258, 1146, 1124; []Na -18.8 (c = 1.09, 
CH2Cl2); 
1
H NMR (500 MHz, CDCl3) 6.01 (dd, J = 17.0, 10.5 Hz, 1H), 5.49 (d, J = 
17.0 Hz, 1H), 5.31 (d, J = 11.0 Hz, 1H), 4.65 (d, J = 10.5 Hz, 1H), 4.28 (s, 1H), 3.01 (d, J 
= 11.0 Hz, 1H), 1.52 (s, 9H), 1.47 (s, 9H); 
13
C NMR (125 MHz, CDCl3) 171.5, 167.7, 
164.2, 131.4, 117.5, 88.1, 86.3, 84.8, 80.5, 72.0, 28.1, 28.0; CSP-SFC analysis 
(Chiralpak AS column, 5% MeOH, 1.5 mL/min, 150 psi, 40 C, 240 nm, tr-minor 6.3 
min, tr-major 18.6 min; TLC (30:70 EtOAc: petroleum ether) Rf 0.17. Anal. Calcd for 
C16H24O8: C, 55.81; H, 7.02. Found: C, 55.79; H, 7.16. 
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3-tert-Butoxycarbonyl-2,3-bis-(tert-butyl-dimethyl-silanyloxy)-4-hydroxy-2-vinyl-
pentanedioic acid di-tert-butyl ester (epi-12).  To a solution of 750 mg (1.15 mmol, 1.0 
equiv) of the alcohol (12) in THF (10 mL) was added 86 μL (0.57 mmol, 0.5 equiv) of 
1,8-diazabicyclo[5.4.0]undec-7-ene.  After 5 h, 1 mL of saturated aqueous ammonium 
chloride was added and the layers were separated.  The aqueous layer was extracted with 
Et2O (3 x 8 mL) and the combined organic layers were dried (MgSO4) and concentrated 
in vacuo.  Purification of the crude material (5:95 Et2O: petroleum ether) furnished 551 
mg (73%) of the alcohol epi-12 as an oil.  Analytical data for epi-12: IR (thin film, cm-1) 
3428, 2930, 2857, 1746, 1729, 1713, 1473, 1393, 1369, 1255, 1155; 
1
H NMR (300 MHz, 
CDCl3) 6.49 (dd, J = 17.1, 10.8 Hz, 1H), 5.45 (dd, J = 17.1, 1.2 Hz, 1H), 5.10 (dd, J = 
10.5, 1.5 Hz, 1H), 4.63 (s, 1H), 4.03 (s, 1H), 1.52 (s, 9H), 1.42 (s, 18H), 0.93 (s, 9H), 
0.87 (s, 9H), 0.20 (s, 3H), 0.11 s, 3H), -0.01 (s, 3H), -0.02 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) 170.7, 170.1, 170.0, 137.6, 123.5, 85.5, 83.6, 82.8, 81.4, 74.6, 28.5, 28.2, 26.8, 
26.1, 25.8, 19.7, 18.3, -1.8, -2.5, -4.3, -4.5 (two overlapping resonances); TLC (5:95 
Et2O: petroleum ether) Rf 0.29. Anal. Calcd for C32H62O9Si2: C, 59.40; H, 9.66. Found: 
C, 59.57; H, 9.78. 
 
4-(2-Benzyloxy-acetoxy)-3-tert-butoxycarbonyl-2,3-bis-(tert-butyl-dimethyl-
silanyloxy)-2-vinyl-pentanedioic acid di-tert-butyl ester (14).  To a solution of 680 mg 
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(1.1 mmol, 1.0 equiv) of the alcohol (12) in Et2O (14 mL) at 0 °C was added 1.3 mL of a 
1.0 M EtMgBr solution in THF (1.26 mmol, 1.2 equiv).  This solution was warmed to 23 
°C and resulted in a thick slurry.  Following stirring for 1 h, a solution of 0.32 mL (2.1 
mmol, 2.0 equiv) of the acid chloride in Et2O (4 mL) was added via cannula (1 mL rinse).  
The reaction was stirred at 23 °C for 18 h, then quenched by the addition of 6 mL of 
saturated aqueous ammonium chloride solution.  After the layers were separated, the 
aqueous layer was extracted with additional Et2O (3 X 10 mL).  The combined organic 
layers were dried (MgSO4) and concentrated in vacuo.  
1
H NMR analysis of the crude 
reaction revealed 74% conversion of the starting material.  Purification of the crude 
reaction by flash chromatography (5:95 EtOAc: petroleum ether) yielded 540 mg (65%, 
88% based on recovered starting material) of the acylated alcohol (14).  Analytical data 
for 14: IR (thin film, cm-1) 2930, 2855, 1757, 1744, 1725, 1594, 1369, 1250, 1152; 
[]Hg -3.8 (c = 2.15, CH2Cl2); 
1
H NMR (400 MHz, CDCl3) 7.34-7.22 (m, 5H), 6.39 
(dd, J = 18.0, 11.2 Hz, 1H), 6.17 (s, 1H), 5.26 (d, J = 10.8 Hz, 1H), 5.23 (d, J = 18.0 Hz, 
1H), 4.63 (d, J = 12.0 Hz, 1H), 4.53 (d, J = 11.6, 1H), 4.06 (s, 2H), 1.56 (s, 9H), 1.39 (s, 
9H), 1.37 (s, 9H), 0.89 (s, 9H), 0.85 (s, 9H), 0.30 (s, 3H), 0.14 (s, 3H), 0.11 (s, 3H), 0.09 
(s, 3H); 
13
C NMR (100 MHz, CDCl3) 169.3, 168.9, 167.9, 164.7, 137.2, 136.8, 128.7, 
128.3, 128.2, 118.4, 87.0, 85.7, 83.9, 83.2, 83.0, 75.7, 73.5, 67.1, 28.7, 28.6, 28.5, 27.5, 
26.9, 20.1, 19.4, -0.5, -0.7, -1.4, -1.7; TLC (5:95 EtOAc: petroleum ether) Rf 0.23. Anal. 
Calcd for C41H70O11Si2 C, 61.93; H, 8.87. Found: C, 62.73; H, 9.01. 
 
33 
 
 
4-(2-Benzyloxy-acetoxy)-3-tert-butoxycarbonyl-2,3-bis-(tert-butyl-dimethyl-
silanyloxy)-2-formyl-pentane dioic acid di-tert-butyl ester (S2).  A solution of 646 mg 
(0.81 mmol, 1.0 equiv) of alkene 14 in 8.9 mL of CH2Cl2/MeOH/pyridine (10:1:1) was 
cooled to -78 °C.  O3 was bubbled slowly through the solution at -78 °C and the reaction 
was monitored by TLC.  After 1 h (reaction complete by TLC), the reaction was purged 
with Ar for 15 min.  Dimethylsulfide (300 μL, 4.1 mmol, 5.0 equiv) was then added via 
syringe and the reaction was warmed to ambient temperature and stirred for 2 h.  
Concentration of the crude reaction in vacuo followed by flash chromatography (5:95 
EtOAc: petroleum ether) afforded 550 mg (85%) of the pure aldehyde (S2) as a white 
foam.  Analytical data for S2: IR (thin film, cm-1) 2977, 2929, 2859, 1758, 1745, 1728, 
1473, 1394, 1368, 1253, 1152, 1129; []D -6.7 (c = 0.73, CH2Cl2); 
1
H NMR (400 MHz, 
CDCl3) 9.86 (s, 1H), 7.34-7.23 (m, 5H), 6.32 (s, 1H), 4.65 (d, J = 11.6 Hz, 1H), 4.57 (d, 
J = 12.0 Hz, 1H); 4.07 (d, J = 16.8 Hz, 1H), 4.02 (d, J = 16.8 Hz, 1H), 1.51 (s, 9H), 1.37 
(s, 18H), 0.90 (s, 9H), 0.81 (s, 9H), 0.29 (s, 3H), 0.11 (s, 3H), 0.067 (s, 3H), 0.034 (s, 
3H); 
13
C NMR (100 MHz, CDCl3) 193.4, 169.0, 166.8, 166.4, 165.2, 137.1, 128.7, 
128.3, 128.2, 87.1, 86.2, 84.4, 84.0, 83.9, 74.9, 73.5, 67.1, 28.4, 28.3, 27.0, 26.7, -1.2, -
1.4, -1.9, -2.7 (two overlapping resonances); TLC (1:9 EtOAc: petroleum ether) Rf 0.39. 
Anal. Calcd for C40H68O12Si2: C, 60.27; H, 8.60. Found: C, 60.45; H, 8.65. 
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6-Benzyloxy-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-7-oxo-5-trimethylsilanyloxy-
oxepane-2,3,4-tricarboxylic acid tri-tert-butyl ester (16).  To a solution of 80 μL of 
diisopropylamine (0.55 mmol, 2.2 equiv) in 2-methyltetrahydrofuran (0.6 mL) at 0 °C 
under an Ar atmosphere was added 360 μL of a 1.4 M n-butyllithium solution in hexane 
(0.50 mmol, 2.0 equiv).  The LDA solution was stirred for 15 min at 0 °C, then added via 
cannula to a solution of 200 mg (0.25 mmol, 1.0 equiv) of aldehyde S2 and 87 mg (1.0 
mmol, 4.0 equiv) of LiBr in 2-methyltetrahydrofuran (1.0 mL) at -78 °C.  Once addition 
was complete (0.4 mL wash), the yellow solution was warmed slowly (ca. 15 min) to -
45°C and maintained at that temperature.  After 1 h, 130 μL of chlorotrimethylsilane was 
added at -45°C.  The reaction was stirred for 15 min, then quenched by the addition of 
saturated aqueous ammonium chloride solution (1.0 mL).  The reaction was extracted 
with Et2O (3 x 8 mL) and the combined extracts were dried (MgSO4) and concentrated in 
vacuo.  The crude material was purified by flash chromatography (1:9 Et2O: petroleum 
ether), to afford 145 mg (67%) of the pure aldol (16) as a crystalline solid.  Analytical 
data for 16: IR (thin film, cm-1) 2976, 2929, 2858, 1761, 1733, 1471, 1369, 1252, 1152, 
1121, 1004; []D  -6.8 (c = 1.06, CH2Cl2); 
1
H NMR (400 MHz, CDCl3) 7.38-7.24 (m, 
5H), 5.24 (s, 1H), 4.92 (d, J = 10.0 Hz, 1H), 4.85 (s, 1H), 4.39 (s, 1H), 4.33 (d, J = 10.0 
Hz, 1H), 1.53 (s, 9H), 1.50 (s, 9H), 1.47 (s, 9H), 0.99 (s, 9H), 0.81 (s, 9H), 0.34 (s, 3H), 
0.28 (s, 3H), 0.18 (s, 3H), 0.14 (s, 3H), 0.049 (s, 9H); 
13
C NMR (100 MHz, CDCl3) 
167.1, 167.0, 166.7, 165.1, 137.2, 128.9, 128.5, 128.2, 87.3, 84.1, 83.7, 83.3, 81.6, 78.5, 
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77.7, 75.0, 72.9, 28.9, 28.4, 28.2, 27.7, 27.6, 20.4, 20.3, 1.5, -0.008, -0.3, -0.6, -0.8; TLC 
(1:9 Et2O: petroleum ether) Rf 0.32. Anal. Calcd for C43H76O12Si3: C, 59.41; H, 8.81. 
Found: C, 59.64; H, 8.87. 
 
6-Benzyloxy-3,4-bis-(tert-butyl-dimethyl-silanyloxy)-7-oxo-5-hydroxy-oxepane-2,3,4-
tricarboxylic acid tri-tert-butyl ester (epi-16).  To a solution of 60 mg (0.075 mmol, 1.0 
equiv) of lactone 16 in Et2O (1.0 mL) was added 56 μL (0.38 mmol, 5.0 equiv) of DBU.  
After 3 h, 0.5 mL of saturated aqueous ammonium chloride was added.  The reaction was 
extracted with Et2O (3 X 3 mL), dried (MgSO4), and concentrated in vacuo to furnish an 
85:15 ratio of diastereomers as judged by 
1
H NMR analysis.  Purification of the reaction 
mixture by flash chromatography (5:95 EtOAc: petroleum ether), afforded 44 mg (73%) 
of epi-16 as an oil.  Analytical data for epi-16: 
1
H NMR (400 MHz, CDCl3) 7.41-7.23 
(m, 5H), 5.16 (d, J = 11.6 Hz, 1H), 4.94 (d, J = 11.6 Hz, 1H), 4.89 (s, 1H), 4.30 (d, J = 
9.6 Hz, 1H), 3.91 (dd, J = 9.6, 6.4 Hz, 1H), 3.61 (d, J = 6.0 Hz, 1H), 1.48 (s, 9H), 1.42 (s, 
9H), 1.31 (s, 9H), 0.93 (s, 9H), 0.84 (s, 9H), 0.24 (s, 3H), 0.05 (s, 3H), 0.03 (s, 3H), 0.01 
(s, 3H); TLC (1:9 EtOAc: petroleum ether) Rf 0.39. 
 
(2R,3S,4R,5S,6R)-tri-tert-butyl 6-(benzyloxy)-7-((4R,5R)-4-(benzyloxy)-5-methyl-6-
phenylhexyl)-3,4-bis(tert-butyldimethylsilyloxy)-7-hydroxy-5-
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(trimethylsilyloxy)oxepane-2,3,4-tricarboxylate (18).  A solution of 94 mg (0.23 mmol, 
5.0 equiv) of iodide S3
34
 in Et2O (0.6 mL) was cooled to -78 °C under an Ar atmosphere 
and 220 μL of a 1.7 M solution of tBuli (0.368 mmol, 8.0 equiv) was added via syringe.  
After 5 min, a solution of 40 mg (0.032 mmol, 1.0 equiv) of lactone 16 in Et2O (0.35 mL) 
was added via cannula (0.35 mL rinse).  After 15 min the reaction was quenched with 1.0 
mL of saturated aqueous ammonium chloride.  The aqueous layer was extracted with 
Et2O (3 X 5 mL).  The combined extracts were dried dried (MgSO4), and concentrated in 
vacuo.  
1
H NMR analysis of the unpurified reaction mixture revealed an isomeric mixture 
of lactols and ketol.  The inseparable isomers were purified by flash chromatography 
(5:95 EtOAc: petroleum ether), to afford 53 mg (94%) of 18 as a mixture of isomers.  
Analytical data for 18 (reported as a mixture of lactol and ketol isomers): 
1
H NMR (400 
MHz, CDCl3) 7.39-7.10 (m), 4.85-4.55 (m), 4.54-4.42 (m), 4.12-4.09 (m), 3.31-3.18 
(m), 2.88-2.71 (m), 2.40-2.14 (m), 2.12-1.95 (m), 1.95-1.82 (m), 1.58 (s), 1.41 (s), 1.20 
(s), 1.03 (s), 0.84 (s), 0.45 (s), 0.36 (s), 0.32 (s), 0.29 (s), 0.25 (s), 0.18 (s), 0.16 (s), 0.14 
(s), 0.11 (s). 0.07 (s); TLC (1:9 EtOAc: petroleum ether) Rf 0.29.  
 
C4 O-tert-butyldimethylsilyl tricyclic ketal -lactone (19Si).  To a solution of 103 mg 
of 18 (0.089 mmol. 1.0 equiv)) in 7 mL of methanol, 136 mg of p-toluenesulfonic acid 
(0.715 mmol, 8.0 equiv) was added.  The reaction flask was fitted with a reflux condenser 
and heated to reflux for 72 h.  Heating was discontinued and the reaction was allowed to 
37 
 
cool to 23 °C.  5 mL of distilled water was added and the MeOH was removed in vacuo.  
The resulting aqueous layer was extracted with EtOAc (4 x 5 mL), the combined extracts 
were dried (Na2SO4), and concentrated in vacuo.  The crude material was purified by 
flash chromatography (2:8 EtOAc: petroleum ether to 1:1 EtOAc: petroleum ether linear 
gradient), to afford 10 mg (15%) of silyl-protected lactone (19Si), 29 mg (48%) of -
lactone 19, and 9 mg (15%) ofketal (19H).  Analytical data for 19Si: IR (thin film, cm-1) 
3566, 2954, 2926, 2857, 2359, 1801, 1772, 1747, 1646, 1496, 1365, 1257, 1028; []Na  -
18.7 (c = 0.05, CH2Cl2); 
1
H NMR (500 MHz, CDCl3) 7.35-7.24 (m, 12H), 7.17-7.08 
(m, 3H), 4.84 (m, 2H), 4.52 (m, 3H), 4.44 (s, 1H), 3.81 (s, 3H), 3.75 (s, 3H), 3.53 (d, J = 
7 Hz),  3.25-3.21 (m, 1H), 2.86 (dd, J =  13, 4.5 Hz, 1H), 2.23-2.25 (m, 1H), 2.00-1.92 
(m, 2H), 1.69-1.65 (m, 1H), 1.53-1.38 (m, 5H), 1.24-1.22 (m, 1H), 0.84 (s, 9H), 0.81 (d, J 
= 7 Hz, 3H), 0.24 (s, 3H), 0.01 (s, 3H); 
13
C NMR (400 MHz, CDCl3) 171.7, 166.2, 
165.5, 141.6, 139.1, 136.6, 129.1, 128.7, 128.4, 128.3, 128.2, 127.7, 127.4, 125.7, 107.0, 
90.5, 82.2, 80.3, 74.0, 72.4, 71.6, 53.2, 52.8, 38.6, 37.7, 34.1, 30.3, 25.6, 18.9, 18.4, 14.5, 
-2.28, -4.04; TLC (3:7 EtOAc: petroleum ether) Rf 0.65. HRMS (ESI) exact mass 
calculated for C44H56O11Na [M + Na]+ 811.3489. Found: 811.3390. 
C4-hydroxy-tricyclic ketal -lactone (19H). 1H NMR (400 MHz, CDCl3) 7.36-7.25 
(m, 11H), 7.19-7.10 (m, 4H), 4.90 (d, J = 6.8, 1H), 4.82 (d, J = 12 Hz, 1H), 4.57-4.49 (m, 
3H), 4.46 (s, 1H), 4.18 (s, 1H), 3.86 (s, 3H), 3.85 (s, 3H),  3.55 (d, J = 6.8, 1H), 3.27-3.24 
(m, 1H), 2.93-2.81 (m, 1H), 2.40-2.30 (m, 1H), 2.01-1.98 (m, 2H), 1.70-1.49 (m, 6H), 
0.83 (d, J = 6.8 Hz, 3H).  
(1R,3S,4R,5S,6R)-dimethyl 6-(benzyloxy)-1-((4R,5R)-4-(benzyloxy)-5-methyl-6-
phenylhexyl)-5-hydroxy-3-((R)-1-hydroxy-2-methoxy-2-oxoethyl)-2,7-
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dioxabicyclo[2.2.1]heptane-3,4-dicarboxylate (S5). 
1
H NMR (300 MHz, CDCl3) 
7.35-7.19 (m, 11H), 7.11-7.09 (m, 4H), 5.67 (d, J = 5.1 Hz, 1H), 5.00 (s, 1H), 4.76 (d, J 
= 10.5 Hz, 1H), 4.66 (d, J = 4.8 Hz, 1H), 4.56 (d, J = 12 Hz, 1H), 4.47 (d, J = 11.7 Hz, 1 
H), 4.32 (d, J = 10.8 Hz, 1H),  3.92 (d, J = 5.4 Hz, 1H), 3.82 (s, 3H), 3.60 (s, 3H), 3.56-
3.52 (m, 1H), 3.23-3.19 (m, 1H), 3.07 (s, 3H), 2.90 (dd, J = 13.8, 5.7 Hz, 1H), 2.36-2.32 
(m, 1H), 2.05-1.97 (m, 1H), 1.76-1.41 (m, 5H), 0.86 (d, J = 5.1 Hz, 3H). 
 
C4-hydroxy-tricyclic ketal -lactone (19H).  To a solution of 16 mg of S5 (0.023 
mmol, 1.0 equiv) in 3 mL of methanol, 46 mg of p-toluenesulfonic acid (0.242 mmol, 8.0 
equiv) was added.  The reaction flask was fitted with a reflux condenser and heated to 
reflux for 72 h.  Heating was discontinued and the reaction was allowed to cool to 23 °C.  
Distilled water (5 mL) was added and the MeOH was removed in vacuo.  The resulting 
aqueous layer was extracted with EtOAc (4 x 5 mL), the combined extracts were dried 
(Na2SO4), and concentrated in vacuo.  The crude material was purified by flash 
chromatography (2:8 EtOAc: petroleum ether to 1:1 EtOAc: petroleum ether linear 
gradient), to afford 11 mg (73%) of -lactone 19H. 
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C4 O-tert-butyldimethylsilyl tricyclic ketal -lactone (19Si): To a solution of 51 mg 
(0.076 mmol) of tertiary alcohol 19H in 0.75 mL CH2Cl2 at 0 °C under an Ar 
atmosphere, was added 42 L (0.308 mmol, 4.0 equiv) of NEt3, and 35 L (0.154 mmol, 
2.0 equiv) of TBSOTf.  The reaction was warmed to 23 °C.  After stirring for 15 min, an 
additional 42 L (0.308 mmol, 4.0 equiv) of NEt3, and 35 L (0.154 mmol, 2.0 equiv) of 
TBSOTf was added.  After 1 h, 0.5 mL of saturated NaHCO3 (aq) was added.  The 
solution was extracted with CH2Cl2 (3 x 5 mL).  The combined extracts were dried 
(Na2SO4) and concentrated in vacuo, affording the crude silyl ether, which was purified 
by flash chromatography (1:5 EtOAc: petroleum ether), to furnish 52 mg (87%) of silyl 
ether -lactone 19Si (characterization data provided above). 
  
(1S,3R,4S,5R,6R,7R)-3,4-di-tert-butyl 5-methyl 7-(benzyloxy)-1-((4R,5R)-4-
(benzyloxy)-5-methyl-6-phenylhexyl)-4,6-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-
3,4,5-tricarboxylate (21).  To a solution of 15 mg (0.019 mmol, 1.0 equiv) of lactone 
19Si in t-amyl alcohol (1.0 mL, freshly distilled from Na) was added a solution of 23 mg 
KOtBu (0.204 mmol, 11 equiv) in 0.75 mL t-amyl alcohol via cannula.  The solution was 
warmed to 35 °C and stirred under an Ar atmosphere for 40 min, at which point it was 
cooled to 23 °C. The reaction was quenched with 2 mL of 1 M HCl.  The aqueous layer 
was extracted with EtOAc (3 x 5 mL).  The combined extracts were dried (Na2SO4) and 
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concentrated in vacuo, affording the crude dicarboxylic acid.  The crude material was 
dissolved in 1 mL toluene and 88 L (0.367 mmol, 19 equiv) of N,N’-diisopropyl-O-tert-
butylisourea 22 was added.  The solution was warmed to 75 °C under an Ar atmosphere 
and stirred at 75 °C.  After 2 h the solution was cooled to 23 °C, diluted with diethyl ether 
and filtered through celite.  Concentration in vacuo afforded the crude triester.  The crude 
material was purified by flash chromatography (1:9 EtOAc:petroleum ether to 2:3 
EtOAc:petroleum ether, linear gradient), to afford 9.5 mg (63%) of the product as a 
mixture of esters, and 4.5 mg (27%) of starting material with t-butyl esters. Distribution 
of products: 6.5 mg (43%) of di-t-butyl ester; 2.0 mg (13%) of tri-t-butyl ester; 1.0 mg of 
mono-t-butyl ester (7%); 90% yield BRSM.  Analytical data for 21: IR (thin film, cm-1) 
2922, 2851, 1737, 1635, 1456, 1370, 1262, 1151; []Hg-16.0 (c = 0.135, CH2Cl2); 
1
H 
NMR (500 MHz, CDCl3) 7.38-7.29 (m, 9H), 7.26-7.24 (m, 2H), 7.18-7.10 (m, 3H), 
5.09 (dd, J = 8.0, 3.5 Hz, 1H), 4.78 (d, J = 12.5 Hz, 1H), 4.66 (d, J = 12.5 Hz, 1H), 4.55 
(d, J = 11.5 Hz, 1H), 4.50 (d, J = 11.5 Hz, 1 H), 4.46 (s, 1H), 4.14 (s, 1H), 3.81 (s, 3H), 
3.61 (d, J = 3.5, 1H), 3.25 (s, 1H), 2.85 (dd, J = 13.5, 5.0 Hz, 1 H), 2.37 (m, 1H), 2.00-
1.93 (m, 2H), 1.80-175 (m, 2H), 1.56 (s, 9H), 1.52 (m, 3H), 1.45 (s, 9H), 1.21 (m, 1H), 
0.84 (d, J = 6.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 169.0, 167.4, 167.2, 141.6, 
139.3, 137.8, 129.1, 128.4, 128.3, 128.2, 12 8.1, 127.8, 127.6, 127.3, 125.6, 106.4, 94.2, 
87.1, 84.9, 82.6, 82.1, 80.6, 72.2, 71.5, 52.4, 39.0, 37.7, 33.9, 30.6, 29.7, 28.1, 28.0, 19.1, 
14.2; TLC (2:3 EtOAc: petroleum ether) Rf 0.24. HRMS (ESI) exact mass calculated for 
C45H58O12Na [M+Na]+ 813.3825. Found: 813.3827. 
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(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 7-(benzyloxy)-1-((4R,5R)-4-(benzyloxy)-5-methyl-
6-phenylhexyl)-4,6-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate 
(23).   0.75 mL of a 1 M solution of NaOMe in MeOH (distilled from Mg metal) was 
added to 14 mg (0.019 mmol, 1.0 equiv) of 21, as a mix of esters, in a shell vial that had 
been purged with Ar.  The solution was stirred for 2 h monitoring by TLC (2:5 
EtOAc:petroleum ether) until no starting material remained.  The solution was poured 
into 1 mL of 1 M HCl.  The aqueous layer was extracted with EtOAc (3 x 5 mL).  The 
combined extracts were dried (Na2SO4) and concentrated in vacuo, affording the crude 
tricarboxylic acid.  The crude material was dissolved in 1 mL of toluene and 81 L 
(0.343 mmol, 18 equiv) of N,N’-diisopropyl-O-tert-butylisourea was added.  The solution 
was warmed to 75 °C under an Ar atmosphere and stirred at 75 °C.  After 2 h the solution 
was cooled to 23 °C, diluted with diethyl ether and filtered through celite.  The filtrate 
was concentrated in vacuo and the residue was purified by flash chromatography (1:5 
EtOAc:petroleum ether to 3:10 EtOAc:petroleum ether, linear gradient) to afford 11 mg 
(69%) of the product as a mixture of epimers (8:1) in favor of the correct C3-(S) 
configuration.  The epimers were separable at the stage of the triacetate 26.  Analytical 
data for 23: IR (thin film, cm-1) 3443, 3031, 2878, 1697, 1616, 1506, 1395, 1367, 1258, 
1198, 1149; []Na  -12.7 (c = 0.16, CH2Cl2); 
1
H NMR (500 MHz, CDCl3) 7.33-7.21 
(m, 9H), 7.15-7.13 (m, 2H), 7.13-7.09 (d, J = 16 Hz, 4H), 5.11 (s, 1H), 4.92 (s, 1H), 4.72 
(d, J = 12.0 Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.54 (d, J = 11.5 Hz, 1 H), 4.47 (d,J = 
11.5 Hz, 1H), 3.83 (s, 1H), 3.78 (s, 1H), 3.27 (s, 1H), 2.83 (dd, J = 13.0, 4.5 Hz, 1 H), 
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2.36 (t,J = 9.5 Hz, 1H), 2.00-1.80 (m, 3H), 1.60-1.40 (m, 4H), 1.56 (s, 9H), 1.45 (s, 9H), 
1.42 (s, 9H), 1.21 (m, 1H), 0.81 (d, J = 6.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 
169.0, 167.4, 166.6, 141.8, 139.3, 137.3, 129.2, 128.5, 128.3, 128.2, 128.1, 127.7, 
127.6, 127.3, 125.5, 104.7, 91.3, 87.7, 84.7, 84.2, 83.0, 82.3, 80.6, 75.3, 74.3, 72.8, 71.5, 
39.1, 37.8, 36.2, 34.4, 30.3, 29.7, 28.2, 28.0, 19.5, 14.1; TLC (1:5 EtOAc: petroleum 
ether) Rf 0.19. HRMS (ESI) exact mass calculated for C48H64O12Na [M+Na]+ 
855.4295. Found: 855.4296. 
 
(1S,3R,4R,5R,6R,7S)-tri-tert-butyl 7-(benzyloxy)-1-butyl-4-hydroxy-6-
(propionyloxy)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (24b).  A dry 
scintillation vial was purged with Ar for 5 minutes and was charged with 10 mg (0.016 
mmol, 1 equiv) of 23b, a stir bar, and 1 mL of CH2Cl2.  The solution was cooled to 0 °C.  
To this solution was added 7 μL (0.05 mmol, 3 equiv) of Et3N dropwise via syringe, 2 mg 
(0.016 mmol, 1 equiv) of DMAP and 6 μL (0.05 mmol, 3 equiv) of propionic anhydride 
dropwise via syringe.  The solution was stirred for 3 h.  The reaction was quenched with 
aqueous 1 M KH2PO4 (1 mL).  The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (3 x 3 mL).  The organic layer was dried over Na2SO4 and 
concentrated in vacuo.  The crude product purified by flash column (1:5 EtOAc: 
petroleum ether) to yield 7 mg (64%) of 24b as a clear oil.  Analytical data for 24b: 
1
H 
NMR (500 MHz, CDCl3) δ 7.34 – 7.25 (m, 5H), 6.48 (s, 1H), 5.07 (s, 1H), 4.82 (d, J = 
12.1 Hz, 1H), 4.52 (d, J = 12.1 Hz, 1H), 4.00 (s, 1H), 3.75 (s, 1H), 2.31 – 2.23 (m, 2H), 
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1.94 – 1.76 (m, 2H), 1.47 – 1.35 (m, 27H), 1.35 – 1.18 (m, 4H), 1.13 (t, J = 7.5 Hz, 3H), 
0.85 (t, J = 7.2 Hz, 3H); TLC (1:5 EtOAc: petroleum ether) Rf 0.27. 
 
(1S,3R,4R,5R,6R,7R)-tri-tert-butyl 1-butyl-4,7-dihydroxy-6-(propionyloxy)-2,8-
dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (25b).  A dry scintillation vial was 
purged with Ar for 5 minutes and was charged with 4 mg (0.006 mmol, 1 equiv) of 24b, 
4 mg (0.012 mmol, 2 equiv) of DDQ, a stir bar, and 0.005 mL of CH3CN.  The solution 
was then irradiated with a 450 watt 365 nm mercury vapor lamp at a distance of 15 cm 
for 4 h.  To this solution was added 7 μL (0.05 mmol, 3 equiv) of Et3N dropwise via 
syringe, 2 mg (0.016 mmol, 1 equiv) of DMAP and 6 μL (0.05 mmol, 3 equiv) of 
propionic anhydride via syringe.  The solution was stirred for 3 h.  The reaction was 
quenched with aqueous saturated NaHCO3 (1 mL).  The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 x 3 mL).  The organic layer was dried over 
Na2SO4 and concentrated in vacuo.  The crude product purified by flash column (1:5 
EtOAc: petroleum ether) to yield 3 mg (86%) of 25b as a clear oil.  Analytical data for 
25b: 
1
H NMR (500 MHz, CDCl3) δ 5.91 (s, 3H), 4.99 (s, 1H), 3.99 (s, 1H), 2.76 (s, 1H), 
2.35 (dd, J = 14.2, 7.6 Hz, 2H), 1.95 (t, J = 27.8 Hz, 3H), 1.56 (s, 9H), 1.46 (s, 9H), 1.43 
(s, 9H), 1.39 – 1.31 (m, 2H), 1.14 (t, J = 7.5 Hz, 3H), 0.89 (t, J = 7.4 Hz, 3H); TLC (1:5 
EtOAc: petroleum ether) Rf 0.30. 
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(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 7-(benzyloxy)-1-butyl-4-hydroxy-6-(((R,E)-6-
methyl-9-phenylnon-4-enoyl)oxy)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate 
(24c). A solution of acyl side chain acid (7 mg, 0.030 mmol, 2 equiv) and DCC (6 mg, 
0.030 mmol, 2 equiv) in 485 µl of CH2Cl2 was stirred under Ar for 15 minutes.  To a 
solution of 23b (9.0 mg, 0.015 mmol, 1.0 equiv) and DMAP (4 mg, 0.035 mmol, 2.3 
equiv) in CH2Cl2 (1.5 mL,) was added the acyl side chain-DCC solution.  The reaction 
was stirred at 23 °C under Ar in a sealed vial for 40 h.  The reaction was quenched with 
1.5 mL of 50% aqueous satd. NaHCO3 solution.  The aqueous layer was extracted with 
Et2O (4 x 2 mL).  The combined extracts were dried (Na2SO4) and concentrated in vacuo, 
affording the crude product.  The crude material was purified by flash chromatography 
(1:5 EtOAc:hexanes), to give product 24c as a colorless film 6.0 mg (50%).  Analytical 
data for 24c: IR (thin film, cm-1) 3398 broad, 2929, 2851, 2347, 1724, 1594, 1451, 1377; 
1172; 
1
H NMR (500 MHz, CDCl3) 7.34 – 7.08 (m, 10H), 6.47 (s, 1H), 5.30 (s, 2H), 
5.05 (s, 1H), 4.80 (d, J = 11.9 Hz, 1H), 4.49 (d, J = 11.9 Hz, 1H), 4.00 (s, 1H), 3.74 (s, 
1H), 2.53 (t, J = 7.1 Hz, 2H), 2.34 – 2.22 (m, 4H), 2.04 (s, 2H), 1.95 – 1.70 (m, 3H), 1.61 
(s, 9H), 1.41 (s, 18H), 1.33 – 1.21 (m, 6H), 0.94 – 0.79 (m, 6H); TLC (1:4 EtOAc: 
petroleum ether) Rf 0.25.  
 
 
45 
 
 
C7 hydroxyl tricyclic ketal -lactone (S6).  A scintillation vial was charged with 28 mg 
(0.064 mmol) of lactone 19b, capped with a rubber septum and purged with Ar for 5 
minutes.  EtOH (2 mL) was added followed by a spatula tip of 10% Pd/C.  The rubber 
septum was pierced with an 18 gauge needle and the vial was placed in a bomb.  The 
bomb was purged with hydrogen gas 7 times and then pressurized to 750 psi.  The 
reaction was stirred in the bomb at 750 psi for 20 h.  The bomb was depressurized and the 
solution was filtered through celite with diethyl ether.  Concentration in vacuo afforded 
the debenzylated diester. The crude material was purified by flash column (20:1 
petroleum ether:EtOAc) to give 22 mg (100%) of S6 as a clear oil.   Analytical data for 
S6: 
1
H NMR (400 MHz, CDCl3) δ 4.92 (d, J = 7.2 Hz, 1H), 4.47 (s, 1H), 3.84 (s, 3H), 
3.82 (s, 3H), 2.94 (d, J = 11.9 Hz, 1H), 1.98 – 1.89 (m, 1H), 1.81 – 1.70 (m, 1H), 1.56 – 
1.40 (m, 2H), 1.40 – 1.26 (m, 2H), 1.21 (dd, J = 8.3, 6.0 Hz, 2H), 0.88 (t, J = 7.3 Hz, 
3H); TLC (1:1 EtOAc:petroleum ether) Rf 0.28. 
 
(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 4,6,7-trihydroxy-1-((4R,5R)-4-hydroxy-5-methyl-
6-phenylhexyl)-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (S7).  A 
scintillation vial was charged with 11 mg (0.013 mmol) of tri-ester 23, capped with a 
rubber septum and purged with Ar for 5 minutes.  EtOH (2 mL) was added followed by a 
spatula tip of 10% Pd/C.  The rubber septum was pierced with an 18 gauge needle and the 
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vial was placed in a bomb.  The bomb was purged with hydrogen gas 7 times and then 
pressurized to 800 psi.  The reaction was stirred in the bomb at 800 psi for 20 h.  The 
bomb was depressurized and the solution was filtered through celite with diethyl ether.  
Concentration in vacuo afforded the debenzylated triester. The material was pure by 1H 
NMR spectroscopy and was used in the next step without further purification.  Analytical 
data for S7: IR (thin film, cm-1) 3443, 3031, 2878, 1697, 1616, 1506, 1395, 1367, 1258, 
1198, 1149; []Na  +11.6 (c = 0.09, CH2Cl2); 
1
H NMR (500 MHz, CDCl3) 7.23 (m, 
3H), 7.13 (d, J = 7.5 Hz, 2H), 4.98 (s, 1H), 4.91 (s, 1H), 4.09 (s, 1H), 3.96 (s broad, 1H), 
3.51 (s broad, 1H), 2.76 (dd, J = 13.3, 6.0 Hz, 1 H), 2.39 (dd, J = 10.0 Hz, J = 9.0 Hz, 
1H), 2.00-1.89 (m, 3H), 1.80-1.50 (m, 4H), 1.55 (s, 9H), 1.45 (s, 9H), 1.41 (s, 9H), 0.82 
(d, J = 4.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 168.7, 166.4, 166.2, 143.5, 141.3, 
129.2, 128.2, 125.7, 105.3, 91.3, 85.1, 84.3, 83.4, 82.4, 78.8, 75.1, 74.3, 74.1, 58.5, 40.7, 
39.8, 35.1, 33.8, 30.3, 30.0, 28.3, 28.1, 28.0, 19.7, 13.3; TLC (1:1 EtOAc: petroleum 
ether) Rf 0.07. HRMS (ESI) exact mass calculated for C34H52O12Na [M+Na]+ 675.3356. 
Found: 675.3357. 
 
(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 6,7-diacetoxy-1-((4R,5R)-4-acetoxy-5-methyl-6-
phenylhexyl)-4-hydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (26).  To 
a solution of 11.8 mg (0.018 mmol, 1.0 equiv) of triester S7 and 4 mg (0.036 mmol, 2.0 
equiv) of DMAP in dichloromethane (1.5 mL,) was added 17 µl (0.1 mmol, 10 equiv) of 
acetic anhydride via syringe.  The solution was stirred at 23 °C under Ar for 3 h until no 
starting material remained by TLC (1:1 EtOAc:petroleum ether).  The reaction was 
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quenched with 1.5 mL aqueous satd. NaHCO3 solution.  The aqueous layer was extracted 
with CH2Cl2 (3 x 5 mL).  The combined extracts were dried (Na2SO4) and concentrated 
in vacuo, affording the crude tri-acetate.  The crude material was purified by flash 
chromatography (1:5 EtOAc:petroleum ether to 3:10 EtOAc:petroleum ether, linear 
gradient), to afford 9 mg (65%) of the desired major diastereomer 26, and 2.5 mg (18%) 
of the minor diastereomer.  Analytical data for 26: IR (thin film, cm-1) 3434 (br), 2930, 
2861, 1724, 1651, 1594, 1374, 1233, 1172, 1034; []Na  +11.1 (c = 0.325, CH2Cl2); 
1
H 
NMR (500 MHz, CDCl3)  7.27-7.24 (m, 2H), 7.17 (t, J = 7.5 Hz, H), 7.13 (d, J = 7.5 
Hz, 2H), 6.33 (d, J = 1.5 Hz, 1H), 5.08 (d, J = 2 Hz, 1H), 4.88 (s, 1H), 4.88-4.86 (m, 1H), 
4.07 (s, 1H), 2.76 (dd, J = 13.3, 4.5 Hz, 1 H), 2.30 (dd, J = 10.5 Hz, J = 13.5 Hz, 1H), 
2.14 (s, 3H), 2.07 (s, 3H), 2.05 (s, 3H), 2.05-1.90 (m, 3H), 1.70-1.50 (m, 4H), 1.61 (s, 
9H), 1.46 (s, 9H), 1.45 (s, 9H), 0.83 (d, J = 7 Hz, 3H); 
13
C NMR (125 MHz, CD3OD) 
173.0, 171.1, 170.2, 168.7, 167.4, 165.6, 141.9, 130.2, 129.3, 127.0, 105.6, 91.2, 86.4, 
85.3, 85.0, 81.6, 77.9 (2 lines), 76.9, 75.6, 40.6, 39.7, 36.5, 32.3, 28.5, 28.4 (3 lines), 
21.1, 20.7, 20.5, 20.1, 14.3; (125 MHz, CDCl3) 170.9, 169.5, 168.7, 168.5, 165.5, 
163.9, 140.7, 129.1, 128.2, 125.8, 104.1, 89.7, 86.1, 84.1, 83.6, 80.4, 76.4, 75.2, 73.8, 
39.3, 38.1, 35.7, 30.8, 28.1, 27.9, 21.2, 20.7, 20.6, 19.0, 13.9;TLC (1:2 EtOAc:hexanes) 
Rf 0.46. HRMS (ESI) exact mass calculated for C40H58O15 [M+Na]+ 801.3673. Found: 
801.3674.  
The spectroscopic data match those reported by Carreira.
14
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(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 1-((4R,5R)-4-acetoxy-5-methyl-6-phenylhexyl)-
4,6,7-trihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (S8).  A solution 
of 6 mg (0.008 mmol, 1.0 equiv) of triacetate 26 in 1.2 mL of 0.2% K2CO3 in MeOH was 
stirred at 23 °C under Ar for 30 minutes.  The reaction was quenched with 1.5 mL 0.3 M 
KH2PO4 solution.  The aqueous layer was extracted with Et2O (5 x 3 mL).  The combined 
extracts were dried (Na2SO4) and concentrated in vacuo, affording the crude mono-
acetate.  The crude material was purified by flash chromatography (2:5 EtOAc:hexanes to 
1:1 EtOAc:hexanes, linear gradient), to afford 4 mg (75%) of the triol S8.  Analytical 
data for S8: IR (thin film, cm-1) 3460 (broad), 2927, 1732, 1371, 1258, 1159; 
1
H NMR 
(500 MHz, CD3OD) 7.24 (t, J = 7.5 Hz, 2H), 7.14-7.15 (m, 3H), 4.97-4.96 (2H), 3.99 
(d, J = 2.0 Hz, 1H), 2.75 (dd, J = 13.5, 5.5 Hz, 1 H), 2.36 (dd, J = 9.5 Hz, J = 13.3 Hz, 
1H), 2.06 (s, 3H),  2.05-2.0 (m, 1H), 1.95-1.70 (m, 2H), 1.70-1.60 (m, 2H), 1.60-1.20 (m, 
2H), 1.60 (s, 9H), 1.46 (s, 9H), 1.45 (s, 9H), 0.87 (d, J = 7.0 Hz, 3H), one proton 
obscured by residual water; 
13
C NMR (125 MHz, CD3OD) 173.0, 169.8, 168.3, 167.4, 
142.0, 130.2, 129.3, 126.9, 106.4, 93.2, 85.4, 84.2 (2 lines), 79.9, 78.2, 76.8, 76.0, 40.6, 
39.5, 36.6, 32.5, 28.7, 28.5, 28.4, 21.1, 20.1, 14.2; TLC (2:5 EtOAc: petroleum ether) Rf 
0.17. HRMS (ESI) exact mass calculated for C36H54O13Na [M+Na]+ 717.3461. Found: 
717.3463. 
The spectroscopic data match those reported by Carreira.
14
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(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 1-((4R,5R)-4-acetoxy-5-methyl-6-phenylhexyl)-7-
(tert-butoxycarbonyloxy)-4,6-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-
tricarboxylate (27).  A solution of 4 mg (0.006 mmol, 1.0 equiv) of monoacetate S8 in 
0.75 mL of dichloromethane under Ar was stirred and cooled to 0 °C.  A solution of 4-
pyrrolidinopyridine (0.1 M in CH2Cl2, 46 µl, 0.005 mmol, 0.8 equiv) was added followed 
by a solution of Et3N (115 µl, 0.2 M in CH2Cl2, 0.024 mmol, 4.0 equiv) and a solution of 
di-tert-butyl dicarbonate (66 µl, 0.1 M in CH2Cl2, 0.007 mmol, 1.15 equiv).  The solution 
was stirred for 6.5 h at 0 °C.  The reaction was quenched with 1.5 mL 1.0 M KH2PO4 
solution.  The aqueous layer was extracted with Et2O (5 x 2 mL).  The combined extracts 
were dried (Na2SO4) and concentrated in vacuo, affording the crude product.  The crude 
material was purified by flash chromatography (1:4 EtOAc:hexanes to 1:1 
EtOAc:hexanes, linear gradient), to afford 3.5 mg (77%) of the boc-protected product 27.  
Analytical data for 27: IR (thin film, cm-1) 3433 (broad), 2927, 2851, 1644, 1451, 1378, 
1259, 1171, 1113, 1026; 
1
H NMR (500 MHz, CDCl3) −7.24 (m, 2H), 7.17 (t, J = 
7.0 Hz, 1H), 7.12 (d, J = 7.0 Hz, 2H), 5.11 (d, J = 1.5 Hz, 1H), 4.87 (m, 1H), 4.72, (s, 
1H), 4.63 (d, J = 1.5 Hz, 1H), 3.95 (s, 1H), 2.84 (broad s, 1H), 2.75 (dd, J = 13.3, 5.5 Hz, 
1 H), 2.30 (dd, J = 13.0, 9.5 Hz, 1H), 2.06 (s, 3H),  2.05-1.90 (m, 4H), 1.70-1.30 (m, 4H), 
1.58 (s, 9H), 1.50 (s, 9H), 1.48 (s, 9H), 1.45 (s, 9H), 0.83 (d, J = 6.5 Hz, 3H); 
13
C NMR 
(125 MHz, CDCl3) 171.0, 168.7, 165.9, 165.3, 153.8, 140.9, 129.3, 128.4, 125.7, 104.0, 
90.9, 85.6, 85.2, 84.1, 84.0, 83.4, 77.4, 75.4, 74.2, 39.5, 38.0, 35.7, 34.4, 31.0, 29.9, 28.3, 
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28.2, 28.1, 27.8, 21.4, 19.0, 13.9; TLC (2:5 EtOAc:petroleum ether) Rf 0.59. HRMS 
(ESI) exact mass calculated for C41H62O15Na [M+Na]+: 817.3986. Found: 817.3987. 
 
(1S,3S,4S,5R,6R,7R)-tri-tert-butyl 1-((4R,5R)-4-acetoxy-5-methyl-6-phenylhexyl)-7-
(tert-butoxycarbonyloxy)-4-hydroxy-6-((R,E)-6-methyl-9-phenylnon-4-enoyloxy)-
2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylate (S9).  A solution of acyl side chain 
acid (12 mg, 0.049 mmol) and DCC (10 mg, 0.049 mmol) in 485 µl of CH2Cl2 was 
stirred under Ar for 15 minutes.  To a solution of boc-protected 27 (8.0 mg, 0.010 mmol, 
1.0 equiv) and DMAP (4 mg, 0.035 mmol, 3.5 equiv) in CH2Cl2 (1.5 mL,) was added 120 
µl (1.2 equiv) of the acyl side chain-DCC solution.  The reaction was stirred at 23 °C 
under Ar in a sealed vial for 40 h.  The reaction was quenched with 1.5 mL of 50% 
aqueous satd. NaHCO3 solution.  The aqueous layer was extracted with Et2O (4 x 2 mL).  
The combined extracts were dried (Na2SO4) and concentrated in vacuo, affording the 
crude product.  The crude material was purified by flash chromatography (1:5 
EtOAc:hexanes), to give product S9 as a colorless film 5.1 mg (51%) and 3 mg (38%) of 
recovered boc-protected starting material 27.  Analytical data for S9: IR (thin film, cm-1) 
3398 broad, 2929, 2851, 2347, 1724, 1594, 1451, 1377; 1172; 
1
H NMR (500 MHz, 
CDCl3) 7.24 (m, 4H), 7.18-7.12 (m, 6H), 6.40 (d, J = 2.0 Hz, 1H), 5.39-5.28 (m, 
2H), 4.91 (s, 1H), 4.86 (d, J = 2.0 Hz 1H), 4.88-4.86 (m, 1H), 4.07 (s, 1H), 2.76 (dd, J = 
15.0, 4.5 Hz, 1 H), 2.56 (t, J = 7.5 Hz, 1H), 2.32-2.25 (m, 3H), 2.10-1.91 (m, 6H), 2.05 
(s, 3H), 1.68-1.25 (m, 8H), 1.61 (s, 9H), 1.47 (s, 9H), 1.45 (s, 9H), 1.44 (s, 9H), 0.93 (d, J 
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= 6.5 Hz, 3H), 0.83 (d, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) 170.8, 170.7, 
168.7, 165.6, 164.1, 152.4, 142.8, 140.8, 137.6, 129.2, 128.4, 128.3, 128.2, 126.1, 125.8, 
125.6, 103.7, 89.8, 86.1, 84.0, 83.5, 83.4, 83.0, 76.1, 75.2, 73.9, 39.3, 38.0, 36.6, 36.5, 
36.1, 35.9, 34.1, 30.8, 29.3, 28.1, 28.2, 28.0, 27.9, 27.73, 27.66, 21.3, 20.6, 18.9, 13.8; 
TLC (1:4 EtOAc: petroleum ether) Rf 0.29. HRMS (ESI) exact mass calculated for 
C57H82O16Na [M+Na]+: 1045.5500 Found: 1045.5501. 
 
Zaragozic Acid C (1).  To a solution of S9 (5.0 mg, 0.005 mmol, 1.0 equiv) in 2.55 mL 
of dichloromethane under Ar was added TFA (850 µl).  The solution was stirred for 16 h 
at 23 °C.  Volatiles were removed in vacuo.  The pale green residue was dissolved in 5 
mL of toluene, concentrated in vacuo, and lyophilized from 1.5 mL of benzene to afford 
3.6 mg (100%) of the product 5 as a white flocculent solid.  Analytical data for 5: IR 
(thin film, cm-1) 3427 broad, 2929, 2360, 1717, 1646, 1378, 1268, 1171; [α]Na  +3.81 (c 
= 0.040, EtOH); 
1
H NMR (500 MHz, CD3OD) δ 7.23−7.21 (m, 4H), 7.14-7.10 (m, 6H), 
6.23 (d, J = 1.5 Hz, 1H), 5.37 (m, 1H), 5.32 (m, 1H), 5.23 (s, 1H), 4.90 (m, 1H, masked 
by solvent signal), 4.01 (s, 1H), 2.73 (dd, J = 13.5, 5.5 Hz, 1 H), 2.56 (dd, J = 7.0 Hz, 
12.5 Hz, 2H), 2.36-2.32 (m, 3H), 2.28-2.24 (m, 2H) 2.08-2.00 (m, 2H), 2.05 (s, 3H) 1.92-
1.85 (m, 2H), 1.7-1.66 (m, 2H), 1.61-1.52 (m, 4H), 1.40-1.20 (m, 2H), 0.93 (d, J = 6.5 
Hz, 3H), 0.86 (d, J = 7.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) δ 173.1, 173.06, 172.7, 
170.3, 168.7, 143.9, 142.0, 138.8, 130.2, 129.4, 129.3, 129.27, 127.7, 126.9, 126.6, 107.1, 
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91.1, 82.3, 81.2, 78.1, 76.7, 75.7, 40.5, 39.7, 37.9, 37.6, 36.9, 36.3, 35.4, 32.5, 30.5, 28.8, 
21.3, 21.1, 20.1, 14.3; LRMS (ESI) exact mass calculated for C40H50O14 754.3 Found: 
754.4 (376.2 [M-2H]2-).  HRMS (ESI) exact mass calculated C40H50O14Na [M+Na]+: 
777.3098 Found: 777.3068. 
The spectroscopic data match those reported by Carreira and Armstrong.  In addition to 
the published spectral data, we found the scanned spectrum in the Supporting Information 
for the Armstrong synthesis to be useful for comparison purposes.  An authentic sample 
of zaragozic acid C (<200 μg) was generously provided by Dr. Sheo Singh (Merck 
Research Laboratories).  This sample also contains what we surmise to be the des-acetyl 
zaragozic acid C (LC-MS analysis).  Purification was not feasible due to the quantity 
provided.   
 
4-Azidobenzyl-tert-butyldimethylsilyl glyoxylate (44).  To NBu4I (388 mg, 1.05 mmol, 
0.1 equiv) and 42 (3.35 g, 15.8 mmol, 1.5 equiv) was added a solution of 43 (1.98 g, 10.5 
mmol, 1.0 equiv) in CH2Cl2 (75 mL), followed by Et2O (75 mL), and Et3N (2.05 mL, 
14.7 mmol, 1.4 equiv).  The solution was heated to reflux for 17 h, and then cooled to 
room temperature.  The reaction was quenched with saturated NH4Cl (50 mL) and 
extracted with Et2O (3 X 500 mL).  The combined organic phases were dried with 
MgSO4 and concentrated under reduced pressure.  The crude material was purified by 
flash chromatography (97:3 petroleum ether:EtOAc) to afford 44 (1.86 g, 5.81 mmol, 
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55% yield) as a yellow liquid.  Analytical data for 44: 
1
H NMR (300 MHz, CDCl3) δ 
7.39 (d, J = 8.4 Hz, 2H), 7.02 (d, J = 8.4 Hz, 2H),  5.21 (s, 2H), 0.92 (s, 9H), 0.24 (s, 6H). 
 
3-((1,3-bis(prop-2-yn-1-yloxy)propan-2-yl)oxy)prop-1-yne (45).  To NaH (60% in 
mineral oil, washed with petroleum ether: 1.09 g, 27.2 mmol, 5.0 equiv) in THF (10 mL) 
at 0 °C was added glycerol (500 mg, 5.43 mmol, 1.0 equiv).  The solution was stirred for 
10 min at 0 °C before propargyl bromide (80% solution, 3.98 mL, 38.0 mmol, 7.0 equiv) 
was added.  The solution was heated to reflux for 15 h and then cooled to room 
temperature.  The reaction was quenched with saturated NH4Cl, and extracted with Et2O 
(3 X 100 mL).  The combined organic phases were washed with brine, dried with 
MgSO4, and concentrated under reduced pressure.  The crude material was purified by 
flash chromatography (90:10 petroleum ether:EtOAc) to afford 45 (810 mg, 3.93 mmol, 
72% yield) as a clear liquid.  Analytical data for 45: 
1
H NMR (300 MHz, CDCl3) δ 4.35 
(d, J = 2.4 Hz, 2H), 4.20 (d, J = 2.4 Hz, 4H), 3.96-3.91 (m, 1H), 3.73-3.63 (m, 4H), 2.44 
(t, J = 2.4 Hz, 3H). 
 
Tris-triazole (46).  To CuSO4 (45 mg, 0.182 mmol, 0.16 equiv), 44 (1.30 g, 4.07 mmol, 
3.8 equiv), and 45 (221 mg, 1.07 mmol, 1.0 equiv) in H2O (18 mL) and 
t
BuOH (18 mL) 
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was added Na ascorbate (276 mg, 1.39 mmol, 1.3 equiv).   The solution was stirred at 
room temperature for 18 h and was then diluted with CH2Cl2 (50 mL).  The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (2 X 50 mL).  The combined 
organic phases were concentrated under reduced pressure.  The crude material was 
purified by flash chromatography (95:5 CH2Cl2:MeOH) to afford 46 (740 mg, 0.635 
mmol, 59% yield) as a yellow foam.  Analytical data for 46: 
1
H NMR (300 MHz, CDCl3) 
δ 8.16 (s, 1H), 8.09 (s, 2H), 7.78-7.73 (m, 6H), 7.56-7.51 (m, 6H), 5.30-5.27 (m, 6H), 
4.93 (s, 2H), 4.77 (s, 4H), 4.00-3.94 (m, 1H), 3.75 (t, J = 3.9 Hz), 0.94 (s, 27H), 0.26 (s, 
18H); 
13
C NMR (100 MHz, CDCl3) δ 162.6, 146.3, 145.9, 137.1, 135.5, 131.3, 130.0, 
121.0, 120.8, 120.6, 120.5, 77.6, 70.6, 66.2, 65.8, 64.9, 63.9, 26.4, 17.0, -6.9.  LRMS 
(ESI) exact mass calculated for C57H77N9O12Si3Na: 1,186.49. Found: 1,186.50. 
 
(4S,5S)-tert-butyl 5-(furan-2-yl)-2,2-dimethyl-1,3-dioxolane-4-carboxylate (49d).  To 
56
39
 (4.33 g, 19.0 mmol, 1.0 equiv) in CH2Cl2 (85 mL) was added dimethoxypropane 
(22.99 mL, 186 mmol, 9.8 equiv) and CSA (97 mg, 0.418 mmol, 0.022 equiv).  The 
solution was stirred at room temperature for 26 h.  Saturated NaHCO3 (50 mL) was added 
and the layers were separated.  The organic phase was dried with MgSO4 and 
concentrated under reduced pressure to afford 49d (>95% pure by 
1
H NMR analysis, 4.35 
g, 16.2 mmol, 85%).  Analytical data for 49d: 
1
H NMR (300 MHz, CDCl3)  7.46 (s, 
1H), 6.42 (d, J = 3.3 Hz, 1H), 6.37 (d, J = 1.8 Hz, 1H), 5.09 (d, J = 7.8 Hz, 1H), 4.61 (d, 
J = 7.8 Hz, 1H), 1.54 (s, 3H), 1.53 (s, 3H), 1.43 (s, 9H). 
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Furyl glycolic ester (49f).  To 
i
Pr2NH (0.57 mL, 4.10 mmol, 1.1 equiv) in THF (10 mL) 
at -78 °C was added 
n
BuLi (1.5 M solution in hexane, 2.73 mL, 4.10 mmol, 1.1 equiv).  
The solution was stirred at -78 °C 10 min before a solution of 49d (1.00 g, 3.73 mmol, 
1.0 equiv) in THF (14 mL) was added.  The solution was stirred at -78 °C for 15 min 
before a solution of ethyl glyoxylate (0.76 g, 4.48 mmol, 1.2 equiv) in THF (2 mL) was 
added dropwise.  The solution was stirred at -78 °C for 1 h before it was quenched with 
saturated NH4Cl (10 mL).  The solution was diluted with CH2Cl2 (50 mL), and the phases 
were separated.  The organic phase was dried with Na2SO4 and concentrated under 
reduced pressure.  The crude material was purified by flash chromatography (90:10 
petroleum ether:EtOAc) to afford 49f (1:1 mix of two diastereomers: 1.00 g, 2.70 mmol, 
72% yield) as a clear liquid.  Analytical data for 49f: 
1
H NMR (300 MHz, CDCl3) δ 7.42 
(s, 1H), 6.42-6.38 (m, 2H), 5.70 (s, 0.5H), 5.62 (s, 0.5H), 4.71 (d, J = 7.2 Hz, 0.5H), 4.53 
(d, J = 9.9 Hz, 0.5H), 4.33-4.24 (m, 2H), 3.44-3.39 (m, 1H), 1.73 (s, 1.5H), 1.70 (s, 
1.5H), 1.52-1.23 (m, 15H). 
 
(4S,5R)-tert-butyl 4-(2-ethoxy-2-oxoacetyl)-5-(furan-2-yl)-2,2-dimethyl-1,3-
dioxolane-4-carboxylate (62).  To 49f (990 mg, 2.67 mmol, 1.0 equiv) in CH2Cl2 (50 
mL) at 0 °C was added Dess-Martin periodinane (1.47 g, 3.47 mmol, 1.3 equiv).  The 
solution was slowly warmed to rt over 1 h, then stirred at room temperature for 1 h.  The 
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reaction was quenched with saturated Na2S2O3 (5 mL) and stirred 10 min.  The solution 
was extracted with Et2O (3 X 50 mL) and the combined organic phases were washed with 
brine (50 mL), dried with MgSO4, and concentrated under reduced pressure.  The crude 
material was purified by flash chromatography (90:10 petroleum ether:EtOAc) to afford 
62 (438 mg, 1.19 mmol, 45% yield) as a clear oil.  Analytical data for 62: 
1
H NMR (300 
MHz, CDCl3) δ 7.42 (s, 1H), 6.49 (d, J = 3 Hz, 1H), 6.37 (d, J = 1.8 Hz, 1H), 5.91 (s, 
1H), 4.36 (q, J = 7.2 Hz, 2H), 1.76 (s, 3H), 1.39-1.34 (m, 6H), 1.23 (s, 9H). 
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  CHAPTER 2 
DEVELOPMENT OF A BROOK/IRELAND-CLAISEN 
 REARRANGEMENT SEQUENCE 
 
2.1 Introduction 
 New methods to produce the glycolic acid moiety continue to be important in the 
creation of small molecule building blocks.  ,-Unsaturated glycolic acid derivatives 
represent a functional group-rich subset of substituted -hydroxy acids with significant 
potential for further elaboration. A common approach to the preparation of such 
compounds is the Ireland-Claisen rearrangement of allyl glycolate esters (Scheme 2-
1).
1,2,3
    While the standard Ireland-Claisen rearrangement is performed by sequential 
enolization and silylation of allylic esters, creative alternative approaches to the requisite 
silyl ketene acetal have been reported.  Known methods include 1,4-addition to enoates,
4
 
silylene transfer followed by 6-electrocyclization,5 and Rh-catalyzed reduction of 
enoates.
6
  All of these methods allow for the generation of chiral products from achiral 
starting materials; however, a glycolate Ireland-Claisen rearrangement that introduces 
two -substituents in one step has remained elusive. 
Scheme 2-1. Ireland-Claisen Rearrangement of Allyl Glycolate Esters 
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Silyl glyoxylates (1, Scheme 2-2) are reagents for the geminal linking of 
nucleophile/electrophile pairs at a glycolic acid junction (see Chapter 1).
7,8
  Since 
multicomponent couplings involving silyl glyoxylates are believed to proceed by a 
glycolate enolate intermediate, the use of an allylic ester might allow [3,3]-sigmatropic 
rearrangement to proceed in preference to intermolecular addition to an electrophile 
(Scheme 2-2).   
Scheme 2-2. Silyl Glyoxylate Reactivity 
 
The Ireland-Claisen rearrangement proceeds via a well-understood transition state 
wherein the enolate geometry dictates the stereochemistry of the product.  The E/Z 
geometry of the intermediate glycolate enolate has not been established in reactions of 
silyl glyoxylates; therefore, determination of enolate geometry would augment our 
understanding of silyl glyoxylate reactivity and provide mechanistic insight for future 
endeavors (Scheme 2-3).  Furthermore, this process would create two new CC bonds, 
allowing access to densely functionalized glycolic acids.   
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Scheme 2-3. Proposed Rearrangement Cascade 
 
2.2 Results and Discussion 
2.2.1 Preparation of Allylic Silyl Glyoxylates 
 Development of the Brook/Ireland-Claisen rearrangement cascade first required 
preparation of allylic silyl glyoxylates.  The established synthesis of alkyl silyl 
glyoxylates involves a four step sequence from the alkyl acetoacetate, involving diazo 
transfer, retro-Claisen fragmentation, silylation, and oxidation (eq. 1, Scheme 2-4).
9
  
Although allyl acetoacetate is commercially available, the preparation and subsequent 
Ireland-Claisen rearrangement of simple allyl silyl glyoxylate would not yield useful 
information regarding the enolate geometry, as only one chiral center would be 
generated; therefore, substituted allylic silyl glyoxylates (cinnamyl, crotyl, etc.) needed to 
be prepared.  Preparation of cinnamyl acetoacetate proved to be more challenging than 
originally anticipated.   
The preparation of alkyl acetoacetates involves the thermal transesterification of t-
butyl acetoacetate, driven by distillative removal of t-butanol.  However, when 
transesterification of t-butyl acetoacetate was attempted with cinnamyl alcohol, an 
undesired [3,3]-rearrangement followed by decarboxylation (Carroll rearrangement) 
occurred as a consequence of the allylic ester (eq. 2, Scheme 2-4).
10
  Following some 
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experimentation, allylic alcohol acetoacetylation by treatment with diketene proved to be 
effective as it did not require elevated temperatures and thus avoided Carroll 
rearrangement (eq. 3, Scheme 2-4).  With cinnamyl acetoacetate in hand, subsequent 
diazo transfer, retro-Claisen, and C-silylation proceeded smoothly.  However, in the final 
step, treatment with Oxone
®
 resulted in competitive overoxidation to epoxide 2.   
Scheme 2-4. Allylic Esters Incompatible with Traditional Silyl Glyoxylate Synthesis 
 
 Due to these difficulties, we modified our approach and installed the allylic ester 
following acylsilane formation.  The silyl glyoxylic acid 3 can undergo nucleophilic 
esterification with allylic bromides (Scheme 2-5) under identical conditions to those 
developed in Chapter 1 for esterification with benzylic bromides.  This method was found 
to be effective with both TBS and TIPS silyl glyoxylic acids with various allylic 
bromides.   
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Scheme 2-5. Nucleophilic Esterification of Silyl Glyoxylic Acids 
 
 
 
2.2.2 Identification of Competent Nucleophiles 
Preliminary work focused on defining a compatible nucleophilic component.  
Previously employed nucleophiles such as vinylmagnesium bromide and zinc acetylides 
were found to trigger oligomerization of the silyl glyoxylate.  This result underscores the 
chemoselectivity displayed in previously reported three-component coupling reactions, 
where the nucleophile reacts selectively with the silyl glyoxylate, rather than the terminal 
electrophile, and the intermediate glycolate enolate reacts selectively with a terminal 
electrophile, rather than a second equivalent of silyl glyoxylate.  The proposed 
transformation would need to proceed in the absence of a secondary electrophile (vide 
infra).  We hypothesized that two requirements exist for any given nucleophile to initiate 
the desired rearrangement cascade (Scheme 2-6): (1) the nucleophile must fully consume 
the silyl glyoxylate prior to Brook rearrangement in order to prevent oligomerization, and 
(2) following Brook rearrangement the intermediate glycolate enolate must be stable 
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enough to undergo Ireland-Claisen rearrangement in preference to decomposition via 
ketene formation.   
Scheme 2-6. Rate Requirements for the Desired Cascade 
 
In an effort to identify competent nucleophiles, a screen of organometallics was 
performed.  In each case, the result was silyl glyoxylate oligomerization or other forms of 
decomposition (Figure 2-1).  Attempts to inhibit Brook rearrangement by holding the 
reaction at -78 °C for several hours still resulted in oligomerization; this result may be 
due to slower nucleophilic addition to silyl glyoxylate at low temperature, leaving behind 
unreacted silyl glyoxylate that could participate in oligomerization. 
 Figure 2-1. Nucleophiles that Generate Oligomers or Unidentified Products 
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2.2.3 Scope and Limitations 
An assessment of Grignard reagents revealed that MeMgBr had potential as an 
effective nucleophile as it cleanly added to cinnamyl silyl glyoxylate 1b at 0 °C.  In this 
case, Brook rearrangement did not occur below room temperature (Scheme 2-7).  When 
the reaction was allowed to warm, decomposition was observed within 30 minutes.  In an 
attempt to stabilize the glycolate enolate intermediate, silyl ketene acetal formation was 
attempted by addition of MeMgBr at 0 °C followed by warming to room temperature and 
addition of TMSCl; however, this experiment also resulted in decomposition.  Given that 
no TMS incorporation was observed, we turned to TMSOTf, which induced the desired 
Ireland-Claisen rearrangement and provided the -unsaturated glycolic acid S1 in 55% 
yield (Scheme 2-7).  
Scheme 2-7. Successful Ireland-Claisen Rearrangement with MeMgBr 
 
Various organozinc nucleophiles were also found to be effective nucleophilic 
initiators. ZnEt2 serves as an efficient hydride donor, triggering the sequential Brook and 
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Ireland-Claisen rearrangements, to afford the glycolic acid in 69% yield with good 
diastereoselectivity (Table 2-1, entry 5).  The hydride reduction of -ketoesters with 
ZnEt2 or EtMgBr has been previously reported; however, it is typically a minor 
byproduct to ethyl addition.
11
  Allyl zinc bromide and allenyl zinc bromide were useful 
triggers as well (Table 2-1, entries 6-10).   
Table 2-1. Sequenced Brook and Ireland-Claisen Rearrangements 
 
entry silyl glyoxylate Nu yield, d.r. 
1 1b MeMgBr/TMSOTf 
 
2 1d MeMgBr/TMSOTf 
 
3 1g MeMgBr/TMSOTf 
 
4 1b 
 
 
5 1b ZnEt2 
 
6 1b 
 
 
7 1d 
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8 1g 
 
 
9 1b 
 
 
10 1d 
 
 
11 1b 
 
 
12 1d 
 
 
 
Substituted allylic zinc nucleophiles were also competent initiators.  
Methallylzinc bromide provided the desired products with slightly diminished 
diastereoselectivity relative to allylzinc bromide (entries 11-12).  Crotyl- and 
cinnamylzinc reagents provided a complex mixture of diastereomeric products (Scheme 
2-8).  Notably, none of the organozinc nucleophiles required silyl ketene acetal 
formation, as the zinc enolate underwent [3,3]-rearrangement spontaneously.  The lithium 
enolate of 
t
BuOAc also initiated the Brook/Ireland-Claisen sequence without TMS 
trapping and proceeded with excellent diastereoselectivity (Table 2-1, entry 4). 
Scheme 2-8. Crotyl Zinc Bromide Generates Three Adjacent Chiral Centers 
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Extension to other organozinc bromides proved challenging.  Benzylzinc 
bromide, propynylzinc bromide, and Reformatsky nucleophiles resulted in alkene dimer 5 
(Scheme 2-9).  This dimer was cleanly formed by addition of the glycolate enolate to a 
second equivalent of silyl glyoxylate.  The derived alkoxide suffered Brook 
rearrangement and elimination.  It appears that allyl and allenyl zinc bromide 
nucleophiles consumed the silyl glyoxylate more rapidly and therefore dimerization was 
not competitive. 
Scheme 2-9. Organozinc Bromide Induced Dimerization 
 
 The scope of the ester component was also investigated.  While cinnamyl (1b), 
crotyl (1d), and substituted crotyl (1g) silyl glyoxylates were effective, the more hindered 
silyl glyoxylates 1f and 1h failed to undergo the desired transformation (Figure 2-2).  
This may be due to steric hindrance preventing the approach of the enolate and ester 
termini, slowing the Ireland-Claisen rearrangement and eventually resulting in enolate 
decomposition. 
Figure 2-2. Ineffective Silyl Glyoxylates 
 
Geranyl silyl glyoxylate 1e underwent the title transformation when treated with 
allenyl or allylic zinc bromides, providing glycolic acid derivatives in moderate 
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diastereoselectivity (Table 2-2).  These results demonstrate that the Brook/Ireland-
Claisen sequence may show promise for the construction of adjacent chiral quaternary 
centers.   
Table 2-2. Preparation of Contiguous Quaternary Centers 
 
entry nucleophile product (yield) d.r. 
1  
 
3.0:1 
2  
 
3.7:1 
3 
 
 
2.5:1 
 
2.2.4 Determination of Stereochemistry 
Enolate geometry was inferred by examination of the relative stereochemistry of 
the -unsaturated glycolic acid products.  The majority of these products were unknown 
compounds, so derivatization was required in order to allow NOESY analysis for 
determination of stereochemistry.  The -unsaturated acids resulting from addition of 
allyl zinc bromide were treated with Grubbs II catalyst to form cyclopentenes via RCM 
(6a-6c, Scheme 2-10).  The products of allenyl zinc bromide addition (Table 2-1, entries 
9-10), failed to undergo clean enyne RCM, so they were subjected to Lindlar reduction to 
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provide the corresponding dienes.  NOESY stereochemical analysis of the geraniol 
derived cyclopentene 6b was inconclusive, so the carboxylic acid was reduced with LAH 
to diol 6c, revealing an additional diagnostic methylene that facilitated NOESY analysis.  
Scheme 2-10.  Product Derivatization for Stereochemical Determination 
 
Products that possessed only one olefin could be cyclized by iodolactonization to 
the corresponding -lactones 7a-c (Scheme 2-10).  In some other cases, the tertiary silyl 
ethers of the acyclic products could be deprotected with TBAF to provide known 
compounds.  In each case, the major diastereomer was found to be consistent with a (Z)-
glycolate enolate, assuming the Ireland-Claisen rearrangement proceeded through a 
chairlike transition state (Scheme 2-11).   
Scheme 2-11. (Z)-Glycolate Enolate Intermediate 
 
2.2.5 Mechanistic Insight  
The degree of diastereocontrol depended on the identity of both the nucleophile 
and the ester.  While cinnamyl silyl glyoxylate 1b reacted with allylzinc bromide (Table 
2-1, entry 6) and allenylzinc bromide (entry 9) with modest diastereocontrol, analogous 
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reactions with crotyl silyl glyoxylate 1d resulted in substantially higher d.r.’s (entries 7, 
10).  The formation of the chelated alkoxide 8 (Scheme 2-12) appears likely in light of 
the established tendencies for bidentate coordination in dicarbonyl electrophiles and 
the derived addition products.
12
  Proper alignment of the CSi  orbital with the adjacent 
C=O * orbital in tetrahedral intermediate 8 would allow [1,2]-Brook rearrangement to 
proceed,  forming glycolate enolate 9a.  These stereoelectronic considerations would 
suggest subsequent formation of (Z)-enolate 9a arising from Brook rearrangement 
(scheme 2-12).  Without breaking chelation prior to Brook rearrangement, formation of 
(E)-enolate 9b would be challenging, as the proper orbital alignment for silyl migration 
would be inaccessible.   
Scheme 2-12. FMO Analysis 
 
 
Following Brook rearrangement, the resulting silyl ether should dramatically 
weaken chelation,
13
 potentially permitting enolate equilibration (via the CZn tautomer 
9c, scheme 2-13 below) to compete with Ireland-Claisen rearrangement from the (Z)-
isomer.  The rate of the sigmatropic rearrangement should be linked to steric demand, 
C-Si C=O
poor orbital 
overlap
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where a less hindered substrate undergoes more rapid [3,3]-rearrangement;
14
 therefore, it 
is hypothesized that the more encumbered 1b undergoes enolate equilibration to a greater 
extent prior to sigmatropic rearrangement.  The result is an erosion of the initial enolate 
geometric ratio and a corresponding decrease in product diastereoselectivity.  This 
proposal is consistent with the experimental observations within the organozinc 
nucleophile series: the product diastereomer ratio increases as nucleophile bulk decreases 
(hydride > propargyl ≈ allyl > methallyl).15   
Scheme 2-13. Mechanistic Rationale for Diastereoselectivity Trend 
 
It is notable that MeMgBr initiates Ireland-Claisen rearrangement with 
diastereoselectivity independent of ester.  This may be a result of silyl ketene acetal 
formation prior to sigmatropic rearrangement.  Provided there is no enolate equilibration 
after TMSOTf trapping, the diastereoselectivity reflects the (Z)/(E) Mg-enolate ratio at 
the time of TMSOTf addition.  The high diastereoselectivity observed for the Li-enolate 
(Table 2-1, entry 4) can be explained if generation of the CLi tautomer 9c is slow and 
[3,3]-sigmatropic rearrangement outcompetes enolate equilibration.  
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2.2.6 Implications of Enolate Geometry 
A (Z)-glycolate enolate resulting from Brook rearrangement is consistent with the 
results of other silyl glyoxylate couplings with lithium, magnesium, and zinc counterions.  
A recent report by Lu describes the synthesis of amidines via three component coupling 
of lithium aza-enolates, silyl glyoxylates, and aldimines.
16
  The high levels of 
diastereoselectivity can be rationalized by a chairlike transition state wherein the (Z)-
glycolate enolate approaches the aldimines from the opposite direction of the t-butyl 
group (Scheme 2-14). 
Scheme 2-14. Lu’s Highly Diastereoselective Couplings via a (Z)-Lithium Enolate 
 
Evidence of a (Z)-magnesium enolate intermediate was also obtained from the 
Meerwein-Ponndorf-Verley initiated aldol reaction previously developed in our group 
(Scheme 2-15).
17
  The resulting anti stereochemistry is consistent with a (Z)-glycolate 
enolate reacting via a boatlike transition state, a proposal that follows precedent set by 
Evans for (Z)-magnesium enolate anti propionate aldol additions.
18
  Further support for a 
(Z)-magnesium enolate was obtained through Boyce and Liu’s density functional theory 
calculations on a related system that reveal a thermodynamic preference of 6.4 kcal/mol 
relative to the (E)-magnesium glycolate enolate.
19
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Scheme 2-15. Linghu’s Diastereoselective Aldol via a (Z)-Magnesium Enolate 
 
The observed facile equilibration of zinc glycolate enolates further validates 
Greszler’s previously proposed mechanism for the diastereoselective three component 
couplings of Reformatsky reagents, silyl glyoxylates, and ketones.
20
  In that study, 
propionate nucleophiles provided substantially higher diastereoselectivity than acetate 
nucleophiles.  The stereochemical result is consistent with a boat/twist-boat transition 
state in which the ethyl ester chelates to the zinc, necessitating isomerization to the (E)-
glycolate enolate, and approach of the ketone electrophile from the less hindered face 
(Scheme 2-16). 
Scheme 2-16. Greszler’s Couplings via Equilibration to the (E)-Zn Enolate 
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2.3 Conclusion 
In summary, we have developed a one-pot Brook/Ireland-Claisen rearrangement 
sequence that generates -unsaturated glycolic acids containing two new CC bonds 
and two contiguous stereocenters.  The reaction is tolerant of various reaction partners, 
but diastereoselectivity is linked to the identity of the metal cation and the ester.  In cases 
that show good diastereoselectivity, the stereochemical outcome of the reaction is 
consistent with a (Z)-enolate intermediate proceeding through a chairlike transition state.  
The work suggests that diastereocontrol and enolate geometry in reactions with silyl 
glyoxylates can be tuned with the judicious selection of metal cation and that the rate of 
the “second stage” reaction can have an impact.   
2.4 Experimental 
Materials and Methods: General.  Infrared (IR) spectra were obtained using a Nicolet 
560-E.S.P. infrared spectrometer.  Proton and carbon nuclear magnetic resonance spectra 
(
1
H and 
13
C NMR) were recorded on either a Bruker model Avance 600 (
1
H NMR at 600 
MHz and 
13
C NMR at 150 MHz), Bruker model Avance 500 (
1
H at 500 MHz and 
13
C 
NMR at 125 MHz), Bruker model Avance 400 (
1
H NMR at 400 MHz and 
13
C NMR at 
100 MHz), or a Varian Gemini 300 (
1
H NMR at 300 MHz and 
13
C at 75 MHz) 
spectrometer with solvent resonance as the internal standard (
1
H NMR: CDCl3 at 7.26 
ppm; C6D6 at 7.15 ppm and 
13
C NMR: CDCl3 at 77.0 ppm and C6D6 at 128.62 ppm).  
1
H 
NMR data are reported as follows: chemical shift, multiplicity (s = singlet, br s = broad 
singlet, d = doublet, t = triplet, q = quartet, sept = septet, m = multiplet), coupling 
constants (Hz), and integration.  Analytical thin layer chromatography (TLC) was 
performed on Whatman 0.25 mm silica gel 60 plates.  Visualization was accomplished 
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with UV light and aqueous ceric ammonium molybdate solution followed by heating.  
Purification of the reaction products was carried out by flash chromatography using 
Sorbent Technologies silica gel 60 (32-63 µm).  All reactions were carried out under an 
atmosphere of nitrogen in oven-dried glassware with magnetic stirring.  Yield refers to 
isolated yield of analytically pure material.  Yields are reported for a specific experiment 
and as a result may differ slightly from those found in the tables, which are averages of at 
least two experiments.  Diethyl ether, methylene chloride, tetrahydrofuran, and toluene 
were dried by passage through a column of neutral alumina under nitrogen prior to use.
21
 
Unless otherwise noted, reagents were obtained from commercial sources and used 
without further purification.  Triethylamine, diisopropylamine, and pyridine were freshly 
distilled from CaH2 under Ar prior to use. 
 
Synthesis of Silyl Glyoxylates 
General esterification procedure A for formation of allylic silyl glyoxylates: To t-
butyl t-butyldimethylsilyl glyoxylate,
9
 (1.0 equiv) a solution of 20:10:1 CH2Cl2:TFA:H2O 
(0.5 M) was added.  After the yellow solution was stirred at room temperature for 1 h, the 
reaction mixture was concentrated in vacuo.  The yellow oil was then dissolved in 
toluene and again concentrated in vacuo.  The resulting yellow oil was added to a dry 
round bottom flask and the allylic bromide (1.3 equiv), and tetrabutylammonium iodide 
(0.1 equiv) were added.  The mixture was dissolved in 1:1 Et2O:CH2Cl2 (0.1 M) and NEt3 
(1.4 equiv) was added.  The flask was fitted with a reflux condenser and the solution was 
heated to reflux for 10-16 h.  The reaction was then allowed to cool to room temperature.  
The reaction was diluted with 30 mL saturated aqueous NH4Cl solution.  The layers were 
78 
 
separated and the aqueous layer was extracted with Et2O (2 X 30 mL) and then CH2Cl2 (2 
X 30 mL).  The organic extracts were combined, dried with MgSO4, and concentrated in 
vacuo.  The resulting yellow oil was purified as indicated. 
 
 
Cinnamyl tert-butyldimethylsilyl glyoxylate (1b).  The general esterification procedure 
was performed using t-butyl t-butyldimethylsilyl glyoxylate (4.96 g, 20.3 mmol), 
cinnamyl bromide (5.20 g, 26.4 mmol), tetrabutylammonium iodide (750 mg, 2.03 
mmol), and NEt3 (3.95 mL, 28.4 mmol).  Purification by flash chromatography (3:97 
Et2O:petroleum ether) furnished 3.07 g (50%) of 1b as a yellow liquid: IR (thin film, cm
-
1
) 3029, 2930, 2860, 1718, 1654, 1558, 1541, 1254, 968; 
1
H NMR (300 MHz, CDCl3) 
7.41-7.28 (m, 5H), 6.73 (d, J = 15.6 Hz, 1H), 6.33 (dt, J = 15.9, 6.6 Hz, 1H), 4.89 (d, J 
= 6.6 Hz, 2H), 0.97 (s, 9H), 0.30 (s, 6H); 
13
C NMR (100 MHz, CDCl3) 231.9162.8, 
135.9, 135.7, 128.6, 128.3, 126.7, 121.8, 66.0, 26.4, 17.0, -6.9; TLC (5:95 EtOAc: 
petroleum ether) Rf 0.40. LRMS (ESI) exact mass calculated for C17H24O3SiNa: 327.15.  
Found: 327.13. 
 
 
Crotyl tert-butyldimethylsilyl glyoxylate (1d).  The general esterification procedure 
was performed using t-butyl t-butyldimethylsilyl glyoxylate (780 mg, 3.19 mmol), trans-
crotyl bromide
22
 (559 mg, 4.14 mmol), tetrabutylammonium iodide (118 mg, 0.319 
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mmol), and NEt3 (622 L, 4.47 mmol).  Purification by flash chromatography (3:97 
Et2O:petroleum ether) furnished 335 mg (43%) of 1d as a yellow liquid: IR (thin film, 
cm
-1
) 2953, 2931, 2886, 2860, 2360, 1719, 1656, 1465, 1254; 
1
H NMR (400 MHz, 
CDCl3) 5.90-5.84 (m, 1H), 5.67-5.59 (m, 1H), 4.64 (d, J = 6.8 Hz, 2H), 1.73 (d, J = 6.8 
Hz, 3H), 0.96 (s, 9H), 0.27 (s, 6H); 
13
C NMR (100 MHz, CDCl3) 162.8, 133.0, 124.0, 
66.1, 27.9, 26.4, 17.7, 16.9, -7.0; TLC (5:95 EtOAc: petroleum ether) Rf 0.52.  LRMS 
(ESI) exact mass calculated for C12H22O3SiNa: 265.13. Found: 265.12. 
 
 
 
(E)-pent-3-en-2-yl-tert-butyldimethylsilyl glyoxylate (1g).  The general esterification 
procedure was performed using t-butyl t-butyldimethylsilyl glyoxylate (1.09 g, 4.46 
mmol), (E)-4-bromopent-2-ene
 
(864 mg, 5.80 mmol), tetrabutylammonium iodide (165 
mg, 0.446 mmol), and NEt3 (870 L, 6.24 mmol).  Purification by flash chromatography 
(3:97 Et2O:petroleum ether) furnished 337 mg (29%) of 1g as a yellow liquid: IR (thin 
film, cm
-1
) 2954, 2932, 2886, 2860, 1715, 1658, 1558, 1541, 1254; 
1
H NMR (300 MHz, 
CDCl3) 5.85-5.78 (m, 1H), 5.55-5.40 (m, 2H), 1.70 (d, J = 6.6, 3H), 1.38 (d, J = 6.3 Hz, 
3H), 0.95 (s, 9H), 0.27 (s, 6H); 
13
C NMR (100 MHz, CDCl3) 232.1, 162.6, 129.8, 73.2, 
26.4, 20.2, 17.5, 16.9, -6.9; TLC (5:95 EtOAc: petroleum ether) Rf 0.54. LRMS (ESI) 
exact mass calculated for C13H24O3SiNa: 279.15. Found: 279.13. 
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Geranyl tert-butyldimethylsilyl glyoxylate (1e).  The general esterification procedure 
was performed using t-butyl t-butyldimethylsilyl glyoxylate (1.21 g, 4.94 mmol), geranyl 
bromide (1.39 g, 6.42 mmol), tetrabutylammonium iodide (182 mg, 0.494 mmol), and 
NEt3 (0.96 mL, 6.92 mmol).  Purification by flash chromatography (2:98 Et2O:petroleum 
ether) furnished 969 mg (60%) of 1e as a yellow liquid: IR (thin film, cm
-1
) 2930, 2859, 
1717, 1660, 1464, 1377, 1365, 1252, 990; 
1
H NMR (300 MHz, CDCl3) 5.41 (t, J = 6.9 
Hz, 1H), 5.09-5.07 (m,  1H), 4.75 (d, J = 7.5 Hz, 2H), 2.10-2.03 (m, 4H), 1.73 (s, 3H), 
1.68 (s, 3H), 1.60 (s, 3H), 0.96 (s, 9H), 0.27 (s, 6H); 
13
C NMR (100 MHz, CDCl3) 
231.9, 163.1, 143.9, 131.9, 123.6, 117.3, 62.2, 39.5, 28.0, 26.4, 26.3, 25.6, 17.6, 17.0, 
16.5, -6.9; TLC (5:95 EtOAc: petroleum ether) Rf 0.53. LRMS (ESI) exact mass 
calculated for C18H32O3SiNa: 347.21. Found: 347.20. 
  
 
Synthesis of Glycolic Acid Derivatives (Tables 2-1 and 2-2) 
 
General procedure B for reaction of silyl glyoxylates with MeMgBr: A solution of 
MeMgBr (1.7 equiv) in Et2O (3 M) was diluted with Et2O to 0.18 M.  The solution was 
cooled to 0 °C and a solution of silyl glyoxylate (1.0 equiv) in Et2O (0.03 M) was added.  
The ice bath was removed and the reaction was stirred for 1 min.  TMSOTf (2.0 equiv) 
was added and the reaction was stirred at room temperature for 2-8 h.  The reaction was 
diluted with aqueous HCl (1 M, 5 mL).  The layers were separated and the aqueous layer 
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was extracted with CH2Cl2 (3 X 10 mL).  The organic extracts were combined, dried with 
MgSO4, and concentrated in vacuo.  The resulting colorless oil was purified as indicated. 
 
 
 
2-hydroxy-2-methyl-3-phenylpent-4-enoic acid (S1). General procedure B was 
performed using cinnamyl tert-butyldimethylsilyl glyoxylate (80 mg, 0.263 mmol), 
MeMgBr (3 M in Et2O, 0.15 mL, 0.447 mmol), and TMSOTf (95 L, 0.526 mmol).  
Purification by flash chromatography (96:3:1 petroleum ether:Et2O:HOAc) furnished 30 
mg (55%) of S1 as a clear oil that matched analytical data previously reported.
23 
 
 
 
2-hydroxy-2,3-dimethylpent-4-enoic acid (S2).  General procedure B was performed 
using crotyl t-butyldimethylsilyl glyoxylate (80 mg, 0.33 mmol), MeMgBr (0.19 mL, 
0.561 mmol), and TMSOTf (119 L, 0.66 mmol).  Purification by flash chromatography 
(96:3:1 petroleum ether:Et2O:HOAc) furnished 25 mg (53%) of S2 as a clear oil that 
matched analytical data previously reported.
24
 
 
 
(E)-2-(tert-butyldimethylsilyloxy)-2,3-dimethylhex-4-enoic acid (S3).  General 
procedure B was performed using (E)-pent-3-en-2-yl 2-tert-butyldimethylsilyl glyoxylate 
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(70 mg, 0.273 mmol), MeMgBr (0.155 mL, 0.464 mmol), and TMSOTf (99 L, 0.546 
mmol).  Purification by flash chromatography (96:3:1 petroleum ether:Et2O:HOAc) 
furnished 48 mg (65%) of S3 as a white solid.  Analytical data for S3: mp 83 °C; IR (thin 
film, cm
-1
) 2930, 2857, 1715, 1472, 1462, 1410, 1371, 1282, 1198; 
1
H NMR (400 MHz, 
CDCl3) 5.54-5.45 (m, 1H), 5.34-5.26 (m, 1H), 2.46-2.41 (m, 1H), 1.69 (d, J = 6.3 Hz, 
3H), 1.44 (s, 3H), 0.99 (d, J = 6.6 Hz, 3H), 0.93 (s, 9H), 0.16 (s, 3H), 0.14 (s, 3H); 
13
C 
NMR (125 MHz, CDCl3) 130.9, 127.7, 80.8, 46.2, 25.8, 24.2, 18.5, 18.0, 15.7, -2.5, -
2.7; TLC (10:90 EtOAc: petroleum ether) Rf 0.25. LRMS (ESI) exact mass calculated 
for C14H28O3SiNa: 295.18. Found: 295.17. 
Proof of Stereochemistry:  Product stereochemistry was determined by conversion to 
the known 2-hydroxy-2,3-dimethylhex-4-enoic acid.  This was accomplished via TBAF 
deprotection.  Spectral data of the minor diastereomer were identical to those reported in 
the literature (Wood, J. L.; Moniz, G. A.; Pflum, D. A.; Stoltz, B. M.; Holubec, A. A.; 
Dietrich, H.  J. Am. Chem. Soc. 1999, 121, 1748-1749).  Major diastereomer: 
1
H NMR 
(400 MHz, CDCl3) 5.63-5.55 (m, 1H), 5.42-5.36 (m, 1H), 2.52-2.47 (m, 1H), 1.72 (d, J 
= 6.4, 3 H), 1.42 (s, 3H), 1.02 (d, J = 6.8 Hz, 3H).  Minor diastereomer: (400 MHz, 
CDCl3) 5.63-5.55 (m, 1H), 5.42-5.36 (m, 1H), 2.52-2.47 (m, 1H), 1.67 (d, J = 6.4, 3 H), 
1.42 (s, 3H), 1.08 (d, J = 6.8 Hz, 3H). 
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2-(2-tert-butoxy-2-oxoethyl)-2-(tert-butyldimethylsilyloxy)-3-phenylpent-4-enoic 
acid (S4). To 56 mg LiCl in 2.2 mL THF at 0 °C was added diisopropylamine (55 L, 
0.395 mmol, 1.5 equiv) followed by 
n
BuLi (1.5 M in hexanes, 0.245 mL, 0.368 mmol, 
1.4 equiv).  The solution was stirred for 10 min at 0 °C and then warmed to room 
temperature and stirred 15 min.  The solution was then cooled to -78 °C and tBuOAc (46 
L, 0.342 mmol, 1.3 equiv) was added.  The solution was stirred for 1 h at -78 °C.  
Cinnamyl silyl glyoxylate (80 mg, 0.263 mmol, 1.0 equiv) in 2.0 mL Et2O was then 
added via syringe.  The solution was slowly warmed to room temperature and stirred for 
19 h.  The reaction was diluted with 5 mL aqueous HCl (1 M).  The layers were separated 
and the aqueous layer was extracted with CH2Cl2 (3 X 10 mL).  The organic extracts 
were combined, dried with MgSO4, and concentrated in vacuo.  Purification by flash 
chromatography (93:6:1 petroleum ether:Et2O:HOAc) furnished  34 mg (31%) of S4 as a 
white solid.  Analytical data for S4: mp 92 °C; IR (thin film, cm-1) 2929, 2855, 1735, 
1558, 1541, 1473, 1393, 1368, 1152; 
1
H NMR (300 MHz, CDCl3) 7.26-7.20 (m, 5H), 
6.36-6.24 (m, 1H), 5.27 (dd, J = 10.2, 1.2 Hz, 1H), 5.19 (d, J = 17.1, 1H), 3.81 (d, J = 9.6 
Hz, 1H), 2.92 (d, J = 16.8 Hz, 1H), 2.72 (d, J = 16.8 Hz, 1H), 1.46 (s, 9H), 0.93 (s, 1H), 
0.12 (s, 3H), -0.06 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 170.6, 138.9, 135.9, 129.4, 
128.0, 127.2, 118.9, 82.5, 80.9, 57.5, 44.7, 28.1, 26.2, 19.0, -2.6, -2.9; TLC (10:90 
EtOAc: petroleum ether) Rf 0.14. LRMS (ESI) exact mass calculated for C23H36O5SiNa: 
443.23. Found: 443.21. 
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Proof of Stereochemistry:  Product stereochemistry was determined by conversion to 
the iodolactone 7c and subsequent NOESY analysis.  Experimental details are provided 
below. 
 
 
2-(tert-butyldimethylsilyloxy)-3-phenylpent-4-enoic acid (S5). ZnEt2 (1 M in hexanes, 
0.39 mL, 0.394 mmol, 1.5 equiv) was diluted with 1.2 mL Et2O.  The solution was cooled 
to 0 °C and a solution of cinnamyl tert-butyldimethylsilyl glyoxylate (80 mg, 0.263 
mmol, 1.0 equiv) in 2.8 mL Et2O was added.  The reaction was warmed to room 
temperature and allowed to stir for 4 h.  The reaction was diluted with 5 mL aqueous HCl 
(1 M).  The layers were separated and the aqueous layer was extracted with CH2Cl2 (3 X 
10 mL).  The organic extracts were combined, dried with MgSO4, and concentrated in 
vacuo.  Purification by flash chromatography (96:3:1 petroleum ether:Et2O:HOAc) 
furnished 56 mg (69%) of S5 as a white solid.  Analytical data for S5:  mp 82 °C; IR 
(thin film, cm
-1
) 3031, 2954, 2929, 2896, 2858, 2360, 1724, 1255, 1134; 
1
H NMR (300 
MHz, CDCl3) 7.32-7.21 (m, 5H), 6.19-6.07 (m, 1H), 5.19 (d, J = 3.3 Hz, 1H), 5.14 (s, 
1H), 4.44 (d, J = 5.7 Hz, 1H), 3.71 (dd, J = 8.7, 6.0 Hz, 1H), 0.86 (s, 9H), 0.00 (s, 3H), -
0.05 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 176.0, 139.0, 136.9, 128.9, 128.3, 127.1, 
117.5, 76.6, 54.6, 25.6, 18.0, -5.4; TLC (10:90 EtOAc: petroleum ether) Rf 0.20. LRMS 
(ESI) exact mass calculated for C17H26O3SiNa: 329.17. Found: 329.15. 
Proof of Stereochemistry:  Product stereochemistry was determined by conversion to 
the known 2-hydroxy-3-phenylpent-4-enoic acid.  This was accomplished via TBAF 
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deprotection.  Spectral data were identical to that reported in the literature (Kaur, P.; 
Singh, P.; Kumar, S.  Tetrahedron 2005, 61, 8231-8240). 
1
H NMR (400 MHz, CDCl3) 
7.31-7.24 (m, 5H), 6.27-6.18 (m, 1H), 5.27-5.23 (m, 2H), 4.59 (m, 1H), 3.87-3.86 (m, 
1H). 
 
 
General procedure C for reaction of silyl glyoxylates with allyl zinc bromide and 
methallyl zinc bromide: A solution of allyl zinc bromide
25 
(1.5 equiv) or methallylzinc 
bromide (1.5 equiv) in THF (0.33 M) was diluted with Et2O to 0.16 M.  The solution was 
cooled to -78 °C and a solution of silyl glyoxylate (1.0 equiv) in Et2O (0.10 M) was 
added.  The reaction was allowed to slowly warm to room temperature over 1 h and then 
stir for 30 min to 2 h at room temperature.  The reaction was diluted with 5 mL aqueous 
HCl (1 M).  The layers were separated and the aqueous layer was extracted with CH2Cl2 
(3 X 10 mL).  The organic extracts were combined, dried with MgSO4, and concentrated 
in vacuo.  The resulting colorless oil was purified as indicated. 
 
2-allyl-2-(tert-butyldimethylsilyloxy)-3-phenylpent-4-enoic acid (S6).  General 
procedure C was performed using cinnamyl tert-butyldimethylsilyl glyoxylate (40 mg, 
0.131 mmol) and allylZnBr (0.33 M, 0.60 mL, 0.197 mmol).  Purification by flash 
chromatography (96:3:1 petroleum ether:Et2O:HOAc) furnished  31 mg (68%) of S6 as a 
clear oil.  Analytical data for S6 (mix of diastereomers): IR (thin film, cm
-1
) 3079, 3031, 
2955, 2928, 2895, 1723, 1254, 1158; 
1
H NMR (400 MHz, CDCl3) 7.33-7.21 (m, 5H), 
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6.32-6.21 (m, 1H), 5.87-5.74 (m, 1H), 5.25-4.98 (m, 4H), 3.72-3.66 (m, 1H), 2.63-2.24 
(m, 3H), 0.96 (s, 9H), 0.11 (s, 3H), -0.10 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 178.5, 
139.9, 137.3, 136.1, 132.8, 129.8, 129.4, 128.0, 126.9, 119.1, 118.4, 83.3, 57.3, 44.1, 
26.3, 19.2, -1.7, -2.7; TLC (10:90 EtOAc:petroleum ether) Rf 0.20. LRMS (ESI) exact 
mass calculated for C20H30O3SiNa: 369.20. Found: 369.17. 
Proof of Stereochemistry:  Reaction proceeded with low diastereoselectivity.   
 
 
 
2-allyl-2-(tert-butyldimethylsilyloxy)-3-methylpent-4-enoic acid (S7).  General 
procedure C was performed using crotyl tert-butyldimethylsilyl glyoxylate (80 mg, 0.33 
mmol) and allylZnBr (0.33 M, 1.52 mL, 0.50 mmol).  Purification by flash 
chromatography (96:3:1 petroleum ether:Et2O:HOAc) furnished 54 mg (58%) of S7 as a 
clear oil.  Analytical data for S7: IR (thin film, cm
-1
) 3079, 2956, 2929, 2857, 1719, 
1644, 1558, 1254, 1170; 
1
H NMR (400 MHz, CDCl3) 5.84-5.73 (m, 2H), 5.13-5.07 (m, 
4H), 2.63-2.60 (m, 1H), 2.48 (d, J = 7.2 Hz, 1H), 1.01 (d, J = 6.8 Hz, 1H), 0.91 (s, 9H), 
0.17 (s, 3H), 0.14 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 179.0, 138.5, 132.9, 118.8, 
116.8, 83.5, 46.2, 43.5, 26.2, 19.1, 16.0, -2.0, -2.5; TLC (10:90 EtOAc: petroleum ether) 
Rf 0.28. LRMS (ESI) exact mass calculated for C15H28O3SiNa: 307.18. Found: 307.17. 
Proof of Stereochemistry:  Product stereochemistry was determined by ring closing 
metathesis and NOESY analysis of the resulting cyclopentene 6a.  Experimental details 
are provided below. 
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2-allyl-2-(tert-butyldimethylsilyloxy)-3-methylhex-4-enoic acid (S8).  General 
procedure C was performed using (E)-pent-3-en-2-yl 2-tert-butyldimethylsilyl glyoxylate 
(80 mg, 0.312 mmol) and allylZnBr (0.33 M, 1.42 mL, 0.468 mmol).  Purification by 
flash chromatography (94:5:1 petroleum ether:Et2O:HOAc) furnished  61 mg (67%) of 
S8 as a clear oil.  Analytical data for S8:  IR (thin film, cm
-1
) 3080, 2956, 2929, 2857, 
1642, 1416, 1377, 1277, 1106; 
1
H NMR (400 MHz, CDCl3) 5.82-5.72 (m, 1H), 5.54-
5.39 (m, 2H), 5.13-5.07 (m, 2H), 2.59-2.55 (m, 1H), 2.49-2.45 (m, 2H), 1.70 (d, J = 6 Hz, 
3H), 0.99 (d, J = 6.8 Hz, 3H), 0.92 (s, 9H), 0.17 (s, 3H), 0.16 (s, 3H); 
13
C NMR (100 
MHz, CDCl3) 179.5, 133.0, 131.0, 127.4, 118.6, 83.8, 45.7, 43.5, 26.2, 19.1, 18.1, 16.4, 
-2.0, -2.5; TLC (10:90 EtOAc: petroleum ether) Rf 0.26. LRMS (ESI) exact mass 
calculated for C16H30O3SiNa: 321.20. Found: 321.18. 
Proof of Stereochemistry:  Product stereochemistry was determined by ring closing 
metathesis, which provided cyclopentene 6a. Experimental details are provided below.   
 
2-allyl-2-(tert-butyldimethylsilyloxy)-3,7-dimethyl-3-vinyloct-6-enoic acid (S9).  
General procedure C was performed using geranyl tert-butyldimethylsilyl glyoxylate (80 
mg, 0.247 mmol) and allylZnBr (0.33 M, 1.12 mL, 0.370 mmol).  Purification by flash 
chromatography (96:3:1 petroleum ether:Et2O:HOAc) furnished 59 mg (65%) of S9 as a 
clear oil.  Analytical data for S9:  IR (thin film, cm
-1
) 3081, 2956, 2928, 2856, 1714, 
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1640, 1471, 1415, 1155; 
1
H NMR (300 MHz, CDCl3) 5.90 (dd, J = 17.4, 10.8 Hz, 1H), 
5.77-5.70 (m, 1H), 5.22-5.01 (m, 5H), 2.71 (dd, J = 14.4, 7.2 Hz, 1H), 2.43 (dd, J = 14.0, 
7.2 Hz, 1H), 1.80-1.75 (m, 2H), 1.71-1.61 (m, 1H) 1.67 (s, 3H), 1.56 (s, 3H), 1.40-1.36 
(m, 1H), 1.19 (s, 3H), 0.91 (s, 9H), 0.20 (s, 3H), 0.09 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) 178.0, 141.8, 133.9, 133.8, 131.4, 124.6, 119.2, 115.3, 86.9, 48.2, 39.4, 34.7, 
26.4, 25.7, 22.9, 19.4, 17.6, 17.1, -1.85, -2.06; TLC (10:90 EtOAc: petroleum ether) Rf 
0.32. LRMS (ESI) exact mass calculated for C21H38O3SiNa: 389.26. Found: 389.24. 
Proof of Stereochemistry:  Product stereochemistry was determined by ring closing 
metathesis followed by LiAlH4 reduction and NOESY analysis of the resulting 
cyclopentene 6c.  See below for experimental details. 
 
 
 
2-(tert-butyldimethylsilyloxy)-4-methyl-2-(1-phenylallyl)pent-4-enoic acid (S10).  
General procedure C was performed using cinnamyl tert-butyldimethylsilyl glyoxylate 
(80 mg, 0.263 mmol) and methallylZnBr (0.33 M, 1.19 mL, 0.394 mmol).  Purification 
by flash chromatography (96:3:1 petroleum ether:Et2O:HOAc) furnished 70 mg (74%) of 
S10 as a clear oil.  Analytical data for S10 (1:1 mix of diastereomers): IR (thin film, cm
-
1
) 3077, 3031, 2957, 2928, 2856, 1721, 1646, 1472, 1151; 
1
H NMR (400 MHz, CDCl3) 
7.37-7.21 (m, 5H), 6.39-6.33 (m, 1H), 6.27-6.18 (m, 1H), 5.28 (d, J = 10.4 Hz, 1H), 
5.17 (d, J = 17.2 Hz, 1H), 5.09 (d, J = 4.0 Hz, 1H),  5.06 (d, J = 10.8 Hz, 1H), 4.88 (d, J 
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= 14.8 Hz, 2H),  4.76 (d, J = 49.6 Hz, 2H), 3.76 (d, J = 9.6 Hz, 1H), 3.71 (d, J = 9.2 Hz, 
1H), 2.69 (d, J = 13.6 Hz, 1H) , 2.59 (d, J = 13.6 Hz, 1H), 2.56 (d, J = 13.6 Hz, 1H), 2.21 
(d, J = 13.6 Hz, 1H), 1.72 (s, 3H), 1.67 (s, 3H), 0.97 (s, 9H), 0.92 (s, 9H), 0.11 (s, 3H), 
0.10 (s, 3H), 0.05 (s, 3H), -0.19 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 140.1, 140.0, 
139.9, 137.8, 136.6, 129.8, 129.4, 128.2, 127.9, 127.0, 126.9, 118.7, 117.3, 116.8, 116.5, 
83.8, 83.1, 60.1, 58.2, 48.0, 47.4, 27.0, 26.8, 26.7, 23.6, 23.5, 19.5, -1.7, -1.8, -2.1, -2.5; 
TLC (10:90 EtOAc: petroleum ether) Rf 0.21. LRMS (ESI) exact mass calculated for 
C21H32O3SiNa: 383.21. Found: 383.20. 
Proof of Stereochemistry:  Product was obtained as a 1:1 mixture of diastereomers. 
 
 
 
2-(-but-3-en-2-yl)-2-(tert-butyldimethylsilyloxy)-4-methylpent-4-enoic acid (S11).  
General procedure C was performed using crotyl tert-butyldimethylsilyl glyoxylate (40 
mg, 0.165 mmol) and methallylZnBr (0.33 M, 0.75 mL, 0.248 mmol).  Purification by 
flash chromatography (96:3:1 petroleum ether:Et2O:HOAc) furnished  30 mg (61%) of 
S11 as a clear oil.  Analytical data for S11:  IR (thin film, cm
-1
) 3078, 2957, 2929, 2856, 
2360, 1719, 1646, 1472, 1161; 
1
H NMR (400 MHz, CDCl3) 5.90-5.81 (m, 1H), 5.14-
5.07 (m, 2H), 4.84 (s, 1H), 4.77 (s, 1H), 2.65-2.61 (m, 1H), 2.55 (d, J = 14.0 Hz, 1H), 
2.46 (d, J = 14.0, 1H), 1.71 (s, 3H), 1.02 (d, J = 6.8 Hz, 3H), 0.91 (s, 9H), 0.18 (s, 3H), 
0.16 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 178.1, 140.4, 138.7, 117.1, 115.7, 83.3, 
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47.2, 46.8, 26.4, 23.6, 19.3, 16.3, -2.0, -2.1; TLC (10:90 EtOAc: petroleum ether) Rf 
0.28. LRMS (ESI) exact mass calculated for C16H30O3SiNa: 321.20. Found: 321.18. 
Proof of Stereochemistry:  Product stereochemistry was assigned by analogy to 
allylzinc example with crotyl silyl glyoxylate. 
 
 
 
2-(tert-butyldimethylsilyloxy)-3,7-dimethyl-2-(2-methylallyl)-3-vinyloct-6-enoic acid 
(S12).  General procedure C was performed using geranyl tert-butyldimethylsilyl 
glyoxylate (80 mg, 0.247 mmol) and methallylZnBr (0.33 M, 1.12 mL, 0.370 mmol).  
Purification by flash chromatography (96:3:1 petroleum ether:Et2O:HOAc) furnished 52 
mg (55%) of S12 as a clear oil.  Analytical data for S12:  IR (thin film, cm
-1
) 2960, 2928, 
2856, 1712, 1647, 1471, 1414, 1377, 1145; 
1
H NMR (300 MHz, CDCl3) 5.94 (dd, J = 
17.7, 11.1 Jz, 1H), 5.24 (d, J = 11.1 Hz, 1H), 5.08-5.03 (m, 2H), 4.85 (s, 1H), 4.77 (s, 
1H), 2.74 (d, J = 13.5 Hz, 1H), 2.47 (d, J = 13.8 Hz, 1H), 1.79-1.72 (m, 2H), 1.67 (s, 6H), 
1.56 (s, 3H), 1.36-1.30 (m, 2H), 1.14 (s, 3H), 0.91 (s, 9H), 0.20 (s, 3H), 0.09 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3) 178.0, 142.0, 140.4, 131.3, 124.6, 116.9, 115.5, 86.1, 49.0, 
43.0, 34.7, 26.9, 25.6, 23.7, 23.1, 19.9, 17.6, 17.1, -1.4, -1.9; TLC (10:90 EtOAc: 
petroleum ether) Rf 0.32. LRMS (ESI) exact mass calculated for C22H40O3SiNa: 403.27. 
Found: 403.25. 
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Proof of Stereochemistry:  Product stereochemistry was assigned by analogy to 
allylzinc example with geranyl silyl glyoxylate. 
 
General Procedure D for reaction of silyl glyoxylates with allenyl zinc bromide: A 
solution of allenyl zinc bromide
26 
(1.5 equiv) in THF (0.33 M) was diluted with Et2O to 
0.10 M.  The solution was cooled to -78 °C and a solution of silyl glyoxylate (1.0 equiv) 
in Et2O (0.10 M) was added.  The reaction was allowed to slowly warm to room 
temperature over 1 h and then stir for 30 min to 2 h at room temperature.  The reaction 
was diluted with 5 mL aqueous HCl (1 M).  The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (3 X 10 mL).  The organic extracts were combined, 
dried with MgSO4, and concentrated in vacuo.  The resulting colorless oil was purified as 
indicated. 
 
 
2-(tert-butyldimethylsilyloxy)-3-phenyl-2-(prop-2-ynyl)pent-4-enoic acid (S13).  
General procedure D was performed using cinnamyl tert-butyldimethylsilyl glyoxylate 
(80 mg, 0.263 mmol) and allenylZnBr (0.33 M, 2.39 mL, 0.525 mmol).  Purification by 
flash chromatography (96:3:1 petroleum ether:Et2O:HOAc) furnished  53 mg (58%) of 
S13 as a clear oil.  Analytical data for S13:  IR (thin film, cm
-1
) 3310, 3063, 3032, 2954, 
2929, 2895, 2856, 1725, 1158; 
1
H NMR (400 MHz, CDCl3) 7.32-7.21 (m, 5H), 6.31-
6.22 (m, 1H), 5.26 (d, J = 1.6 Hz), 5.23 (d, J = 8.8 Hz, 1H), 3.84 (d, J = 9.6 Hz, 1H), 2.79 
(d, J = 17.2 Hz, 1H), 2.65 (d, J = 16.8 Hz, 1H), 2.10 (t, J = 2.8 Hz, 1H), 0.96 (s, 9H), 0.19 
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(s, 3H), 0.04 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 176.9, 139.0, 136.5, 135.5, 129.7, 
129.2, 128.1, 127.3, 127.2, 118.9, 117.8, 82.4, 79.8, 72.2, 57.6, 29.7, 26.2, 19.0, -2.1, -
3.0; TLC (10:90 EtOAc: petroleum ether) Rf 0.20. LRMS (ESI) exact mass calculated 
for C20H28O3SiNa: 367.18. Found: 367.16. 
Proof of Stereochemistry:  Product was formed with low diastereoselectivity. 
 
 
 
2-(tert-butyldimethylsilyloxy)-3-methyl-2-(prop-2-ynyl)pent-4-enoic acid (S14).  
General procedure D was performed using crotyl tert-butyldimethylsilyl glyoxylate (80 
mg, 0.330 mmol) and allenylZnBr (0.33 M, 3.0 mL, 0.66 mmol).  Purification by flash 
chromatography (96:3:1 petroleum ether:Et2O:HOAc) furnished  31 mg (33%) of S14 as 
a clear oil.  Analytical data for S14:  IR (thin film, cm
-1
) 3313, 2955, 2929, 2857, 1725, 
1471, 1420, 1254, 1168; 
1
H NMR (400 MHz, CDCl3) -5.72 (m, 1H), 5.14 (d, J = 
14.0 Hz, 2H), 2.71-2.59 (m, 3H), 2.06 (s, 1H), 1.05 (d, J = 6.8 Hz, 3H), 0.93 (s, 9H), 0.24 
(s, 3H), 0.22 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 176.9, 137.6, 117.6, 82.7, 79.8, 
72.1, 46.4, 29.1, 26.1, 18.9, 15.7, -2.2, -2.7; TLC (10:90 EtOAc: petroleum ether) Rf 
0.18. LRMS (ESI) exact mass calculated for C15H26O3SiNa: 305.17. Found: 305.12. 
Proof of Stereochemistry:  Product stereochemistry was determined by Lindlar 
reduction to afford 2-allyl-2-(tert-butyldimethylsilyloxy)-3-methylpent-4-enoic acid S7 
characterized above.  
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2-(tert-butyldimethylsilyloxy)-3,7-dimethyl-2-(prop-2-ynyl)-3-vinyloct-6-enoic acid 
(S15).  General procedure D was performed using geranyl tert-butyldimethylsilyl 
glyoxylate (80 mg, 0.247 mmol) and allenylZnBr (0.30 M, 1.64 mL, 0.493 mmol).  
Purification by flash chromatography (96:3:1 petroleum ether:Et2O:HOAc) furnished 24 
mg (27%) of S15 as a clear oil.  Analytical data for S15: IR (thin film, cm
-1
) 3312, 2956, 
2928, 2856, 1717, 1471, 1415, 1378, 1150; 
1
H NMR (400 MHz, CDCl3) 5.85 (dd, J = 
17.6, 10.8 Hz, 1H), 5.23 (d, J = 11.2 Hz, 1H), 5.06-5.02 (m, 2H), 2.94 (dd, J = 16.8, 2.4 
Hz, 1H), 2.46 (dd, J = 16.8, 2.4 Hz, 1H), 2.00-1.98 (m, 1H), 1.78-1.70 (m, 2H), 1.66 (s, 
3H), 1.55 (s, 3H), 1.39-1.31 (m, 1H), 1.10 (s, 3H), 0.94 (s, 9H), 0.28 (s, 3H), 0.23 (s, 3H).  
13
C NMR (100 MHz, CDCl3) 175.4, 140.8, 131.5, 124.4, 116.0, 86.2, 81.2, 72.1, 48.1, 
34.5, 26.3, 25.7, 19.2, 17.6, 17.1, -2.3, -2.4; TLC (10:90 EtOAc: petroleum ether) Rf 
0.24. LRMS (ESI) exact mass calculated for C21H36O3SiNa: 387.24. Found: 387.22. 
Proof of Stereochemistry:  Product stereochemistry was determined by Lindlar 
reduction to afford 2-allyl-2-(tert-butyldimethylsilyloxy)-3,7-dimethyl-3-vinyloct-6-enoic 
acid S9 characterized above. 
  
94 
 
 
 
 
Experimental Details for Cyclizations 
 
 
 
 
tert-butyl-3-(tert-butyldimethylsilyloxy)-5-(iodomethyl)-2-oxo-4-
phenyltetrahydrofuran-3-yl)acetate (7c).  To S4 (12 mg, 0.0285 mmol, 1.0 equiv) in 
2.0 mL CHCl3 was added NaHCO3 (20 mg, 0.239 mmol, 8.4 equiv) in 2.0 mL H2O.  The 
reaction was cooled to 0 °C and iodine (62 mg, 0.245 mmol, 8.6 equiv) was added.  The 
reaction was allowed to warm to room temperature and stirred 24 h.  The reaction was 
diluted with 5 mL CH2Cl2 and the layers were separated.  The organic phase was washed 
with 3 mL 10% Na2S2O3 (aq), then 3 mL H2O, then 3 mL brine.  The organic phase was 
dried with MgSO4 and concentrated in vacuo.  Purification by flash chromatography 
(90:10 petroleum ether:EtOAc) furnished 12 mg (77%) of 7c.  Analytical data for 7c:  IR 
(thin film, cm
-1
) 2953, 2930, 2857, 1786, 1737, 1558, 1495, 1257, 1153; 
1
H NMR (400 
MHz, CDCl3) 7.29-7.27 (m, 3H), 7.14-7.12 (m, 2H), 5.25-5.20 (m, 1H), 4.15 (d, J = 4.8 
Hz, 1H), 3.30 (dd, J = 10.0, 6.0 Hz, 1H), 2.83-2.79 (m, 2H), 2.19 (d, J = 17.6 Hz, 1H), 
1.33 (s, 9H), 0.92 (s, 9H), 0.20 (s, 3H),  0.14 (s, 3H); 
13
C NMR (125 MHz, CDCl3) 
, 167.4, 133.0, 128.6, 128.0, 82.1, 80.9, 80.2, 57.6, 38.1, 28.0, 25.5, 18.3, 0.9, -
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3.3, -4.9; TLC (5:95 EtOAc: petroleum ether) Rf 0.30. LRMS (ESI) exact mass 
calculated for C23H35IO5SiNa: 569.13. Found: 569.11. 
 
 
1-(tert-butyldimethylsilyloxy)-2-methylcyclopent-3-enecarboxylic acid (6a).  To S7 
(12 mg, 0.0421 mmol, 1.0 equiv) in 1.9 mL CH2Cl2 was added Grubbs 2
nd
 generation 
catalyst (3.6 mg, 0.00421 mmol, 0.10 equiv) in 0.90 mL CH2Cl2.  The reaction was 
diluted with 2.8 mL CH2Cl2 and stirred at room temperature for 50 h.  Approximately 200 
mg silica was added and the reaction was stirred for 15 min.  The slurry was filtered 
through a silica plug and concentrated in vacuo to afford 5 mg (46%) cyclopentene 6a.  
Analytical data for 6a:  IR (thin film, cm
-1
) 2930, 2858, 2349, 1708, 1472, 1256, 1201, 
837; 
1
H NMR (400 MHz, CDCl3) 5.70-5.69 (m, 1H), 5.56-5.54 (m, 1H), 3.02-2.97 (m, 
2H), 2.54 (d, J = 18.0 Hz, 1H), 1.05 (d, J = 7.5 Hz, 3H), 0.93 (s, 9H), 0.31 (s, 3H), 0.30 
(s, 3H); 
13
C NMR (100 MHz, CDCl3) , 133.9, 126.6, 81.9, 49.1, 46.1, 25.4, 17.7, 
15.3, 12.6, -4.9, -5.0; TLC (10:90 EtOAc: petroleum ether) Rf 0.27. LRMS (ESI) exact 
mass calculated for C13H24O3SiNa: 279.15. Found: 279.13. 
 
 
 
1-(tert-butyldimethylsilyloxy)-2-methyl-2-(4-methylpent-3-enyl)cyclopent-3-
enecarboxylic acid (6b).  To S9 (24 mg, 0.0654 mmol, 1.0 equiv) in 2.9 mL CH2Cl2 was 
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added Grubbs 2
nd
 generation catalyst (5.6 mg, 0.00654 mmol, 0.10 equiv) in 1.4 mL 
CH2Cl2.  The reaction was diluted with 4.3 mL CH2Cl2 and stirred at room temperature 
for 15 h.  Approximately 300 mg silica was added and the reaction was stirred for 15 
min.  The slurry was filtered through a silica plug (CH2Cl2) and concentrated in vacuo.  
Purification by flash chromatography (94:5:1 petroleum ether: Et2O: HOAc) afforded 13 
mg (59%) cyclopentene 6b.  Analytical data for 6b:  IR (thin film, cm
-1
) 2926, 2349, 
1700, 1684, 1653, 1558, 1541, 1507, 1457; 
1
H NMR (300 MHz, CDCl3) 5.65-5.58 (m, 
2H), 5.11-5.06 (m, 1H), 3.22 (d, J = 17.4 Hz, 1H), 2.54 (dd, J = 16.8, 6.3 Hz, 1H), 2.04-
1.95 (m, 2H), 1.68 (s, 3H), 1.63 (s, 3H), 1.54-1.44 (m, 2H), 1.00 (s, 3H), 0.91 (s, 9H), 
0.14 (s, 3H), 0.10 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 170.0, 137.4, 125.2, 124.9, 
100.1, 55.5, 42.7, 35.1, 29.7, 25.9, 25.6, 23.7, 22.7, 21.1, 18.5, 17.7, -3.1, -3.6; TLC 
(10:90 EtOAc: petroleum ether) Rf 0.21. LRMS (ESI) exact mass calculated for 
C19H34O3SiCs: 471.13. Found: 471.27. 
 
 
 
1-(hydroxymethyl)-2-methyl-2-(4-methylpent-3-enyl)cyclopent-3-enol (6c).  To 6b 
(10 mg, 0.0295 mmol, 1.0 equiv) in 0.5 mL THF at 0 °C was added LiAlH4 (44 L, 
0.044 mmol, 1.5 equiv, 1 M in THF).  The reaction was allowed to warm to room 
temperature and stirred 19 h.  The reaction was quenched with 1 mL 3 M NaOH (aq).  
The aqueous layer was extracted with CH2Cl2 (3 X 3 mL).  The organic extracts were 
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combined, dried with MgSO4, and concentrated in vacuo.  Purification by flash 
chromatography (49:50:1 petroleum ether:Et2O:HOAc) furnished 5 mg (52%) of 6c.  
Analytical data for 6c: IR (thin film, cm
-1
) 2958, 2922, 1771, 1732, 1635, 1558, 1489, 
1376, 1078; 
1
H NMR (400 MHz, CDCl3) 5.69-5.64 (m, 2H), 5.15-5.11 (m, 1H), 3.79-
3.75 (m, 1H), 3.66-3.60 (m, 1H), 2.62 (d, J = 16.8 Hz, 1H), 2.35 (d, J = 16.8 Hz, 1H), 
2.10-1.95 (m, 2H), 1.68 (s, 3H), 1.64 (s, 3H), 1.51-1.46 (m, 2H), 0.93 (s, 3H); 
13
C NMR 
(100 MHz, CDCl3) 139.2, 131.3, 125.7, 125.1, 84.0, 66.3, 52.1, 43.5, 35.0, 25.6, 23.9, 
20.0, 17.6; TLC (30:70 EtOAc: petroleum ether) Rf 0.15. LRMS (ESI) exact mass 
calculated for C13H22O2Na: 233.26. Found: 233.12. 
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 CHAPTER 3 
 
SYNTHESIS OF TRACHYSPIC ACID DIMETHYL ESTER 
 
3.1 Introduction 
3.1.1 Isolation and Biological Activity 
 A current area of study in pharmaceutical research is the development of 
heparanase inhibition agents.  Heparanase is an endo--D-glucuronidase which cleaves 
heparan sulfate sidechains and triggers degradation of the extracellular matrix.
1
  
Breakdown of the extracellular matrix facilitates the spread of metastatic tumor cells and 
leukocytes by allowing their passage into the bloodstream.  Furthermore, the release of 
short heparan sulfate fragments is believed to induce additional problematic processes.  
Since inhibition of heparanase would likely prevent extracellular matrix degradation, 
heparanase inhibitors are of great interest as anti-inflammatory and anti-metastasis 
therapeutics.  
In the course of a screen for heparanase inhibitors, trachyspic acid (1) was 
isolated from the culture broth of Talaromyces trachyspermus SANK 12191 (Figure 3-
1).
2
  The fungal strain SANK 12191 was acquired from a soil sample from Kagoshima 
Pref., southwest Japan.  Trachyspic acid was identified as a potent inhibitor of heparanase 
with an IC50 value 36 M.  The two-dimensional structure was determined in 1995, based 
on NMR experiments and degradation studies.
2
  The relative stereochemistry was
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elucidated by Hatakeyama via the racemic total syntheses of trachyspic acid and a 
diastereomer.
3
 
Like other members of the alkyl citrate family of natural products, trachyspic acid 
is comprised of a substituted citric acid motif.  Other structural attributes include an n-
nonyl sidechain and a furanone ring embedded in a 5,5-spiroketal.  The structurally 
related compounds decylcitric acid 2 and spiculisporic acid 3 are also produced by 
Talaromyces trachyspermus (Figure 3-1).  Notably, these molecules both contain a 
polycarboxylic acid subunit and a hydrophobic alkyl chain, but have not demonstrated 
heparanase inhibition.
2
   
Figure 3-1. Compounds Isolated from Talaromyces trachyspermus  
 
3.1.2 Prior Synthetic Approaches to Trachyspic Acid 
 Since further biological testing hinges on the development of a scalable synthetic 
approach to trachyspic acid or analogues thereof, numerous syntheses have been reported 
to date: trachyspic acid has been the target of four total syntheses and one formal 
synthesis.  Shortly following Hatakeyama’s elucidation of the relative stereochemistry, 
Rizzacasa determined the absolute stereochemistry via total syntheses of the unnatural 
() and the natural (+) enantiomer in 2005 and 2007, respectively.4  One year later, 
Hatakeyama also completed an asymmetric synthesis.
5
  A formal synthesis of unnatural 
()-trachyspic acid was disclosed in 2009 by Barrett.6 
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 Despite its apparent structural simplicity, trachyspic acid has proven itself to be a 
challenging target with extant syntheses ranging from 18 to 26 linear steps.  The primary 
obstacle to concise synthesis is the contiguous C3 and C4 chiral centers.  Installation of 
these stereocenters has been performed by various methods, including Ireland-Claisen 
rearrangement, Seebach alkylation, and aldol reaction.
3,4,6
  
 Hatakeyama’s first synthesis commenced with the assembly of ketoester 5 from 
1,4-butanediol (Scheme 3-1).  The C3C4 bond was then constructed by means of an 
unselective aldol reaction with ester 6, completing the C1-C6 carbon skeleton.  After 
subsequent manipulations, the C7-C9 framework was introduced via a Nozaki-Hiyama-
Kishi coupling.
7
  Oxidation of the resulting C6 alcohol set the stage for spiroketalization 
with HClO4, which afforded 4:1 diastereoselection at the spirocenter.  Trachyspic acid 
was then completed following a series of deprotections and oxidation state modifications.  
Scheme 3-1. Hatakeyama’s Racemic Synthesis of Trachyspic Acid 
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 Barrett’s formal synthesis of ()-trachyspic acid constitutes the shortest approach 
to date.
6
  The C3 and C4 stereocenters were set by an Evans aldol reaction with acrolein 
(Scheme 3-2).  The C3 stereocenter was quaternized stereoselectively with t-butyl 
bromoacetate using Seebach’s “self-regeneration of stereochemistry”.8  Following 
cleavage of the Seebach chiral auxiliary and transesterification, C6 was deprotected and 
oxidized, which induced cyclization to intercept the Rizzacasa lactone 20.  Following 
Rizzacasa’s protocol, completion of the synthesis would require addition of the C7-C9 
organolithium (which would require 10 steps in itself to prepare), HClO4 
spiroketalization, acetylation of the resulting hemiacetal, ozonolysis of the C7 olefin, and 
cleavage of the t-butyl esters (18 linear steps). 
Scheme 3-2. Barrett’s Formal Synthesis of Unnatural (-)-Trachyspic Acid 
 
3.1.3 Retrosynthetic Analysis 
 Silyl glyoxylates were developed in our laboratory as conjunctive reagents for the 
geminal coupling of nucleophiles and electrophiles to a glycolic acid unit.
9
  
Multicomponent couplings of silyl glyoxylates have effectively generated high levels of 
molecular complexity from simple starting materials (see Chapters 1 and 2).  Trachyspic 
acid constitutes a potential application of silyl glyoxylate reactivity due to its C3 
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quaternary glycolic acid motif, as a three component coupling approach to trachyspic 
acid would likely permit its concise synthesis.  The open chain form of trachyspic acid 
reveals a 1,4-relationship between the C3 glycolic acid and the C6 ketone, hinting at a 
potential Michael addition of the geminally dipolar silyl glyoxylate with a 
prefunctionalized ,-unsaturated ketone electrophile (Scheme 3-3).  The ideal 
nucleophilic component for the proposed coupling would be an acetate enolate.  
Scheme 3-3. Three Simple Fragments to Access Trachyspic Acid  
 
If this heretofore unknown three component coupling could be developed, then 
trachyspic acid’s spiroketal would likely be accessible from 21 simply by treatment with 
HClO4, as shown in all prior syntheses.
3,4
  The diastereoselectivity of ketalization has 
been proposed to be dictated by the kinetic preference for cyclization of the C9 oxygen 
from the less hindered face of the oxocarbenium ion intermediate (Scheme 3-4), resulting 
in spiroketal stereoselectivity ranging from 4:1 (Hatakeyama) to 9:1 (Rizzacasa) favoring 
the desired isomer.  Thermodynamic spiroketalization is also a possibility in principle, 
but Rizzacasa notes that no spiroketal epimerization occurs when the spiroketal is treated 
with acid, indicating that reversibility is not a factor.   
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Scheme 3-4. Diastereoselective Spiroketalization  
 
 With the expectation that a tandem aldol/Michael three component coupling of an 
acetate enolate, silyl glyoxylate, and an enone would provide the C1-C6 glycolate 
Michael skeleton of trachyspic acid, we next considered methods of packaging the 
remainder of the carbon framework, including the C7-C9 dicarbonyl and the C8 nonyl 
side chain.  The open chain form of trachyspic acid reveals C6, C7, C9 tricarbonyl 
compound 22 that would pose a significant chemoselectivity challenge in the key three 
component coupling (Scheme 3-3).  We chose to rely on a proven method of masking the 
1,3-dicarbonyl subunit in organic synthesis: the incorporation of an isoxazole.
10
  The C7-
C9 dicarbonyl fragment could be protected as an isoxazole, leaving the C4 enone as the 
most reactive site on the electrophilic component. Reductive cleavage of the NO bond 
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of 3,5-disubstituted isoxazoles has been shown to reveal a -enamino ketone moiety that 
may be hydrolyzed to the -diketone.  While NO reduction of a 3,4-disubstituted 
isoxazole to reveal a -enamino aldehyde has not been demonstrated, it was expected to 
behave analogously.    Enone 25 was anticipated to be accessible from simple isoxazoles 
26 or 27.  The proposed synthetic approach would allow the efficient construction of 
trachyspic acid, as the oxidation state of the carbon backbone would be retained 
throughout the synthesis.   
Scheme 3-5. Retrosynthetic Analysis 
 
 
3.2 Development of the Tandem Aldol/Michael Three Component Coupling 
3.2.1 The Unexpected Byproduct 
 In addition to trachyspic acid’s unique structure and biological activity, our 
interest in its synthesis was further solidified by a serendipitous discovery.  In an effort to 
identify new reaction components compatible with silyl glyoxylates, (-allyl)Pd+ was 
tested as a terminal electrophile.  Methyl Grignard reagent was selected as the 
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nucleophilic trigger for the proposed reaction (Scheme 3-6) due to its relatively unique 
ability to rapidly add to silyl glyoxylate, thus preventing oligomerization (see section 
2.2.2).  Catalytic Pd(dba)2 in conjunction with allyl acetate and PPh3 was selected to 
generate the electrophilic -allyl Pd species.  Following workup, purification of the crude 
reaction mixture did not reveal any of the expected ,-unsaturated ester 29.  However, an 
unexpected three component coupling product, glycolate Michael adduct 30, was 
isolated.  This product results from coupling of the intermediate glycolate enolate with 
dibenzylideneacetone (dba) rather than the allyl electrophile.  While only a small quantity 
of 30 was formed, the yield was 55% based on the catalytic amount of dba used.  This 
regioselective 1,4-addition of silyl glyoxylate to an ,-unsaturated ketone supported the 
feasibility of our proposed approach to trachyspic acid. 
Scheme 3-6. Attempted Three Component Coupling with -Allyl Palladium 
 
 Studies commenced to determine whether the unanticipated Michael reaction 
required all of the reaction components that were not incorporated into ketone 30.  
Mixing methyl Grignard reagent, silyl glyoxylate, and non-Pd-bound 
dibenzylideneacetone provided three component coupling products; however, the 1,2-
addition product 31 was favored (1,2:1,4 = 4.3:1.0).  Notably, when the reaction was 
repeated using Pd(dba)2 as the electrophilic component, approximately equal amounts of 
1,2 and 1,4-addition products were formed (1,2:1,4 = 1.0:1.1).  While using a Pd-bound 
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electrophile helped to form the desired 1,4-addition product, the cost associated with 
stoichiometric levels of Pd precluded this strategy. 
 Other ,-unsaturated carbonyl compounds were tested as potential Michael 
acceptors.  Reaction of methyl Grignard reagent, silyl glyoxylate, and methyl cinnamate 
provided unreacted ester as the sole identifiable compound.  On the other hand, chalcone 
proved to be a good Michael acceptor, affording 55% yield of the 1,4-addition product 
with 6:1 d.r. and no trace of 1,2-addition (Scheme 3-7).  The selectivity for Michael 
addition to chalcone is particularly striking when compared to dibenzylideneacetone’s 
strong preference for 1,2-addition.  This result could be rationalized by chalcone’s 
slightly more hindered carbonyl relative to dibenzylideneacetone.    Noting the strong 
dependence of regioselectivity on substrate structure, our efforts shifted toward the 
development of a three component coupling more amenable to trachyspic acid’s carbon 
skeleton.  
Scheme 3-7. Regioselectivity of Different Michael Acceptors 
 
 
3.2.2 Acetate Enolates as Nucleophilic Triggers 
 The retrosynthetic plan for trachyspic acid required an acetate enolate to initiate 
the cascade coupling sequence.  Reformatsky reagents had been previously identified as 
nucleophiles compatible with silyl glyoxylates in Greszler’s three component synthesis of 
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-lactones.11  For this reason, the Reformatsky reagent of t-butyl bromoacetate was first 
selected as the most promising nucleophile.   
Addition of a premixed solution of silyl glyoxylate 28a and chalcone to the 
Reformatsky reagent afforded 1,2-addition of Reformatsky reagent to chalcone, with no 
silyl glyoxylate incorporation (entry 1, Table 3-1).  Sequential addition of silyl glyoxylate 
followed by chalcone resulted in three component coupling, but 1,2-addition to chalcone 
was the major product (entry 2).  Difurylideneacetone as the terminal electrophile 
provided comparable results, with three component 1,2-addition being the major product 
(entry 3).  Running the reaction at -20 °C rather than room temperature provided 
exclusively 1,2-addition, with incomplete conversion (entry 4).  This indicates that the 
1,2-addition product could be the kinetic product and the desired 1,4-addition could be 
the thermodynamic product.  However, increasing reaction temperature to 40 °C resulted 
in a complex mixture.  Subsequent reactions were not heated above room temperature. 
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Table 3-1. Optimization with Reformatsky Nucleophile 
 
entry enone addition  additive temp ratio 35:36 
1 
 
33; 34 and 28a none -30 °C to rt NA
a
 
2  33; 28a; 34 none -30 °C to rt 1.0 : 2.0 
3 
 
33; 28a; 34 none -30 °C to rt 1.0 : 4.2 
4 
 
33; 28a; 34 none -30 °C to -20 °C 1.0 : >20 
5 
 
33; 28a; 34 ZnCl2 -30 °C to rt 1.2 : 1.0 
6 
 
33; 28a; 34 ZnBr2 -30 °C to rt 1.0 : 1.0 
7 
 
33; 28a; 34 ZnI2 -30 °C to rt 3.3 : 1.0 
8 
 
33; 28a; 34 Zn(OTf)2 -30 °C to rt 1.0 : >20 
a) Major product was 1,2-addition of acetate enolate to chalcone.  
Zinc salt additives were evaluated in an effort to improve conversion via Lewis 
acid activation of the enone.  It was expected that these additives could potentially 
influence the regioselectivity of the coupling as well.  Zinc triflate provided complete 
regioselection, but was selective for undesired 1,2-addition.   Of the zinc salt additives, 
ZnI2 demonstrated the best selectivity for Michael addition (3.3:1). 
 Noting the strong influence of anionic counterions on selectivity, a series of metal 
cationic counterions were evaluated as well.  After a number of metal enolates proved 
ineffective as nucleophilic triggers, lithium enolates were found to provide exclusively 
the desired 1,4-addition (Table 3-2).  The addition of superstoichiometric lithium chloride 
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was found to provide optimal conversion and diastereoselectivity, which may be due to 
altered aggregation of the glycolate enolate or an increased degree of chelation during 
Michael addition. 
Table 3-2. Optimization with Various Metal Enolates 
 
entry M additive major products 
1 Li MgBr2 38 and decomposed 28a 
2 Li TiCl4 38 and decomposed 28a 
3
a
 Li MnCl4Li2 38 and decomposed 28a 
4
b
 Li CuCl2 
38 and  
5
b
 Li CuBr 
38 and  
6 Li none 
 
7 Na none 38 and decomposed 28a 
8 K none decomposition 
9 Li LiI decomposition 
10 Li LiBr 
 
11 Li LiCl 
 
Reactions were not purified; yields are unknown. a) MnCl4Li2 prepared by treatment of MnCl2 with 2 
equiv. of LiCl in THF. b) 39 is formed by addition of acetate enolate to 28a, subsequent Brook 
rearrangement, and proton quenching. 
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3.2.3 Scope and Limitations of Three Component Glycolate Michael Reaction 
 In addition to regioselective multicomponent 1,4-addition to difurylideneacetone, 
lithium enolates proved to be effective initial nucleophiles in three component couplings 
with other ,-unsaturated ketones as well.  Both vinyl and aryl enones were effective 
terminal electrophiles and demonstrated complete 1,4-regioselectivity (Scheme 3-8).  The 
yields were modest due to incomplete conversion; yields based on recovered starting 
material were >80% in most cases.  In some cases, the diastereoselectivity could be 
increased by adding the Michael acceptor and the silyl glyoxylate simultaneously to a 
solution of the lithium enolate, rather than sequential reagent addition.  Simultaneous 
reagent addition requires the lithium enolate to chemoselectively react with the silyl 
glyoxylate in preference to the enone.  Certain enones suffered from competitive direct 
coupling with the acetate enolate using this protocol, including those with imidazoles or 
isoxazoles adjacent to the ketone.   
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Scheme 3-8. Enones Compatible with Tandem Aldol/Michael Reaction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reagent addition: premixed solution of enone and silyl glyoxylate added to a solution of acetate 
enolate at -78 °C. a) Yield determined by 1H NMR analysis of crude reaction mixture. b) Isolated 
yield of analytically pure material. 
  
Ineffective Michael acceptors included those with sterically hindered -positions 
and ,-unsaturated aldehydes,  both of which were found to favor three component 1,2-
addition.  Aliphatic enones did undergo the desired three component coupling but usually 
suffered from either an additional Dieckmann cyclization or low conversion, which 
resulted in poor yields.  Methyl cinnamate was found to be an unreactive terminal 
electrophile, as it was in Grignard-initiated couplings (section 3.2.1, Scheme 3-7).   
Future studies will involve quenching of the three component coupling reactions 
with prochiral electrophiles rather than a proton source; these potential four component 
couplings would further increase the level of molecular complexity accessible in one 
step.  Additional studies could apply the regioselective three component coupling of 
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enolates, silyl glyoxylates, and ,-unsaturated ketones to the synthesis of other alkyl 
citrate natural products, such as the viridiofungins, citrafungins, and zaragozic acids 
(Scheme 3-9). 
Scheme 3-9. Potential Applications of Glycolate Michael Coupling 
 
3.3 A Three Component Coupling Approach to Trachyspic Acid Dimethyl Ester 
3.3.1 Enone Synthesis 
 Our retrosynthetic plan called for the preparation of an enone containing the 
majority of trachyspic acid’s carbon framework, including the C8 alkyl side chain 
(Scheme 3-5).  Our initial approach to the C7-C9 isoxazole 27 relied on the 
hydroxylamine cyclocondensation method developed by Martins.
12
 For the purpose of 
initial test reactions, a methyl group was substituted for the nonyl side chain (Scheme 3-
10).  Methoxide allylation followed by olefin migration provided enol ether 41.  
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Treatment of 41 with trichloromethyl acetyl chloride and pyridine furnished vinylogous 
ester 42.  Subsequent cyclocondensation occasionally gave desired carboxyisoxazole; 
however, yields were <20% in most cases.  Experimentation with different temperatures 
and acids did not improve yields.  Due to the low reliability of this approach, we sought 
an alternative synthesis of the C7-C9 isoxazole.   
Scheme 3-10. Cyclocondensation Approach to Isoxazole 27b 
 
Nitrile-oxide cycloaddition with alkynes represents a direct and reliable route to 
isoxazoles; however, due to steric effects, monosubstituted dipolarophiles always provide 
the 3,5-disubstituted  isoxazoles, the incorrect regioisomer needed for the projected 
trachyspic acid synthesis (Scheme 3-11).
13
  Examples of the preparation of 3,4-
disubstituted isoxazoles by nitrile-oxide cycloaddition are scarce.  The majority of these 
approaches rely on a tethered nitrile-oxide
14
 or a vinylogous amide directing group 
(Scheme 3-11).
15
    
Electronic regiocontrol for the nitrile-oxide cycloaddition appeared to be a 
prospective strategy for preparation of the C7-C9 isoxazole 26.  While a vinylogous 
amide dipolarophile would afford 4-acyl isoxazole 46 after aromatization, we postulated 
that another directing group could potentially provide the necessary 4-alkyl isoxazole 26.  
Considerations for the directing group included its ability to serve dually as an electron-
donating group for regiocontrol, and as a leaving group for aromatization. 
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Scheme 3-11. Regiochemistry of Nitrile-Oxide Cycloadditions 
 
For the nitrile-oxide component we selected carboethoxyformonitrile oxide 44 
(CEFNO), due to its facile in situ preparation from stable ethyl chlorooximidoacetate 43 
(Scheme 3-11).  While 43 is commercially available, it can also be prepared in one step 
from ethyl glycine.
16
  Initial experiments utilized enol acetate and alkyl enol ether 
dipolarophiles.  In each case, triethylamine was added slowly in an attempt to limit 
formation of furoxan dimer 48.  Both enol acetate 49 and enol ether 50 provided the 
furoxan dimer 48 as the major product.  We hypothesized that employing a more 
electron-rich dipolarophile would facilitate cycloaddition with the electron-poor nitrile-
oxide; thus, enolsilane 51 was tested.  Syringe pump addition of triethylamine over 3 h to 
a solution of oxime 43 and enolsilane 51 provided 21% yield of a diastereomeric mixture 
of isoxazoline 47, wherein the desired cycloaddition had occurred, but aromatization via 
elimination had not.  Addition of triethylamine over 14 h provided increased yield of 47 
while limiting yield of dimer 48.  A series of other bases were screened, but were 
ineffective.   
117 
 
Table 3-3. Enol Ether Dipolarophiles in Nitrile-Oxide Cycloaddition 
 
entry enol rate of addition of Et3N product 
1 
 
3 h 48 
2 
 
4 h 48 
3 
 
3 h 47:48 = 1:2 
4 
 
14 h 47 
 
We next sought to develop conditions for the aromatization of isoxazoline 47 to 
isoxazole 26 (Table 3-4).  Heating 47 in toluene failed to induce any change.  BF3·OEt2 
also proved to be unreactive.  Heating with HCl or TsOH in ethanol resulted in exchange 
of the OTMS substituent for –OEt, without any trace of aromatization.  Returning to 
TsOH but using toluene as a non-nucleophilic solvent, we isolated 83% yield of the 
desired aromatized 26.  Since isolated yields of isoxazoline 47 were always modest due 
to its limited stability to silica gel, we attempted a single-pot cycloaddition/aromatization 
process.  Syringe pump addition of triethylamine, followed by addition of TsOH and 
heating to 70 °C for 24 h resulted in the one-pot synthesis of isoxazole 26 from enolsilane 
51.   
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Table 3-4. Identification of Isoxazoline Aromatization Conditions 
 
entry conditions solvent products 
1 110 °C PhMe no reaction 
2 BF3
.
OEt2, NBu4I CH2Cl2 no reaction 
3 TsOH EtOH 
 
4 HCl EtOH 
 
5 TsOH PhMe 
 
 
Since the preparation of 3,4-disubstituted isoxazoles is an unsolved problem in 
organic synthesis, we evaluated the scope and limitations of this cycloaddition.  Various 
enolsilanes of aldehydes were effective dipolarophiles, including both aromatic and 
aliphatic (linear and branched) aldehydes (Table 3-5).  The preparation of fused-ring 
isoxazoles is another challenge to organic chemists that was addressed by this method.  
Small and medium ring alkynes are unstable due to ring strain, so the preparation of 
fused-ring isoxazoles has inspired creative methods.
17,18
 Five-, six-, and seven-membered 
ring enolsilanes were found to be competent in the cycloaddition (entries 7-9).  The 
modest yields are believed to be due to ester hydrolysis during the second stage 
elimination reaction, as well as product volatility.  The enolsilanes could be used without 
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prior distillation in most cases, allowing for the operationally simple preparation of 
isoxazoles in two steps from carbonyl compounds.   
Table 3-5. Scope of Enolsilane Dipolarophiles in Nitrile-Oxide Cycloaddition 
 
entry enolsilane 51 product 52 yield
a
 
1 
 
 
34% 
2 
 
 
22% 
3 
 
 
29% 
4 
 
 
44% 
5 
 
 
31% 
6
b
 
 
 
10% 
7 
  
40% 
8 
  
70% 
9 
  
44% 
a) Isolated yields (average of at least two experiments). b) Enolsilane purified prior to use (all 
other enolsilanes used crude). 
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Another advantage of enolsilanes as dipolarophiles over alkynes is their ability to 
completely control regiochemistry.  Disubstituted alkynes with sterically and 
electronically similar substituents demonstrate poor regiocontrol; direct comparison of 
the enolsilane 51j to 2-pentyne revealed complete regiocontrol in the case of the 
enolsilane, while the alkyne displayed both poor regiocontrol and lower yield (Scheme 3-
12).   
Scheme 3-12. Direct Comparison of Enolsilane to Alkyne Dipolarophile 
 
Having developed a reliable, scalable method for the preparation of isoxazole 26, 
we next pursued the completion of enone 25.  Claisen condensation with lithiated methyl 
dimethyl phosphonate provided -ketophosphonate 54 (Scheme 3-13).  Subsequent 
Horner-Wadsworth-Emmons olefination with t-butyl glyoxylate furnished enone 25a as a 
separable 5:1 E:Z mixture.  Enone 25b was also prepared with the expectation that the 2-
furyl group could ultimately be cleaved oxidatively.
19
  Olefination of t-butyl glyoxylate 
proceeded smoothly with triethylamine at room temperature; however, olefination of 
furfural proved to be more challenging, likely due to its reduced electrophilicity.  After 
screening temperatures, bases, and solvents, K2CO3 in refluxing water was found to 
afford the desired enone 25b (>20:1 E:Z). 
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Scheme 3-13. Preparation of C4-C9 Michael Acceptors 
 
3.3.2 Three Component Coupling with C4-C9 Michael Acceptor 
 Using the conditions developed for the three component coupling with 
difurylideneacetone as the terminal electrophile, enones 25a and 25b were evaluated.  
Unfortunately, -carboxy-enone 25a was ineffective as a Michael acceptor, producing 
only decomposition.  However, -furyl-enone 25b was found to be a viable Michael 
acceptor, providing the desired three component coupling product with 2.7:1 d.r.  
Although the desired product was formed, the conversion and yield were poor.  Initial 
experiments employed 1.2 equivalents of both the acetate enolate and silyl glyoxylate 
relative to the C4-C9 enone as the limiting reagent, which was recovered in substantial 
quantities due to low conversion.  Increasing the equivalents of acetate enolate and silyl 
glyoxylate to 2.0 was effective at increasing consumption of enone 25b, providing 100% 
conversion in most cases.   
 Solvent was found to have an influence on diastereoselectivity.  While THF 
induced 2.7:1 d.r. favoring the desired isomer, the diastereoselectivity was inverted when 
toluene (1:1.7), hexanes (1:1.5), or diethyl ether (1:2.0) were utilized.  The ability to 
switch the diastereoselectivity by switching solvents could be an asset for analogue 
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synthesis.  The identity of the ester on the silyl glyoxylate was also found to be 
important: both ethyl and benzyl esters provided lower diastereoselectivity than the 
originally used t-butyl silyl glyoxylate.  Optimized three component coupling conditions 
gave the chiral ketone 55 in 84% yield and 2.7:1 d.r. (Scheme 3-14).  This coupling 
generates the critical C3 and C4 stereogenic centers and completes the full carbon 
skeleton of trachyspic acid.   
Scheme 3-14. Three Component Coupling with C4-C9 Michael Acceptor 
 
 
3.3.3 Completion of Trachyspic Acid Dimethyl Ester 
 With ketone 55 in hand, remaining synthetic operations included isoxazole NO 
cleavage, furan oxidation, and spiroketalization.  Treatment of ketone 55 with either 
oxidative or reductive conditions was ineffective at cleaving the furan or the isoxazole 
respectively.  Isoxazole NO reduction attempts on alcohol 56 resulted in clean 
formation of acid 57, which likely results from retro-Claisen fragmentation of the C7C8 
bond following isoxazole reduction (Scheme 3-15).  It was necessary to first form mixed 
methyl ketal 58, which underwent successful NO reduction with Mo(CO)6 to provide 
enamine 59.  
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Scheme 3-15. Synthesis of Spiroketalization Precursor 
 
We expected that BrØnsted acid-promoted ketalization of 59 would furnish C6 
spiroketal 60.  Following the model of Rizzacasa and Hatakeyama, enamine 59 was 
treated with 3 M HClO4; however, rather than the expected spiroketal 60, ketone 61 was 
generated as the major product.  Ketone 61 presumably is formed by enamine hydrolysis 
and retro-Claisen fragmentation of the C8C9 bond.  Other aqueous BrØnsted acids were 
also found to cause the same undesired fragmentation (Table 3-6, entries 1-3).   
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Table 3-6. Spiroketalization 
 
entry conditions result entry conditions result 
1 3 M HClO4, THF, rt 61 9 YbCl3, CH2Cl2, rt no reaction 
2 TsOH
.
H2O, 65 °C 61 10 BCl3, CH2Cl2, rt no reaction 
3 1 M HCl, rt 61 11 MeAlCl2, CH2Cl2, rt no reaction 
4 CSA, CH2Cl2, rt taut.
a
 12 Sc(OTf)3, CH2Cl2, rt isom.
b
 
5 TfOH, Et2O, rt taut.
a
 13 BF3
.
OEt2, MeCN, 82 °C decomp. 
6 MgCl2, CH2Cl2, rt no reaction 14 SnCl4, CH2Cl2, rt decomp. 
7 BaCl2, CH2Cl2, rt no reaction 15 Ti(OiPr)4, CH2Cl2, rt x-esterif.
c
 
8 LaCl3, CH2Cl2, rt no reaction 16 TiCl4, CH2Cl2, rt 62 
a) “taut.” Indicates tautomerization of either the enamine or the aldehyde. b) “isom.” Indicates 
isomerization of enamine olefin geometry. c) “x-esterif.” Indicates methyl to isopropyl 
transesterification. 
In an effort to avoid retro-Claisen fragmentation, we tested a series of less 
nucleophilic ketalization conditions (Table 3-6, entries 4-16).  After a number of Lewis 
acids were found to induce only tautomerization or no reaction, TiCl4 demonstrated the 
unique ability to promote spiroketalization.  The product that directly resulted from 
treatment with TiCl4 at room temperature followed by aqueous workup is believed to be 
spirocyclic imine 62.  The proposed imine 62 was incompatible with subsequent furan 
oxidation attempts and was unstable to flash chromatography, so hydrolysis was 
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performed to afford ketone 60 as an inseparable mixture of stereoisomers.  Ketalization 
and hydrolysis could be conducted in a single flask, simply by quenching the reaction 
with 1 M HCl.  Since the diastereoselectivity at the C6 spirocenter was difficult to 
determine at this juncture, we proceeded with the synthetic plan without attempting 
optimization of the spiroketalization.  Cleavage of furan 60 to reveal the C4-CO2H was 
successful with both NaIO4/RuCl3 (cat.) and ozone.
19,20
  Ultimately, the catalytic RuCl3 
method was found to be superior due to its slightly improved yields as well as increased 
levels of safety and operational simplicity relative to ozonolysis.  With the C1-C4 citric 
acid motif installed, we aimed to complete trachyspic acid’s dimethyl ester via 
dehydration of hemiacetal 63 (Scheme 3-16).  Trifluoroacetic anhydride was found to 
induce decomposition; however, both acetic anhydride and MsCl were effective at 
cleanly promoting the desired elimination.  Hemiacetal dehydration revealed two 
separable C6 spirocyclic diastereomers in a varying diastereomeric ratio which ranged 
from 1.5:1 up to 5:1, with the natural configuration constituting the major diastereomer.  
Methylation of the C4-CO2H of the major diastereomer provided a trimethyl ester that 
was found to be identical to the known trachyspic acid trimethyl ester by 
1
H NMR 
(Figure 3-2) and 
13
C NMR spectroscopy. 
Scheme 3-16. Furan Cleavage and Synthesis of Trachyspic Acid Trimethyl Ester 
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Figure 3-2. 
1
H NMR Spectral Overlay (DMSO-d6) 
 
A wide range of conditions were evaluated in an effort to convert the di- or tri-
methyl esters to the naturally occurring tri-acid; this transformation proved to be more 
challenging than originally anticipated (Table 3-7).  Saponification attempts with metal 
hydroxides resulted in formation of unidentifiable product mixtures, possibly resulting 
from enolization of the least hindered C1-ester, -elimination resulting in spiroketal 
opening, and subsequent retro-Claisen fragmentation of the resulting C7-C9 dicarbonyl.  
Another common approach to methyl ester deprotection is attack of the methyl group by 
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a discriminating nucleophile, which displaces the carboxylate as the leaving group.  
These methods typically offer the advantage of being able to react with sterically 
encumbered methyl esters (like the C3 glycolate ester), presumably since they do not 
require addition to the congested carbonyl carbon.  A series of these reagents proved to 
be unable to cleanly demethylate diester 64 (entries 8-17).   
Table 3-7. Methyl Ester Cleavage Attempts 
 
entry conditions result entry conditions result 
1 LiOH, THF/H2O/MeOH decomp. 10 LiI, EtOAc decomp. 
2 NaOH, H2O decomp. 11 BBr3, CH2Cl2 decomp. 
3 KOH, H2O decomp. 12 AlBr3
a
 decomp. 
4 Ba(OH)2, H2O no reaction 13 BCl3, CH2Cl2 decomp. 
5 LiSEt, THF no reaction 14 PhSH, Cs2CO3, DMF decomp. 
6 LiOOH, THF epoxidation 15 KOTMS, THF decomp. 
7 Me3SnOH, DCE low conv. 16 NaCN, HMPT decomp. 
8 TMSI, CH3CN decomp. 17 LiPPh2, THF low conv. 
9 LiI, pyridine decomp. 18 3.6 M HCl, H2O no reaction 
Reactions run at 0 °C and monitored by TLC.  If no conversion was observed at 0 °C,reactions were 
warmed as necessary.  a) solvent was tetrahydrothiophene. 
 
We eventually tried reduction of the tricarboxyl motif to their respective alcohols, 
which could be re-oxidized to the triacid via Jones Oxidation.  Treatment of 64 with five 
equivalents of DIBAL resulted in a mixture of unidentified products.  Using three 
equivalents of LAH, both ketone and monoester reduction were observed, but one methyl 
ester remained intact.  When increasing the LAH equivalents to 8.0, only decomposition 
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resulted.  Saponification attempts on earlier intermediates in the synthetic sequence were 
also unsuccessful.  While a method for conversion of 64 or 65 to trachyspic acid remains 
elusive, a synthesis of its dimethyl ester has been achieved in ten steps from 
commercially available undecanal.   
3.3.4 Attempts to Increase the Diastereoselectivity of Spiroketalization 
 Having completed a concise synthesis of trachyspic acid dimethyl ester 64, efforts 
were shifted toward optimization of the spiroketalization step.  Multiple repetitions of the 
synthetic sequence had revealed the sporadic diastereoselectivity of the spiroketalization; 
in some cases, the C6 spirocenter was formed as a 5:1 mixture of isomers, while in other 
cases the center was only formed with 1.5:1 d.r. (Scheme 3-17).  It was unclear whether 
the final spiroketal stereochemistry was determined during treatment with TiCl4, or if 
isomerization was occurring during the subsequent steps; attempts to evaluate the d.r. of 
the stereoisomeric mixtures by 
1
H NMR analysis was challenging due to the presence of 
eight diastereomers.   
Scheme 3-17. Spiroketal Isomerization 
 
 Although Rizzacasa’s diastereoselective spiroketalization on a similar substrate 
was proposed to proceed under kinetic control due to steric constraints,
4
 we recognized 
the possibility that thermodynamic spiroketal equilibration may have been occurring 
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during the imine hydrolysis step with 1 M HCl.  Attempts to increase the degree of 
equilibration by hydrolysis with stronger acids were ineffective at increasing the 
diastereomeric ratio.  We next tried to alter the d.r. of the spiroketal by “chelation 
controlled spiroketalization” with zinc chloride, a strategy reported by Dudley for 5,5-
spiroketals.
21
  Ketalization attempts using solely ZnCl2 resulted in no conversion; 
Ketalization with TiCl4 and stoichiometric ZnCl2 as an additive did not significantly 
change the d.r.  Assuming the natural spiroketal configuration was the thermodynamic 
diastereomer, we attempted isomerization following spiroketalization by treatment with 
Lewis acids, but observed no change. 
 Since it was unclear whether spiroketal isomerization would increase or decrease 
the d.r., we also attempted to hydrolyze imine 62 under milder conditions which could 
prevent spiroketal isomerization.  Various copper salts were tested as azaphilic lewis 
acids to promote imine hydrolysis without spiroketal isomerization.  3 M Cu(NO3)2 (aq) 
effectively induced imine hydrolysis without enol ether hydration, allowing a direct 
readout of ~3:1 d.r. at C6, which may or may not have resulted from spiroketal 
equilibration during the milder imine hydrolysis.  This method was not pursued further 
since the resulting C8C9 olefin would likely be incompatible with the subsequent furan 
oxidation.  Having failed to develop a set of conditions for the reproducible, 
diastereoselective spiroketalization of enamine 59, we next sought to induce a substrate 
bias. 
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Scheme 3-18.  Selective Hydrolysis with Cu(NO3)2 
 
 Rizzacasa and Hatakeyama both propose that spiroketalization 
diastereoselectivity results from the approach of the C9 oxygen from the less hindered 
face of the intermediate oxocarbenium ion (see section 3.1.3).  According to this model, 
increased steric bulk on the furan would further block the undesired approach and 
improve spiroketal d.r. (Scheme 3-4).  To this end, Michael acceptors 69 and 72 were 
prepared (Scheme 3-19).  Formylation of commercially available menthofuran provided 
furyl aldehyde 68.  Subsequent Horner-Wadsworth-Emmons olefination with the C5-C9 
ketophosphonate 54 provided enone 69.  Enone 72 was prepared in three steps by 
formylation of 3-bromofuran, Suzuki cross coupling, and olefination. 
Scheme 3-19. Preparation of Enones with Hindered Furans 
 
 With the bulky -furyl enones in hand, they were each subjected to three 
component coupling conditions.  Menthofuran-derived enone 69 was found to provide 
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low conversion (60% conversion after 40 h) and d.r. (1:1).  Enone 72 was found to be 
unreactive in the three component coupling, affording <5% conversion.  Three 
component 1,2-addition products were not identified, but may have been major 
byproducts.  Since these bulky furyl enones provided poor results in the three component 
coupling, their performance in the spiroketalization was not evaluated. 
 An alternative strategy to access a spiroketalization precursor with a larger C4 
substituent was developed, involving conversion of the furan to a t-butyl ester prior to 
spiroketalization.  While furan ozonolysis was found to provide decomposition at every 
synthetic intermediate besides lactol 63, RuCl3/NaIO4 was capable of chemoselective 
furan oxidation in the presence of the isoxazole (Scheme 3-20).  Esterification with 
isourea 18 afforded triester 73.  Subsequent NO reduction and one-pot spiroketalization 
/ hydrolysis provided trachyspic acid dimethyl ester 64 with low diastereoselectivity 
(1.5:1), wherein the t-butyl ester had been unexpectedly cleaved, decreasing the intended 
facial bias in spiroketalization.  Having been unsuccessful at improving the spiroketal d.r. 
by substrate bias, we shifted our focus to the development of an asymmetric route. 
Scheme 3-20. Spiroketalization with C4 t-Butyl Ester 
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3.3.5 Asymmetric Three Component Couplings of Chiral Silyl Glyoxylates 
 Although silyl glyoxylates have proven to be valuable conjunctive reagents for 
the rapid production of dense molecular complexity in diverse settings, they have seen 
limited use in nonracemic reactions.  Chiral silyl glyoxylates have been shown to induce 
asymmetry in two systems to date: Xin Linghu and Andrew Satterfield utilized chiral 
silyl glyoxylate 28b in a Meerwein-Ponndorf-Verley/aldol sequence which induced 
excellent diastereoselectivity (Scheme 3-21, eq. 1).
22
  Recently, Gregory Boyce used 
chiral silyl glyoximide 28c in a three component coupling with vinylmagnesium bromide 
and -nitrostyrene which also provided excellent diastereoselectivity (Scheme 3-21, eq. 
2).
23
 
Scheme 3-21. Diastereoselective Couplings of Chiral Silyl Glyoxylates 
 
An asymmetric route to trachyspic acid could exploit chiral auxiliary control in 
the three component coupling.  For this reason, a number of chiral silyl glyoxylates were 
prepared for evaluation in the key step.  Silyl glyoxylates 28d-j were prepared by initial 
acylation of the chiral alcohols followed by the standard synthetic sequence (Scheme 3-
22).
24
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Scheme 3-22. Synthesis of Chiral Silyl Glyoxylates 
 
 Following their preparation, the chiral silyl glyoxylates were each tested in the 
three component coupling with the trachyspic acid C4-C9 Michael acceptor.  While 28e, 
28i, 28j, and glyoximide 28c failed to provide any of the desired coupling product, the 
other silyl glyoxylates all provided the desired chiral ketones 55 as the major product 
with various levels of diastereoselection (Table 3-8).  The best chiral silyl glyoxylate was 
found to be 28f, which provided 4.5:1 d.r. (major diastereomer :  minor diastereomers).   
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Table 3-8. Enolate Initiated Couplings of Chiral Silyl Glyoxylates with C4-C9 Enone 
 
entry silyl glyoxylate result 
1 28c 0% conversion 
2
a
 28d 57% yield, 3.7:1 d.r.
b
 
3 28e 0% conversion 
4
c
 28f 87% yield, 4.5:1 d.r.
b
 
5
d
 28g 3.5:1 d.r.
b
 
6
d
 28h 1.9:1 d.r.
b
 
7 28i 0% conversion 
8 28j 0% conversion 
a) Isolated yield of analytically pure material. b) Diastereomeric ratio of major diastereomer to the 
sum of three minor diastereomers. c) Yield determined by 
1
H NMR analysis of crude reaction 
mixture. d) Yield not determined due to inferior diastereoselection. 
 
3.3.6 Chiral Auxiliary Cleavage 
 In order to apply this asymmetric three component coupling to trachyspic acid, 
the chiral auxiliary had to be removed.  Thiolate, hydroxide, and alkoxide nucleophiles 
did not provide clean transesterification of the hindered chiral ester (Table 3-9).  In most 
cases no reactivity occurred at room temperature, but heating resulted in formation of 
complex mixtures.  We recalled that acidic conditions removed both t-butyl esters in the 
racemic synthesis (see Scheme 3-15, section 3.3.3).  However, acidic conditions were 
found to methylate the C1-ester and induce mixed methyl ketal formation, but did not 
react with the C3 chiral ester.  Employing more forcing conditions, we observed the 
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desired dimethyl ester 58 (entry 6); however, the yield was <10%, as substantial 
decomposition also occurred. 
Table 3-9. Chiral Auxiliary Cleavage Attempts 
 
entry substrate
a
 conditions temp. (°C) result 
1 55g LiSEt, THF 40 No Reaction 
2 55d KOH, H2O/THF 66 decomposition 
3
b
 55d NaOMe, MeOH 65 decomposition 
4 55d NaOEt, EtOH 78 decomposition 
5 55d HC(OMe)3, TsOH 65 C1-methyl ester 
6 55d HC(OMe)3, TsOH 100
c
 58 (<10% yield) 
a) Absolute stereochemistry of C3 and C4 unknown.  b) Wolfe successfully cleaved 2-
phenylcyclohexanol ester to methyl ester using identical conditions.
25
  c) Reaction performed in 
sealed pressure tube (methanol solvent). 
 
 
Having previously observed facile cleavage of the C3 t-butyl ester with 
TsOH/MeOH, we hypothesized that the C3 chiral ester was more robust because it was 
comprised of a secondary alcohol rather than a tertiary alcohol.  t-Butyl esters are acid-
labile due to the relative stability of the resulting tertiary carbocation.  Therefore, we 
speculated that if a chiral tertiary alcohol was employed as the auxiliary, its direct 
cleavage to mixed methyl ketal 58 would be possible under mild acidic conditions.  With 
this in mind, and in an effort to deviate minimally from optimal secondary auxiliary 28f, 
silyl glyoxylate 28k was prepared from enantioenriched tertiary alcohol 77.  The tertiary 
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chiral alcohol 77 was prepared by Shi epoxidation and subsequent Cu-catalyzed epoxide 
opening (Scheme 3-23). 
Scheme 3-23. Preparation of Tertiary Chiral Silyl Glyoxylate 
 
 After elaboration of chiral tertiary alcohol 77, silyl glyoxylate 28k was tested in 
the three component glycolate Michael coupling.  The coupling proceeded cleanly with 
full conversion of the C4-C9 enone; however the d.r. was unfortunately 1.9:1.7:1.0:trace 
(compared to 4.5:1 for silyl glyoxylate 28f).  It is likely that the additional methyl group 
altered the conformation of the glycolate enolate intermediate, preventing the adjacent 
aryl ring from adequately blocking one face of the enolate.   
Scheme 3-24. Poor Diastereoselection with Tertiary Auxiliary  
 
 Despite the poor d.r. of the three component coupling, we proceeded with 
cleavage of the chiral auxiliary by treatment of the diastereomeric mixture with TsOH 
and (MeO)3CH in refluxing methanol.  As predicted, the tertiary auxiliary underwent 
facile cleavage to mixed methyl ketal 58 (mixture of syn and anti, 53% combined yield; 
compare to <10% yield with auxiliary 55d).  The enantiopurity of the mixed methyl ketal 
was not tested, but should be ~63:37 e.r. based on the 1.7:1.0 ratio of diastereomers that 
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are believed to possess the desired relative stereochemistry between C3 and C4.  Future 
work could involve the synthesis of more chiral tertiary silyl glyoxylates for testing in the 
three component coupling, since we have demonstrated their acid lability.   
3.4 Conclusion 
 In summary, we have developed a three component coupling of enolates, silyl 
glyoxylates, and enones which demonstrates counterion-dependent regioselectivity.  
Additionally, we have developed a nitrile-oxide cycloaddition with enolsilane 
dipolarophiles for the synthesis of isoxazoles that are challenging to access by other 
means.  These new reactions allowed the synthesis of trachyspic acid dimethyl ester in 10 
linear steps from undecanal in 4% overall yield (average of >70% yield per step).  The 
three component coupling step may be done asymmetrically by utilizing a chiral silyl 
glyoxylate.  The aim of future work is to evaluate the scope of the tandem aldol/Michael 
reaction in the context of other alkyl citrate natural products. 
3.5 Experimental 
Materials and Methods: General.  Infrared (IR) spectra were obtained using a Nicolet 
560-E.S.P. infrared spectrometer.  Proton and carbon nuclear magnetic resonance spectra 
(
1
H and 
13
C NMR) were recorded on either a Bruker model Avance 600 (
1
H NMR at 600 
MHz and 
13
C NMR at 150 MHz), Bruker model Avance 500 (
1
H at 500 MHz and 
13
C 
NMR at 125 MHz), Bruker model Avance 400 (
1
H NMR at 400 MHz and 
13
C NMR at 
100 MHz), or a Varian Gemini 300 (
1
H NMR at 300 MHz and 
13
C at 75 MHz) 
spectrometer with solvent resonance as the internal standard (
1
H NMR: CDCl3 at 7.26 
ppm; C6D6 at 7.15 ppm and 
13
C NMR: CDCl3 at 77.0 ppm and C6D6 at 128.62 ppm).  
1
H 
NMR data are reported as follows: chemical shift, multiplicity (s = singlet, br s = broad 
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singlet, d = doublet, t = triplet, q = quartet, sept = septet, m = multiplet), coupling 
constants (Hz), and integration.  Analytical thin layer chromatography (TLC) was 
performed on Whatman 0.25 mm silica gel 60 plates.  Visualization was accomplished 
with UV light and aqueous ceric ammonium molybdate solution followed by heating.  
Purification of the reaction products was carried out by flash chromatography using 
Sorbent Technologies silica gel 60 (32-63 µm).  All reactions were carried out under an 
atmosphere of nitrogen in oven-dried glassware with magnetic stirring.  Yield refers to 
isolated yield of analytically pure material.  Yields are reported for a specific experiment 
and as a result may differ slightly from those found in the tables, which are averages of at 
least two experiments.  Diethyl ether, methylene chloride, tetrahydrofuran, and toluene 
were dried by passage through a column of neutral alumina under nitrogen prior to use.
21
 
Unless otherwise noted, reagents were obtained from commercial sources and used 
without further purification.  Triethylamine, diisopropylamine, and pyridine were freshly 
distilled from CaH2 under Ar prior to use. 
General Procedure A for Aldol/Michael Three Component Couplings:  To a solution 
of LiCl (8.0 equiv, 1.9 M) in THF was added iPr2NH (2.1 equiv).  The solution was 
cooled to 0 °C and 
n
BuLi (1.4 M in hexanes, 2.0 equiv) was added.  The solution was 
stirred at 0 °C for 10 min, then stirred at room temperature for 10 min.  The solution was 
cooled to -78 °C and a solution of 
t
BuOAc (1.9 equiv) in THF (1.1 M) was added. The 
solution was stirred at -78 °C for 1 h.  A solution of ,-unsaturated ketone (1.0 equiv, 
0.2 M) and t-butyl t-butyldimethylsilyl glyoxylate23 (2.1 equiv) in THF was added.  The solution 
was allowed to slowly warm to room temperature over 3 h and then stirred at room temperature 
for 14-24 h.  The reaction was diluted with Et2O (15 mL) and quenched with saturated 
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NH4Cl (5 mL).  The layers were separated and the aqueous layer was extracted with Et2O 
(3 X 20 mL).  The organic extracts were combined, washed with brine (15 mL), dried 
with MgSO4, and concentrated under reduced pressure.  The resulting oil was purified as 
indicated. 
 
(E)-di-tert-butyl 2-(1,5-bis(4-methoxyphenyl)-3-oxopent-4-en-1-yl)-2-((tert-
butyldimethylsilyl)oxy)succinate (35a). General procedure A was performed using 
dianisylideneacetone (59 mg, 0.200 mmol, 1.0 equiv).  Purification by flash 
chromatography (95:5 to 85:15 petroleum ether:Et2O gradient) furnished 35a (52 mg, 
0.0794 mmol, 40% yield) as a clear oil.  Analytical data for 35a:  IR (thin film, cm
-1
) 
2930, 2854, 1740, 1658, 1602, 1513, 1463, 1422, 1393, 1107, 1036; 
1
H NMR (400 MHz, 
CDCl3) 7.43-7.37(m, 3H), 7.27-7.25 (m, 2H), 6.88 (d, J = 8.8 Hz, 2H), 6.78 (d, J = 8.8 
Hz, 2H), 6.45 (d, J = 16.4 Hz, 1H), 3.83 (s, 3H), 3.76 (s, 3H), 3.61 (dd, J = 2.4, 10.4 Hz, 
1H), 3.20 (dd, J = 10.8, 16.8 Hz, 1H), 3.06 (dd, J = 2.8, 16.8 Hz, 1H), 2.65 (d, J = 17.2 
Hz, 1H), 2.22 (d, J = 16.8 Hz, 1H), 1.43 (s, 9H), 1.39 (s, 9H), 0.93 (s, 9H), 0.37 (s, 3H), 
0.16 (s, 0.16); 
13
C NMR (150 MHz, CDCl3) 198.3, 172.3, 169.0, 161.5, 158.5, 142.1, 
131.8, 130.9, 130.0, 127.2, 124.3, 114.3, 113.4, 81.6, 80.6, 80.2, 55.4, 55.2, 48.8, 44.3, 
42.6, 28.1, 27.8, 26.5, 19.2, -2.1, -2.6; LRMS (ESI) exact mass calculated for 
C37H54O8SiNa: 677.35. Found: 677.37. 
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(E)-di-tert-butyl 2-(1,5-bis(3,5-dimethoxyphenyl)-3-oxopent-4-en-1-yl)-2-((tert-
butyldimethylsilyl)oxy)succinate (35b).  General procedure A was performed using 
(1E,4E)-1,5-bis(3,5-dimethoxyphenyl)-1,4-pentadien-3-one (60 mg, 0.169 mmol, 1.0 
equiv).  Purification by flash chromatography (85:15 petroleum ether:Et2O) furnished 
35b (50 mg, 0.0699 mmol, 41% yield) as a clear oil.  Analytical data for 35b:  IR (thin 
film, cm
-1
) 2929, 2850, 1740, 1651, 1595, 1463, 1428, 1368, 1067; 
1
H NMR (400 MHz, 
CDCl3)   7.37-7.33 (m, 1H), 6.61-6.47 (m, 6H)  6.28 (d, J = 18.4 Hz, 1H), 3.80 (s, 3H), 
3.75 (s, 3H), 3.48 (d, J = 7.2 Hz, 1H), 3.26-3.14 (m, 2H), 2.71 (d, J = 17.2 Hz, 1H), 2.35 
(d, J = 17.2 Hz, 1H), 1.42 (s, 9H), 1.40 (s, 9H), 0.95 (s, 9H), 0.36 (s, 3H), 0.16 (s, 3H); 
LRMS (ESI) exact mass calculated for C39H58O10SiNa: 737.37. Found: 737.39. 
 
(E)-di-tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(1,5-di(furan-2-yl)-3-oxopent-4-
en-1-yl)succinate (35c).  General procedure A was performed using difurylideneacetone 
(31 mg, 0.145 mmol, 1.0 equiv).  Purification by flash chromatography (97:3 
hexanes:Et2O) furnished 35c (40 mg, 0.0695 mmol, 48% yield) as a clear oil.  Analytical 
data for 35c:  IR (thin film, cm
-1
) 2855, 1739, 1614, 1555, 1473, 1369, 1150, 1107, 1017; 
1
H NMR (300 MHz, CDCl3)   7.48 (s, 1H), 7.30 (d, J = 1.2 Hz, 1H), 7.21 (s, 1H), 6.62 
(d, J = 3.3 Hz, 1H), 6.54 (d, J = 15.9 Hz, 1H), 6.46 (dd, J = 1.8, 3.6 Hz, 1H), 6.25 (dd, J 
= 1.8, 3.0 Hz, 1H), 6.13 (d, J = 3.0 Hz, 1H), 3.81 (dd, J = 2.7, 11.1 Hz, 1H), 3.23-3.15 
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(m, 1H), 2.97 (dd, J = 2.4, 16.5 Hz, 1H), 2.89 (d, J = 16.8 Hz, 1H), 2.42 (d, J = 16.8 Hz, 
1H), 1.44 (s, 9H), 1.42 (s, 9H), 0.87 (s, 9H), 0.30 (s, 3H), 0.12 (s, 3H); 
13
C NMR (100 
MHz, CDCl3) 197.3, 171.8, 168.9, 152.9, 151.1, 144.8, 141.4, 128.6, 123.2, 115.6, 
112.5, 110.2, 108.6, 81.7, 80.3, 79.7, 43.6, 43.4, 40.5, 28.1, 28.0, 27.9, 27.8, 27.7, 26.2, 
19.0, -2.5, -2.9; LRMS (ESI) exact mass calculated for C31H46O8SiNa: 597.29. Found: 
597.30. 
 
di-tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(3-oxo-3-phenyl-1-(4-
(trifluoromethyl)phenyl)propyl)succinate (35d).  General procedure A was performed 
using (E)-1-phenyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-one (40 mg, 0.145 mmol, 
1.0 equiv).  Purification by flash chromatography (97:3 hexanes:Et2O) furnished 35d (49 
mg, 0.0769 mmol, 53% yield) as a clear oil.  Analytical data for 35d:  IR (thin film, cm
-1
) 
2931, 2359, 1741, 1618, 1472, 1394, 1325, 1255, 1222, 1164, 1069, 1019; 
1
H NMR (600 
MHz, CDCl3)  7.85 (d, J = 8.4 Hz, 2H), 7.53-7.50 (m, 5H), 7.44-7.40 (m, 2H), 3.88 (dd, 
J = 2.4, 10.2 Hz),  3.58 (t, J = 10.2 Hz, 1H), 3.51 (dd, J = 3, 18 Hz, 1H), 2.63 (d, J = 17.4 
Hz, 1H), 2.22 (d, J = 17.4 Hz, 1H), 1.42 (s, 9H), 1.40 (s, 9H), 0.93 (s, 9H), 0.39 (s, 3H), 
0.18 (s, 3H); 
13
C NMR (150 MHz, CDCl3) 197.5, 171.8, 168.6, 136.8, 133.1, 130.3, 
128.6, 127.8, 124.9, 82.1, 80.6, 80.2, 48.6, 44.4, 40.6, 28.1, 27.7, 26.5, 19.2, -2.2, -2.6; 
LRMS (ESI) exact mass calculated for C34H47F3O6SiNa: 659.30. Found: 659.32. 
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di-tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(1-(furan-2-yl)-3-oxo-3-
phenylpropyl)succinate (35e).  General procedure A was performed using (E)-3-(furan-
2-yl)-1-phenylprop-2-en-1-one (29 mg, 0.145 mmol, 1.0 equiv).  Purification by flash 
chromatography (97:3 hexanes:Et2O) furnished 35e (53 mg, 0.0948 mmol, 65% yield) as 
a clear oil.  Analytical data for 35e:  IR (thin film, cm
-1
) 2930, 2855, 1741, 1692, 1598, 
1472, 1393, 1368, 1251, 1149, 1106, 1012; 
1
H NMR (500 MHz, CDCl3)  7.90 (d, J = 
Hz, 2H), 7.53 (t, J = 7 Hz, 1H), 7.44-7.40 (m, 2H),  7.28 (s, 1H), 6.24 (d, J = 2 Hz, 1H), 
6.14 (d, J = 3.5 Hz, 1H), 3.95 (dd, J = 2, 10.5 Hz, 1H), 3.66 (dd, J = 10.5, 17.5 Hz, 1H), 
3.31 (dd, J = 2, 17 Hz, 1H), 2.92 (d, J = 16.5 Hz, 1H), 2.45 (d, J = 17 Hz, 1H), 1.43 (s, 
9H), 1.39 (s, 9H), 0.87 (s, 9H), 0.33 (s, 3H), 0.14 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 
197.7, 171.9, 168.9, 153.1, 141.4, 137.0, 132.9, 128.5, 128.0, 110.2, 108.5, 81.7, 80.3, 
79.8, 43.6, 43.3, 28.1, 27.7, 26.2, 19.0, -2.4, -2.9; LRMS (ESI) exact mass calculated for 
C31H46O7SiNa: 581.29. Found: 581.31. 
 
di-tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(3-oxo-1,3-diphenylpropyl)succinate 
(35f).  General procedure A was performed using trans-chalcone (42 mg, 0.200 mmol, 
1.0 equiv).  Purification by flash chromatography (97:3 petroleum ether:Et2O) furnished 
35f (67 mg, 0.118 mmol, 59% yield) as a clear oil.  Analytical data for 35f:  IR (thin film, 
cm
-1
) 2929, 2855, 2360, 2124, 1739, 1691, 1607, 1578, 1495, 1017; 
1
H NMR (600 MHz, 
CDCl3)   7.86 (d, J = 6.6 Hz, 2H), 7.51-7.49 (m 1H), 7.49-7.36 (m, 4H), 7.25-7.19 (m, 
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3H), 3.79 (d, J = 10.2 Hz, 1H), 3.60 (dd, J = 10.2, 18.0 Hz, 1H),  3.47 (d, J = 18.0 Hz, 
1H), 2.70 (d, J = 16.8 Hz, 1H), 2.24 (d, J = 17.4 Hz, 1H), 1.40 (s, 9H), 1.39 (s, 9H), 0.92 
(s, 9H), 0.39 (s, 3H), 0.18 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 198.0, 172.3, 169.0, 
140.0, 137.2, 132.8, 130.2, 130.0, 128.5, 128.0, 127.9, 127.5, 126.9, 81.7, 80.5, 80.3, 
49.1, 44.4, 40.6, 28.1 (2 peaks), 27.8, 26.5, 26.3, 19.2, -2.1, -2.6; LRMS (ESI) exact 
mass calculated for C15H26O3SiNa: 591.31. Found: 591.33. 
 
di-tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-((1E,4E)-1,5-di(furan-2-yl)-3-
hydroxypenta-1,4-dien-3-yl)succinate (36a).  To the Reformatsky reagent of t-butyl 
bromoacetate
11
 (0.39 M in Et2O, 1.5 mL, 0.583 mmol, 2.5 equiv) was added 0.9 mL 
Et2O.  The solution was cooled to -30 °C and a solution of t-butyl t-butyldimethylsilyl 
glyoxylate
24
 (142 mg, 0.583 mmol, 2.5 equiv) in Et2O (1.5 mL) was added.  The solution was 
slowly warmed to 0 °C over 30 min before a solution of Zn(OTf)2 (85 mg, 0.233 mmol, 1.0 
equiv) and difurylideneacetone (50 mg, 0.233 mmol, 1.0 equiv) in Et2O (3.0 mL) was 
added (Some Zn(OTf)2 would not dissolve and was not transferred into reaction).  The 
solution was slowly warmed to room temperature over 15 h and then saturated NH4Cl (5 
mL) was added.  The layers were separated and the aqueous layer was extracted with 
Et2O (3 X 20 mL).  The organic extracts were combined, washed with brine (15 mL), 
dried with MgSO4, and concentrated under reduced pressure.  Purification by flash 
chromatography (97:3 to 95:5 petroleum ether:EtOAc gradient) furnished 36a (56 mg, 
0.0974 mmol, 42% yield) as a colorless oil.  Analytical data for 36a: 
1
H NMR (400 
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MHz, CDCl3)  7.33 (s, 2H), 6.59-6.52 (m, 3H), 6.38-6.33 (m, 3H), 6.21 (t, J = 4.4 Hz, 
2H), 3.83 (brs, 1H), 3.17 (d, J = 17.6 Hz, 1H), 2.64 (d, J = 17.6 Hz, 1H), 1.46 (s, 9H), 
1.42 (s, 9H), 0.93 (s, 9H), 0.25 (s, 3H), 0.16 (s, 3H); 
13
C NMR (150 MHz, CDCl3) 
171.7, 169.7, 152.9, 142.0, 128.5, 127.6, 118.1, 117.5, 111.2, 108.0 (2 peaks), 83.1, 
82.7, 80.6, 78.8, 41.4, 28.1, 27.9, 26.2, 19.0, -2.5, -2.8. 
 
General Procedure B for Dipolar Cycloadditions:  To a solution of enolsilane (2.0 to 
8.0 equiv) and ethyl chlorooximidoacetate (1.0 equiv, 0.04 M in hexanes) was added a 
solution of Et3N (1.5 equiv, 0.1 M in hexanes) via syringe pump over 15 h.  The solution 
was stirred at room temperature for 4-72 h and then TsOH
.
H2O (4.0 equiv) was added.  
The flask was fitted with a reflux condenser and the solution was heated to reflux for 4-
24 h.  The reaction was cooled to room temperature and H2O was added.  The solution 
was extracted with EtOAc (3X) and the combined organic extracts were dried with 
MgSO4 and concentrated under reduced pressure.  The resulting brown oil was purified 
as indicated. 
 
Ethyl 4-isopropylisoxazole-3-carboxylate (52a).  General procedure B was performed 
using the trimethylsilyl enol ether of 3-methylbutyraldehyde (1.69 g, 10.6 mmol, 8.0 
equiv), ethyl chlorooximidoacetate (200 mg, 1.32 mmol, 1.0 equiv), Et3N (0.276 mL, 
1.98 mmol, 1.5 equiv), and TsOH
.
H2O (1.00 g, 5.28 mmol, 4.0 equiv).  Purification by 
flash chromatography (95:5 petroleum ether:Et2O) furnished 52a (87 mg, 0.475 mmol, 
36% yield) as a clear oil.  Analytical data for 52a: IR (thin film, cm
-1
) 3448, 3114, 2967, 
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2936, 2874, 1731, 1587, 1468, 1338, 1270, 1163, 1016; 
1
H NMR (400 MHz, CDCl3) 
8.29 (s, 1H), 4.46 (q, J = 6.8 Hz, 2H), 3.29-3.22 (m, 1H), 1.44 (t, J = 7.2 Hz, 3H), 1.27 
(d, J = 6.8 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) 160.5, 155.9, 153.3, 128.3, 61.8, 
23.0, 14.1; TLC (10:90 EtOAc: petroleum ether) Rf 0.29; LRMS (ESI) exact mass 
calculated for C9H13NO3Na: 206.08. Found: 206.10. 
 
Ethyl 4-butylisoxazole-3-carboxylate (52b).  General procedure B was performed using 
the trimethylsilyl enol ether of hexanal (230 mg, 1.32 mmol, 2.0 equiv), ethyl 
chlorooximidoacetate (100 mg, 0.66 mmol, 1.0 equiv), Et3N (0.138 mL, 0.990 mmol, 1.5 
equiv), and TsOH
.
H2O (0.50 g, 2.64 mmol, 4.0 equiv).  Purification by flash 
chromatography (97:3 petroleum ether:Et2O) furnished 52b (29 mg, 0.147 mmol, 22% 
yield) as a clear oil.  Analytical data for 52b: IR (thin film, cm
-1
) 2960, 1732, 1457, 1236, 
1119; 
1
H NMR (400 MHz, CDCl3)  8.29 (s, 1H), 4.45 (q, J = 7.2 Hz, 2H), 2.67 (t, J = 
7.2 Hz, 2H), 1.58 (m, 2H), 1.45-1.36 (m, 4H), 0.95 (t, J = 7.2 Hz, 3H); 
13
C NMR (150 
MHz, CDCl3) 160.5, 157.1, 153.8, 121.4, 61.8, 31.6, 22.3, 21.8, 14.1; TLC (10:90 
EtOAc: petroleum ether) Rf 0.19; LRMS (ESI) exact mass calculated for C10H15NO3Na: 
220.10. Found: 220.11. 
 
Ethyl 4-octylisoxazole-3-carboxylate (52c).  General procedure B was performed using 
the trimethylsilyl enol ether of decanal (300 mg, 1.32 mmol, 2.0 equiv), ethyl 
chlorooximidoacetate (100 mg, 0.66 mmol, 1.0 equiv), Et3N (0.138 mL, 0.990 mmol, 1.5 
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equiv), and TsOH
.
H2O (0.50 g, 2.64 mmol, 4.0 equiv).  Purification by flash 
chromatography (97:3 petroleum ether:Et2O) furnished 52c (49 mg, 0.194 mmol, 29% 
yield) as a clear oil.  Analytical data for 52c: IR (thin film, cm
-1
) 3115, 2927, 2856, 1732, 
1592, 1461, 1390, 1291, 1236, 1173, 1122, 1018; 
1
H NMR (400 MHz, CDCl3)  8.29 (s, 
1H), 4.45 (q, J = 6.8 Hz, 2H), 2.67 (t, J = 7.2 Hz, 2H), 1.44 (t, J = 6.8 Hz, 3H), 1.34-1.27 
(m, 12H), 0.89 (t, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 160.5, 157.0, 153.9, 
121.4, 61.8, 31.8, 29.5, 29.3, 29.2, 22.6, 22.1, 14.1, 14.0; TLC (10:90 EtOAc: petroleum 
ether) Rf 0.33; LRMS (ESI) exact mass calculated for C14H23NO3Na: 276.16. Found: 
276.17. 
 
Ethyl 4-benzylisoxazole-3-carboxylate (52d).  General procedure B was performed 
using the trimethylsilyl enol ether of hydrocinnamaldehyde (540 mg, 2.64 mmol, 4.0 
equiv), ethyl chlorooximidoacetate (100 mg, 0.66 mmol, 1.0 equiv), Et3N (0.138 mL, 
0.990 mmol, 1.5 equiv), and TsOH
.
H2O (0.50 g, 2.64 mmol, 4.0 equiv).  Purification by 
flash chromatography (97:3 petroleum ether:Et2O) furnished 52d (40 mg, 0.172 mmol, 
26% yield) as a clear oil.  Analytical data for 52d: IR (thin film, cm
-1
) 2360, 1732, 1456, 
1237, 1105, 708; 
1
H NMR (400 MHz, CDCl3)  8.12 (s, 1H), 7.36-7.23 (m, 5H), 4.47 (q, 
J = 7.2 Hz, 2H), 4.05 (s, 2H), 1.42 (t, J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 
160.3, 158.3, 153.6, 138.4, 128.7, 128.6, 126.8, 121.0, 63.6, 62.0, 53.4, 28.5, 14.1; 
TLC (10:90 EtOAc: petroleum ether) Rf 0.15; LRMS (ESI) exact mass calculated for 
C13H13NO3Na: 254.08. Found: 254.09. 
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Ethyl 4-phenylisoxazole-3-carboxylate (52e).  General procedure B was performed 
using the trimethylsilyl enol ether of phenylacetaldehyde (250 mg, 1.32 mmol, 2.0 
equiv), ethyl chlorooximidoacetate (100 mg, 0.66 mmol, 1.0 equiv), Et3N (0.138 mL, 
0.990 mmol, 1.5 equiv), and TsOH
.
H2O (0.50 g, 2.64 mmol, 4.0 equiv).  Purification by 
flash chromatography (95:5 petroleum ether:Et2O) furnished 52e (14 mg, 0.066 mmol, 
10% yield) as a clear oil.   
 
Ethyl 5,6-dihydro-4H-cyclopenta[d]isoxazole-3-carboxylate (52f).  General procedure 
B was performed using the trimethylsilyl enol ether of cyclopentanone (413 mg, 2.64 
mmol, 4.0 equiv), ethyl chlorooximidoacetate (100 mg, 0.66 mmol, 1.0 equiv), Et3N 
(0.138 mL, 0.990 mmol, 1.5 equiv), and TsOH
.
H2O (0.50 g, 2.64 mmol, 4.0 equiv).  
Purification by flash chromatography (95:5 petroleum ether:Et2O) furnished 52f (77 mg, 
0.425 mmol, 64% yield) as a clear oil.  Analytical data for 52f: IR (thin film, cm
-1
) 2981, 
1747, 1618, 1434, 1389, 1307, 1239, 1134, 1040; 
1
H NMR (400 MHz, CDCl3)  4.42 (q, 
J = 7.2 Hz, 2H), 2.88-2.83 (m, 2H), 2.76-2.69 (m, 4H), 1.41 (t, J = 7.2 Hz, 3H); 
13
C 
NMR (150 MHz, CDCl3) 181.7, 160.3, 151.8, 124.5, 61.9, 30.4, 24.6, 21.5, 14.1; TLC 
(10:90 EtOAc: petroleum ether) Rf 0.17; LRMS (ESI) exact mass calculated for 
C9H11NO3Na: 204.06. Found: 204.08. 
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Ethyl 4,5-dihydronaphtho[2,1-d]isoxazole-3-carboxylate (52g).  General procedure B 
was performed using the trimethylsilyl enol ether of tetralone (870 mg, 3.95 mmol, 6.0 
equiv), ethyl chlorooximidoacetate (100 mg, 0.66 mmol, 1.0 equiv), Et3N (0.138 mL, 
0.990 mmol, 1.5 equiv), and TsOH
.
H2O (0.50 g, 2.64 mmol, 4.0 equiv).  Purification by 
flash chromatography (95:5 petroleum ether:Et2O) furnished 52g (112 mg, 0.461 mmol, 
70% yield) as a white solid.  Analytical data for 52g: 1745, 1634, 1596, 1569, 1367, 
1350, 1285, 1192, 1018; 
1
H NMR (600 MHz, CDCl3)  8.01 (d, J = 7.8 Hz, 1H), 7.46-
7.27 (m, 3H), 4.45 (q, J = 7.2 Hz, 2H), 3.05-3.00 (m, 4H), 1.44 (t, J = 7.2 Hz, 3H); 
13
C 
NMR (100 MHz, CDCl3) 167.6, 160.3, 153.2, 136.5, 130.1, 128.3, 126.9, 124.3, 121.8, 
113.6, 61.7, 28.4, 18.4, 14.0; TLC (10:90 EtOAc: petroleum ether) Rf 0.21.  
 
Ethyl 5,6,7,8-tetrahydro-4H-cyclohepta[d]isoxazole-3-carboxylate (52h).  General 
procedure B was performed using the trimethylsilyl enol ether of cycloheptanone (487 
mg, 2.64 mmol, 4.0 equiv), ethyl chlorooximidoacetate (100 mg, 0.66 mmol, 1.0 equiv), 
Et3N (0.138 mL, 0.990 mmol, 1.5 equiv), and TsOH
.
H2O (0.50 g, 2.64 mmol, 4.0 equiv).  
Purification by flash chromatography (97:3 petroleum ether:Et2O) furnished 52h (89 mg, 
0.421 mmol, 64% yield) as a clear oil.  Analytical data for 52h: IR (thin film, cm
-1
) 1730, 
1619, 1452, 1389, 1369, 1348, 1120, 1094, 1074;  
1
H NMR (400 MHz, CDCl3)  (q, 
J = 6.8 Hz, 2H), 2.93 (t, J = 6.0 Hz, 2H), 2.81 (t, J = 6.0 Hz, 2H), 1.86-1.83 (m, 2H), 
1.77-1.70 (m, 4H), 1.44 (t, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 173.4, 161.1, 
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154.3, 117.5, 61.6, 30.4, 27.8, 25.4, 22.1, 14.1; TLC (10:90 EtOAc: petroleum ether) Rf 
0.19. LRMS (ESI) exact mass calculated for C11H15NO3Na: 232.10. Found: 232.11. 
 
Ethyl 4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxylate (52i).  General procedure B 
was performed using the trimethylsilyl enol ether of cyclohexanone (900 mg, 5.28 mmol, 
4.0 equiv), ethyl chlorooximidoacetate (200 mg, 1.32 mmol, 1.0 equiv), Et3N (0.280 mL, 
1.98 mmol, 1.5 equiv), and TsOH
.
H2O (1.00 g, 5.28 mmol, 4.0 equiv).  Purification by 
flash chromatography (95:5 petroleum ether:Et2O) furnished 52i (64 mg, 0.330 mmol, 
25% yield) as a clear oil.  Analytical data for 52i: IR (thin film, cm
-1
) 1728, 1630, 1455, 
1333, 1272, 1240, 1213, 1177, 1045; 
1
H NMR (400 MHz, CDCl3)  4.43 (q, J = 7.2 Hz, 
2H), 2.75 (t, J = 6.0 Hz, 2H), 2.67 (t, J = 4.4 Hz, 2H), 1.91-1.86 (m, 2H), 1.80-1.76 (m, 
2H), 1.42 (t, J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 170.5, 160.8, 153.7, 113.9, 
61.6, 22.7, 22.2, 21.9, 20.2, 14.1; TLC (10:90 EtOAc: petroleum ether) Rf 0.17; LRMS 
(ESI) exact mass calculated for C10H13NO3Na: 218.08. Found: 218.09. 
 
ethyl 5-ethyl-4-methylisoxazole-3-carboxylate (52j).  General procedure B was 
performed using the trimethylsilyl enol ether of 3-pentanone (830 mg, 5.28 mmol, 4.0 
equiv), ethyl chlorooximidoacetate (100 mg, 0.660 mmol, 1.0 equiv), Et3N (0.138 mL, 
0.990 mmol, 1.5 equiv), and TsOH
.
H2O (0.502 g, 2.64 mmol, 4.0 equiv).  Purification by 
flash chromatography (95:5 petroleum ether:Et2O) furnished 52j (49 mg, 0.268 mmol, 
41% yield) as a clear oil.  Analytical data for 52j: IR (thin film, cm
-1
) 1731, 1624, 1466, 
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1454, 1389, 1365, 1328, 1293, 1270, 1201, 1165, 1085, 1019; 
1
H NMR (400 MHz, 
CDCl3)  4.42 (q, J = 6.8 Hz, 2H), 2.76 (q, J = 7.6 Hz, 2H), 2.14 (s, 3H), 1.41 (t, J = 7.2 
Hz, 3H), 1.28 (t, J = 7.6 Hz, 3H); 
13
C NMR (150 MHz, CDCl3) 172.1, 160.9, 154.7, 
110.3, 61.6, 53.4, 18.8, 14.1, 11.8; TLC (10:90 EtOAc: petroleum ether) Rf 0.25; LRMS 
(ESI) exact mass calculated for C9H13NO3Na: 206.08. Found: 206.09. 
 
Trimethyl(undec-1-en-1-yloxy)silane (51d).  To undecanal (20.0 g, 117 mmol, 1.0 
equiv) in 35 mL DMF was added Et3N (37.6 mL, 270 mmol, 2.3 equiv) followed by 
TMSCl (17.8 mL, 140 mmol, 1.2 equiv).  The flask was fitted with a reflux condenser 
and stirred at reflux for 46 h and then cooled to room temperature.  Water (200 mL) was 
added, and the solution was extracted with petroleum ether (400 mL).  The organic phase 
was separated and washed with 1 M HCl (3 X 100 mL), followed by saturated aqueous 
NaHCO3 (3 X 100 mL), followed by brine (1 X 150 mL).  The organic phase was dried 
with MgSO4 and concentrated under reduced pressure to give trimethyl(undec-1-en-1-
yloxy)silane (51d) (25.4 g, 105 mmol, 90% yield) as a pale orange liquid.  The product 
was >95% pure by 
1
H NMR analysis, and was used in the following step without 
purification.  Analytical data for 51d (~1:1 Z:E): IR (thin film, cm
-1
) 3029, 2958, 2925, 
2854, 2359, 1730, 1659, 1465, 1401, 1253, 1162, 1093; 
1
H NMR (300 MHz, CDCl3) 
6.21-6.13 (m, 2H),  5.00 (dd, J = 6.9, 11.7 Hz, 1H), 4.48 (d, J = 6, 13.2 Hz, 1H), 2.08-
2.04 (m, 2H), 1.90-1.85 (m, 2H), 1.26 (brs, 28H), 0.88 (t, J = 6.3 Hz, 6H); 
13
C NMR 
(100 MHz, CDCl3) 139.3, 137.6, 112.2, 111.8, 32.0, 30.5, 29.7, 29.7, 29.6, 29.5, 29.4, 
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29.3, 29.1, 27.4, 23.6, 22.7, 14.1, -0.5, -0.6; LRMS (ESI) exact mass calculated for 
C14H30OSiH: 243.21. Found: 243.23. 
 
Ethyl 4-nonylisoxazole-3-carboxylate (26). To ethyl chlorooximidoacetate (10.2 g, 67.2 
mmol, 1.0 equiv) and 51d (48.9 g, 202 mmol, 3.0 equiv) in hexanes (2.0 L) at room 
temperature was added slowly a solution of Et3N (14.1 mL, 101 mmol, 1.5 equiv) and 
hexanes (10 mL) via syringe pump over 15 h.  The solution was stirred at room 
temperature for an additional 9 h, then TsOH (76.8 g, 404 mmol, 6.0 equiv) was added 
and the flask was fitted with a reflux condenser and stirred at reflux for 70 h.  The 
reaction was cooled to room temperature and 500 mL of water was added.  The solution 
was extracted with hexanes (3 X 700 mL).  The organic extracts were combined, dried 
with MgSO4, and concentrated under reduced pressure.  Purification by flash 
chromatography (97:3 petroleum ether:EtOAc) furnished ethyl 4-nonylisoxazole-3-
carboxylate (26) (8.26 g, 30.9 mmol, 46% yield) as a pale yellow liquid. Analytical data 
for 26: IR (thin film, cm
-1
) 3114, 2926, 2856, 1732, 1592, 1460, 1389, 1302, 1236, 1173, 
1122, 1018; 
1
H NMR (400 MHz, CDCl3) 8.27 (s, 1H), 4.43 (q, J = 7.2 Hz, 2H), 2.64 (t, 
J = 8 Hz, 2H), 1.60-1.54 (m, 2H), 1.41 (t, J = 7.2 Hz, 3H), 1.32-1.24 (m, 12H), 0.87 (t, J 
= 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 160.4, 157.0, 153.4, 121.3, 61.6, 31.8, 
29.5, 29.4, 29.2, 22.5, 22.0, 14.0; LRMS (ESI) exact mass calculated for C15H25NO3Na: 
290.17. Found: 290.17. 
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Dimethyl (2-(4-nonylisoxazol-3-yl)-2-oxoethyl)phosphonate (54). To dimethyl 
methylphosphonate (163 L, 1.50 mmol, 2.0 equiv) in THF (3 mL) at -78 °C was added 
n
BuLi (1.5 M in hexanes, 1.00 mL, 1.50 mmol, 2.0 equiv) and the solution was 
stirred at -78 °C for 1 h.  A solution of ester 26 (201 mg, 0.752 mmol, 1.0 equiv) 
in THF (6.7 mL) was added dropwise.  The resulting solution was stirred at -78 °C 
for 1 h, gradually turning dark red.  The reaction mixture was quenched with 
saturated NH4Cl (10 mL) and extracted with CH2Cl2 (3 X 40 mL).  The organic 
phase was washed with brine (40 mL), dried with MgSO4, and concentrated under 
reduced pressure.  Purification by flash chromatography (50:50 petroleum ether:EtOAc) 
furnished dimethyl (2-(4-nonylisoxazol-3-yl)-2-oxoethyl)phosphonate (54) (224 mg, 
0.649 mmol, 86% yield) as a clear liquid.  Analytical data for 54: IR (thin film, cm
-1
) 
2926, 2855, 1703, 1455, 1263, 1033; 
1
H NMR (300 MHz, CDCl3) 8.26 (s, 1H), 3.82-
3.75 (m, 8H), 2.65 (t, J = 7.8 Hz, 2H), 1.56-1.51 (m, 2H), 1.26 (brs, 12H), 0.88 (t, J = 6.9 
Hz, 3H); TLC (50:50 EtOAc: petroleum ether) Rf 0.18;  LRMS (ESI) exact mass 
calculated for C16H28NO5PNa: 368.16. Found: 368.17. 
 
 
(E)-3-(furan-2-yl)-1-(4-nonylisoxazol-3-yl)prop-2-en-1-one (25b). To 54 (2.22 g, 6.43 
mmol, 1.0 equiv) and furfural (1.85 g, 19.3 mmol, 3.0 equiv) in H2O (20 mL) at room 
temperature was added a solution of K2CO3 (1.07 g, 7.71 mmol, 1.2 equiv) in H2O 
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(175 mL).  The solution was stirred at reflux for 4.5 h and then was cooled to 
room temperature.  The reaction mixture was quenched with 1 M HCl (50 mL) 
and extracted with Et2O (3 X 150 mL).  The organic phase was washed with brine 
(75 mL), dried with MgSO4, and concentrated under reduced pressure.  Purification by 
flash chromatography (95:5 petroleum ether:EtOAc) furnished (E)-3-(furan-2-yl)-1-(4-
nonylisoxazol-3-yl)prop-2-en-1-one (25b) (1.76 g, 5.58 mmol, 87% yield) as a yellow 
solid.  Analytical data for 25b: MP 39 °C; IR (thin film, cm-1) 2925, 2852, 1672, 1605, 
1556, 1431, 1389, 1264, 1202, 1166, 1097, 1014; 
1
H NMR (400 MHz, CDCl3)  (s, 
1H), 7.64 (d, J = 15.6 Hz, 1H), 7.53 (d, J = 15.6 Hz, 2H), 6.78 (d, J = 3.2 Hz, 1H), 6.52 
(dd, J = 2, 3.6 Hz, 1H), 2.71 (t, J = 8 Hz, 1H), 1.60-1.56 (m, 2H), 1.35-1.25 (m, 12H), 
0.88 (t, J = 6.8 Hz, 3H); 
13
C NMR (125 MHz, CDCl3) 183.9, 158.9, 156.6, 151.4, 
145.5, 131.0, 121.1, 120.7, 116.9, 112.7, 31.8, 29.5, 29.4, 29.3, 29.2, 22.6, 22.2, 14.1; 
TLC (10:90 EtOAc: petroleum ether) Rf 0.35; LRMS (ESI) exact mass calculated for 
C19H25NO3Na: 338.17. Found: 338.17. 
 
Di-tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(1-(furan-2-yl)-3-(4-nonylisoxazol-3-
yl)-3-oxopropyl)succinate (56). To LiCl (3.97 g, 93.6 mmol, 8.0 equiv) in THF (110 
mL) at room temperature was added 
i
Pr2NH (3.60 mL, 25.7 mmol, 2.2 equiv).  The 
solution was cooled to 0 °C and nBuLi (1.5 M in hexanes, 16.4 mL, 24.6 mmol, 
2.1 equiv) was added.  The solution was stirred at 0 °C for 10 min and then the ice 
bath was removed.  The solution was stirred at room temperature for 10 min and 
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then cooled to -78 °C.  A solution of tBuOAc (3.15 mL, 23.5 mmol, 2.0 equiv) in 
THF (110 mL) was added and the solution was stirred at -78 °C for 1 h.  A 
solution of t-butyl t-butyldimethylsilyl glyoxylate
24
 (5.74 g, 23.5 mmol, 2.0 equiv) 
in THF (35 mL) was added and the solution was slowly warmed to 0 °C over 1.5 
h.  A solution of enone 25b (3.70 g, 11.7 mmol, 1.0 equiv) in THF (85 mL) was 
added and the solution was slowly warmed to room temperature over 2 h.  The 
reaction was stirred at room temperature for 21 h and then was quenched with 
saturated NH4Cl (100 mL) and extracted with Et2O (3 X 300 mL).  The combined 
organic extracts were washed with brine (200 mL), dried with MgSO4, and 
concentrated under reduced pressure.  Purification by flash chromatography (97:3 
petroleum ether:Et2O) furnished di-tert-butyl 2-((tert-butyldimethylsilyl)oxy)-2-(1-(furan-
2-yl)-3-(4-nonylisoxazol-3-yl)-3-oxopropyl)succinate (56) (4.85 g of shown 
diastereomer, 7.17 mmol; 1.80 g of undesired diastereomer, 2.66 mmol; 84% overall 
yield) as a clear liquid.  Analytical data for 56: IR (thin film, cm
-1
) 3118, 2928, 2856, 
1740, 1705, 1592, 1504, 1471, 1393; 1368; 1252; 1153; 1106; 1012 
1
H NMR (400 MHz, 
CDCl3) 8.18 (s, 1H), 7.29 (d, J = 1.2 Hz, 1H) 6.24 (t, J = 1.2 Hz, 1H), 6.14 (d, J = 3.2 
Hz, 1H), 3.94 (dd, J = 2, 11.2 Hz, 1H), 3.78 (dd, J = 11.2 Hz, 17.6, 1H), 3.41 (dd, J = 2.4, 
17.6 Hz, 1H), 2.90 (d, J = 16.8 Hz, 1H), 2.55-2.48 (m, 3H), 1.42 (s, 9H), 1.38 (s, 9H), 
1.25 (brs, 14H), 0.88 (t, J = 6.6 Hz, 3H), 0.85 (s, 9H), 0.29 (s, 3H), 0.13 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3) 193.7, 171.6, 168.8, 158.2, 156.6, 152.9, 141.4, 120.4, 110.1, 
108.6, 81.6, 80.1, 79.7, 31.8, 29.4, 29.2, 29.2, 29.1, 28.1, 27.6, 26.1, 22.6, 21.9, 18.9, 
14.0, -2.6, -3.0; TLC (10:90 EtOAc: petroleum ether) Rf 0.45; LRMS (ESI) exact mass 
calculated for C37H61NO8SiNa: 698.41. Found: 698.40. 
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Methyl 3-(furan-2-yl)-5-methoxy-2-(2-methoxy-2-oxoethyl)-5-(4-nonylisoxazol-3-
yl)tetrahydrofuran-2-carboxylate (58).  To 56 (3.48 g, 5.15 mmol, 1.0 equiv) in MeOH 
(220 mL) at room temperature was added (MeO)3CH (5.64 mL, 51.5 mmol, 10 
equiv) and TsOH
.
H2O (3.92 g, 20.6 mmol, 4.0 equiv).  The solution was stirred at 
reflux for 42 h and then was cooled to room temperature.  The reaction mixture 
was concentrated under reduced pressure and redissolved in CH2Cl2 (200 mL). 
The solution was washed with saturated NaHCO3 (200 mL) and the aqueous phase 
was extracted with CH2Cl2 (3 X 100 mL).  The combined organic layers were 
dried with Na2SO4 and concentrated under reduced pressure.  Purification by flash 
chromatography (80:20 petroleum ether:EtOAc) furnished a mixture of diastereomers of 
methyl methyl 3-(furan-2-yl)-5-methoxy-2-(2-methoxy-2-oxoethyl)-5-(4-nonylisoxazol-
3-yl)tetrahydrofuran-2-carboxylate (58) (2.23 g, 4.54 mmol, 88% yield) as a clear liquid.  
Analytical data for 58: IR (thin film, cm
-1
) 2926, 2855, 2359, 1745, 1436, 1359, 1205, 
1042; 
1
H NMR (300 MHz, CDCl3) 8.16 (s, 1H), 7.33 (t, J = 0.6 Hz, 1H), 6.30 (dd, J = 
1.8, 3 Hz, 1H), 6.17 (d, J = 3 Hz, 1H), 4.33 (dd, J = 7.5, 11.4 Hz, 1H), 3.84 (s, 3H), 3.56 
(s, 3H), 3.28 (s, 3H), 2.85-2.55 (m, 4H), 2.46 (t, J = 7.8 Hz, 2H), 1.60-1.54 (m, 2H), 1.25 
(brs, 12H), 0.86 (t, J = 6.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 172.4, 169.7, 160.3, 
156.0, 150.5, 142.3, 118.9, 110.5, 108.9, 106.0, 86.6, 52.5, 51.5, 50.9, 43.3, 42.0, 40.0, 
31.8, 29.5, 29.4, 29.2, 22.6, 22.3, 14.0; TLC (30:70 EtOAc: petroleum ether) Rf 0.50;  
LRMS (ESI) exact mass calculated for C26H37NO8Na: 514.24. Found: 514.18. 
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Methyl 5-(1-amino-2-formylundec-1-en-1-yl)-3-(furan-2-yl)-5-methoxy-2-(2-
methoxy-2-oxoethyl)tetrahydrofuran-2-carboxylate (59).  To 58 (42 mg, 0.0854 
mmol, 1.0 equiv) in MeCN (13 mL) at room temperature was added H2O (24 L) and 
Mo(CO)6 (34 mg, 0.128 mmol, 1.5 equiv).  The solution was stirred at reflux for 5 
h and then was cooled to room temperature.  The reaction mixture was diluted 
with Et2O (50 mL). The solution was washed with NaHCO3 (25 mL) and the 
aqueous phase was extracted with Et2O (3 X 30 mL).  The combined organic 
layers were dried with MgSO4 and concentrated under reduced pressure.  Purification by 
flash chromatography (70:30 petroleum ether:EtOAc) furnished a mixture of 
diastereomers of methyl 5-(1-amino-2-formylundec-1-en-1-yl)-3-(furan-2-yl)-5-methoxy-
2-(2-methoxy-2-oxoethyl)tetrahydrofuran-2-carboxylate (59) (31 mg, 0.0628 mmol, 74% 
yield) as a clear oil.  Analytical data for 59 (4 diastereomers): IR (thin film, cm
-1
) 3211, 
1743, 1600, 1485, 1437, 1360, 1297, 1198, 1076, 1034; 
1
H NMR (400 MHz, CDCl3) 
9.90 (s, 0.28H), 9.26 (s, 0.72H), 7.36 (s, 1H), 6.34 (s, 1H), 6.23-6.19 (m, 1H), 4.27-4.22 
(m, 1H), 3.85 (s, 3H), 3.68-3.65 (m, 3H), 3.33 (s, 0.64H), 3.30 (s, 1.67H), 3.23 (s, 
0.19H), 3.20 (s, 0.50H), 2.86-2.27 (m, 5H), 1.26 (brs, 14H), 0.86 (t, J = 5.6 Hz, 3H); 
13
C 
NMR (150 MHz, CDCl3) 193.0, 192.6, 171.8, 170.2, 158.1, 157.4, 149.6, 149.2, 142.6, 
110.6, 109.3, 109.1, 106.6, 104.0, 85.7, 52.8, 52.1, 51.9, 50.6, 44.2, 42.6, 39.9, 39.2, 33.1, 
31.9, 29.8, 29.6, 29.4, 29.3, 27.3, 22.7, 22.6, 14.1; TLC (50:50 EtOAc: petroleum ether) 
Rf 0.53; LRMS (ESI) exact mass calculated for C26H39NO8Na: 516.26. Found: 516.24. 
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Methyl 3-(furan-2-yl)-7-hydroxy-2-(2-methoxy-2-oxoethyl)-8-nonyl-9-oxo-1,6-
dioxaspiro[4.4]nonane-2-carboxylate (60).  To 59 (1.17 g, 2.37 mmol, 1.0 equiv) in 
CH2Cl2 (275 mL) at room temperature was added a solution of TiCl4 (0.47 mL, 4.27 
mmol, 1.8 equiv) in CH2Cl2 (20 mL).  The solution was stirred at room 
temperature for 1.5 h and then 1 M HCl (275 mL) was added.  The solution was 
stirred vigorously for 20 h and was extracted with CH2Cl2 (2 X 200 mL).  The 
combined organic layers were dried with MgSO4 and concentrated under reduced 
pressure.  Purification by flash chromatography (60:40 petroleum ether:EtOAc) furnished 
a mixture of diastereomers of methyl 3-(furan-2-yl)-7-hydroxy-2-(2-methoxy-2-
oxoethyl)-8-nonyl-9-oxo-1,6-dioxaspiro[4.4]nonane-2-carboxylate (60)  (1.07 g, 2.23 
mmol, 94% yield) as a clear oil.  Analytical data for 60 (8 diastereomers): 
1
H NMR (400 
MHz, CDCl3) 7.39-7.37 (m, 1H), 6.35-6.26 (m, 2H), 5.78-5.36 (m, 1H), 4.12-4.07 (m, 
1H), 3.86-3.79 (m, 3H), 3.64-3.56 (m, 3H), 2.90-2.15 (m, 5H), 1.62-1.39 (m, 2H), 1.26 
(brs, 12 H), 0.88 (t, J = 6.8 Hz, 3H); LRMS (ESI) exact mass calculated for C25H36O9Na: 
503.23. Found: 503.22. 
 
Trachyspic acid dimethyl ester 9-hydrate (63).  To NaIO4 (1.16 g, 5.43 mmol, 7.0 
equiv) in H2O (18 mL) was added a solution of RuCl3
.
3H2O (10 mg, 0.0383 mmol, 0.05 
equiv) in H2O (3.5 mL).  The solution was stirred at room temperature for 10 min, and 
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then a solution of 60 (373 mg, 0.776 mmol, 1.0 equiv) in EtOAc (18 mL) was added.  
The solution was stirred at room temperature for 5.5 h.  Brine (15 mL) was added, and 
the solution was extracted with EtOAc (3 X 120 mL).  The combined organic layers were 
dried with MgSO4 and concentrated under reduced pressure.  Purification by flash 
chromatography (60:38:2 petroleum ether:EtOAc:HOAc) furnished a mixture of 
diastereomers of trachyspic acid dimethyl ester 9-hydrate (63)  (242 mg, 0.528 mmol, 
68% yield) as a clear oil.  Analytical data for 63 (8 diastereomers): IR (thin film, cm
-1
) 
3460, 2954, 2926, 2855, 1744, 1611, 1439, 1366, 1211, 1178, 1136, 1073; 
1
H NMR (400 
MHz, CDCl3) 5.76-5.39 (m, 1H), 3.88-3.78 (m, 3H), 3.71-3.64 (m, 3H), 3.32-2.09 (m, 
5H), 1.49-1.39 (m, 2H), 1.25 (brs, 12 H), 0.88 (t, J = 6 Hz, 3H); TLC (50:50 EtOAc: 
petroleum ether) Rf 0.16;   LRMS (ESI) exact mass calculated for C13H22O2Na: 481.22. 
Found: 481.21. 
 
Trachyspic acid dimethyl ester (64).  To 63 (467 mg, 1.02 mmol, 1.0 equiv) in pyridine 
(20 mL) at room temperature was added a solution of MsCl (0.120 mL, 1.53 mmol, 1.5 
equiv) in pyridine (5 mL).  The solution was stirred for 17 h and then was diluted with 
Et2O (100 mL).  The solution was washed with 1 M HCl (3 X 50 mL), followed by 
saturated CuSO4 (50 mL).  The organic phase was dried with MgSO4 and concentrated 
under reduced pressure.  Purification by flash chromatography (70:28:2 petroleum 
ether:EtOAc:HOAc) furnished trachyspic acid dimethyl ester (64)  (286 mg, 0.649 mmol, 
64% yield overall; 5:1 mixture of separable spiroketal diastereomers) as a clear oil.  
Analytical data for 64: IR (thin film, cm
-1
) 2926, 2855, 2358, 1746, 1557, 1506, 1437, 
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1371, 1212; 
1
H NMR (400 MHz, CDCl3) 7.89 (s, 1H), 3.93-3.82 (m, 1H), 3.89 (s, 3H) 
3.68 (s, 3H), 3.17 (d, J = 16.4 Hz, 1H), 3.11 (d, J = 16.4 Hz, 1H), 2.71 (dd, J = 13.4, 17.4 
Hz, 1H), 2.39 (dd, J = 7.2, 13.6 Hz, 1H), 2.10 (t, J = 6.8 Hz, 2H), 1.49-1.39 (m, 2H), 1.25 
(brs, 12 H), 0.88 (t, J = 6.8 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) 197.9, 172.7, 172.6, 
171.3, 169.7, 118.3, 107.8, 86.9, 53.6, 52.2, 48.5, 38.9, 37.4, 31.8, 29.5, 29.3, 27.8, 22.6, 
21.1, 14.1; TLC (30:70 EtOAc: petroleum ether) Rf 0.12;  LRMS (ESI) exact mass 
calculated for C22H32O9Na: 463.20. Found: 463.24. 
 
Trachyspic acid trimethyl ester (65).  To 64 (52 mg, 0.118 mmol, 1.0 equiv) in DMF 
(3.0 mL) at 0 °C was added K2CO3 (24 mg, 0.177 mmol, 1.5 equiv) followed by a 
solution of MeI (11 L, 0.177 mmol, 1.5 equiv) in DMF (0.17 mL).  The solution was 
warmed to room temperature and stirred for 5 h.  1 M HCl (3 mL) was added and the 
solution was extracted with EtOAc (3 X 10 mL).  The combined organic phases were 
washed with 1 M HCl (4 X 10 mL), dried with Na2SO4, and concentrated under reduced 
pressure.  Purification by flash chromatography (60:40 petroleum ether:EtOAc) furnished 
trachyspic acid trimethyl ester (65)  (45 mg, 0.099 mmol, 84% yield) as a clear oil.  
Analytical data for 65: IR (thin film, cm
-1
) 2927, 2855, 2359, 1746, 1613, 1438, 1369, 
1210, 1074; 
1
H NMR (600 MHz, DMSO-d6) 8.48 (s, 1H), 3.81 (dd, J = 7.2, 12 Hz, 
1H), 3.71 (s, 3H), 3.65 (s, 3H), 3.56 (s, 3H), 2.94 (d, J = 16.8 Hz, 1H), 2.91 (d, J = 16.8 
Hz, 1H), 2.50-2.47 (m, 1H), 2.40 (t, J = 13.2 Hz, 1H), 2.03 (t, J = 7.8 Hz, 2H), 1.39 (brs, 
2H), 1.28 (brs, 12H), 0.85 (t, J = 7.2 Hz, 3H); 
1
H NMR (400 MHz, CDCl3)7.86 (s, 
1H), 3.91 (dd, J = 7.2, 12.4 Hz, 1H), 3.84 (s, 3H), 3.73 (s, 3H), 3.66 (s, 3H), 3.10 (s, 2H), 
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2.71 (dd, J = 12.8, 13.2 Hz, 1H), 2.32 (dd J = 7.2, 13.2 Hz, 1H), 2.09 (t, J = 7.6 Hz, 2H), 
1.50-1.37 (m, 2H), 1.24 (brs, 12H), 0.88 (t, J = 6.8 Hz, 3H) 
13
C NMR (150 MHz, 
DMSO-d6) 198.1, 175.1, 170.2, 169.9, 169.5, 117.4, 108.1, 86.9, 53.4, 53.0, 52.2, 48.0,  
38.9, 37.7, 31.8, 29.4, 29.2, 27.9, 22.6, 20.9, 14.4; 
13
C NMR (125 MHz, CDCl3) 197.7, 
172.3, 170.5, 169.8, 169.7, 118.3, 107.9, 87.1, 53.3, 52.7, 52.0, 47.8, 38.7, 37.9, 31.8, 
29.5, 29.3, 27.8, 22.7, 21.1, 14.1; TLC (50:50 EtOAc: petroleum ether) Rf 0.53;  LRMS 
(ESI) exact mass calculated for C23H34O9Cs: 587.13. Found: 587.13. 
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